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Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial 
pathogen associated with significant morbidity and mortality. Previous colonisation 
with this pathogen is a risk factor for the development of subsequent infection. Toll-
like receptors (TLRs) are a family of transmembrane receptors of the innate immune 
system that recognize pathogen-associated molecular patterns. The role of nasal 
colonisation of S. aureus has started to receive more attention. In spite of this, there 
are not enough studies looking at its effects on human primary nasal epithelial cells 
and their response to TLR ligands. The respiratory ract itself seems to pose a 
contradiction given by the clinical observation that its upper portion (nasal 
compartment) allows the growth of bacteria, acting like a reservoir, whereas the 
lower portion (lung compartment) reacts with an exuberant inflammatory response to 
the same organisms, as noted during pneumonia. The mechanism related with this 
phenomenon remains to be elucidated. A negative regulator of the TLR signalling 
cascade called toll-interacting protein (tollip) has been demonstrated to induce hypo-
responsiveness in the gastrointestinal tract in the presence of bacteria. So far, tollip 
has not been demonstrated in the respiratory tract. 
 
Aims: To compare the responses of the upper and lower respiratory tract to TLR 
ligands, to characterise the role of tollip in the respiratory tract and its effects in the 




Materials and Methods: The cell line RPMI 2650 (representative of nasal 
epithelium) and the cell line A549 (representative of type II alveolar epithelium) 
were used to establish the cytokine response to stimulation with TLR ligands and to 
demonstrate the presence of tollip protein by immunocytochemistry and enzyme-
linked immunosorbent assay (ELISA). Primary human nsal epithelial and type II 
alveolar epithelial cells were isolated and cultured from consented subjects. The 
cytokine response to stimulation was measured using cytokine bead array and the 
presence of tollip was determined by immunofluorescence and quantitative 
polymerase chain reaction. The presence of TLRs was assessed by 
immunocytochemistry in primary nasal and type II alveolar epithelial cells and the 
response to stimulation with the TLR9 agonist CpG-C ODN was assessed in these 
cells as well as in primary human type II alveolar epithelial cells. Subjects were also 
assessed for nasal carriage of S. aureus and their associated cytokine responses. 
 
Results: The RPMI 2650 cell line, despite retaining phenotypic characteristics of the 
nasal epithelium, appears unresponsive to stimulation with TLR ligands. In contrast, 
the A549 cell line responded significantly to stimulation with TLR ligands. Primary 
human nasal epithelial cells responded by secreting h gher amounts of interleukin 
(IL)-8 and IL-6 in response to stimulation with S. aureus peptidoglycan (PGN) and 
tumour necrosis factor alpha (TNF-α) with a strong trend toward statistical 
significance. These cells did not respond to stimulation with Pseudomonas 
aeruginosa LPS. Primary type II alveolar epithelial cells responded significantly to 
stimulation with S. aureus PGN by increasing the secretion of IL-8, IL-6, IL-1β, 
TNF-α and IL-10 into cultured supernatant. Cells from the upper respiratory tract 
 xvi
displayed a more tolerant phenotype given by the lower levels in cytokine production 
in response to stimulation with S. aureus PGN, in contrast to alveolar epithelial cells. 
TLRs were identified in primary nasal epithelial cels. The negative regulator tollip 
was identified in cell lines as well as primary cells of the respiratory tract in its three 
segments: nasal, bronchial and type II alveolar. It was not possible to demonstrate an 
up-regulation of tollip after stimulation with TLR ligands in any of the cell types 
studied, although, it was possible to observe a significantly higher constitutive level 
in tollip mRNA transcripts from primary nasal epithelial cells in comparison to type 
II alveolar epithelial cells. TLR9 was identified in human primary nasal epithelial 
cells, although it was not possible to observe an increase in cytokine production after 
stimulation with a TLR9 agonist. TLR9 was expressed trongly in primary type II 
alveolar epithelial cells which responded by significantly increasing IL-8 production 
after stimulation with CpG-C ODN. 
Primary nasal epithelial cells from individuals who carry S. aureus exhibit a pro-
inflammatory profile, as evidenced by higher basal levels of IL-8 and IL-6 in 
comparison to non-colonised controls. 
 
Conclusion: The upper respiratory tract epithelium displays a tolerant phenotype in 
response to stimulation with TLR ligands in comparison to the lower respiratory 
epithelium, potentially favouring nasal colonisation by S. aureus. Tollip m-RNA 
transcripts appear to be up-regulated constitutively in the nasal epithelium which 
might favour this response. Staphylococcus aureus colonisation is however 






I would like to acknowledge the Medical Research Council (MRC) that provided the 
grant for my training fellowship which allowed producing this work. 
 
I like to thank to my supervisors Professors John Simpson and Ian Poxton for their 
excellent scientific advice and support during my time in the laboratory and during 
the preparation of this dissertation. 
In addition, I like to thank to Professor Sir John Savill for his encouragement and 
support during my time in his laboratory, as well as to Dr. Simone Brown whom 
thought me the basics of research techniques. 
I also would like to thank Professors Chris Haslett and John Iredale for allowing me 
the opportunity to work in such an intellectually stimulating environment such as the 
Centre for Inflammation Research. 
My gratitude also to fellow group members, particularly Dr. Andrew Conway-Morris 
for technical help, as well as interesting scientific and statistics discussions, Dr. Tom 
Wilkinson for initial help with the molecular biology aspects of the project, Mrs. 
Lesley Farrell for great technical assistance, Dr. Mairi Brittan, Dr. Neil MacDonald 
for advice and help on confocal microscopy, Dr. Kev Dhaliwal and Mr. Richard 
Jones. I also would like to mention Dr. Donald Davidson and members of his group: 
Dr. Hsin-Ni Li for help with the LPS activity assays, Dr. Peter Barlow, Ms. Annie 
Mackellar and Ms. Paula Beaumont for interesting discussions. Special thanks to Dr. 
Paul Fitch from the Schwarze/Immunity and Chronic Iflammation Group based at 
the QMRI for his help with flow cytometry experiments of nasal brushing samples. 
 
 xviii
I should also mention my family, my mother Lucia and my father Hernan for their 
support, as well as my aunt Elsa. 
I want to mention my always beloved daughter Laura Carolina: my inspiration and 
my drive. Dearest Laurita, thanks for all your help and patience during my time in 
the laboratory, as well as during the process of writing this dissertation, your 
imaginative comments and interest in my work were a great incentive during 
challenging times. 
 
Finally, I would like to thank to all the staff at the University and the Queen’s 








All the experiments and procedures presented in this thesis were performed by the 














1.1 Innate Immunity 
The interaction between bacteria and humans has proved t  be an enigma, whereas 
their coexistence has been demonstrated by the fact th t the mitochondria is a 
remnant of bacteria illustrating the nature of the symbiotic relationship during 
evolution (Andersson, S. et al, 2003), the fact thae same bacteria that inhabit 
humans can also provide a lethal challenge for theiimmune system have not only 
produced as a result a very complex immune system but also fuelled a great deal 
of research in both fields: microbiology and immunology. 
 
The innate immune system confers the first line of defence against the 
environment in a host multicellular organism. It can be considered as a collection 
of distinct subsystems or modules that carry out different functions in host defence 
(Medzhitov, R., 2007). These modules consist of mechanical barriers or flushing 
actions (e.g. skin or mucosal epithelium, peristalsis, cilia, fluid flow in urinary 
tract and GI tract), chemicals (gastric acid, sweat, sebaceous secretions and bile), 
production of circulating or mucosal proteins (e.g. acute phase proteins, 
complement, and interferons) and finally, circulating effector cells such as 
phagocytes, natural killer cells, eosinophils, basophils, and mast cells. The final 
desired outcome is the detection, neutralization and killing of invading pathogens, 
restoring homeostasis and allowing the host to survive. Evolution has helped 
multicellular organisms to refine and adapt their immune systems in order to 
 3 
survive. Much initial immunological research was directed toward the fascination 
with the development of antibody responses to infections and the development of 
vaccination due to its strong protective effect by the development of 
immunological memory (Morgan, A. and Parker, S., 2007). However, further 
observation of these responses allowed the realization of the limitations that the 
adaptive immune response itself has including the relatively slow generation of T 
and B cell receptors during the development of these cells and, the need for them 
to be “reinvented” by every generation of lymphocytes (Janeway, C., 1992). 
Furthermore, the time-line needed to achieve such a precise response is around 3-5 
days, by which, if there was not another “more efficient” line of defence, the host 
would certainly succumb to the deleterious effects of the invading pathogen 
(Medzhitov, R. and Janeway, C., 2000). However 1988 heralded a new era in the 
study of immunity, when the first receptor of the Toll family was identified in 
Drosophila melanogaster by Hashimoto, C., et al, 1988 as a key component of a 
signalling pathway controlling dorso-ventral polarity in fly embryos. It was noted 
that it encoded a transmembrane protein with a large extracellular domain 
containing leucine rich repeats (LRRs). Further studies by Gay, N. and Keith, F., 
1991 demonstrated that the sequence of the cytoplasmic domain of the Toll 
proteins was remarkably similar to the cytoplasmic domain of the mammalian 
interleukin-1 receptor. It became apparent later that, the activation of the 
interleukin-1 receptor in humans and Toll in Drosophila generates a cascade of 
events that finally leads to the activation of the ranscription factors of the nuclear 
factor-κB (NF-κB) family. Subsequent linkage to the immune role of T ll was 
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demonstrated in studies by Hoffmann’s group (Lemaitre, B., et al, 1996) when it 
was observed that Drosophila with a loss of function mutation in the Toll gene 
were highly susceptible to fungal infection, although this mutation did not impair 
the response to bacterial infections. We now know that Drosophila has in total 
eight Toll-like proteins and that the other members of the family are programmed 
to recognize bacterial pathogens and induce antibacteri l responses (Imler, J. and 
Hoffmann, J., 2000). It was not until 1997 that human homologues of Toll were 
identified by Janeway’s group and were called Toll-like receptors (TLRs) 
(Medzhitov, R., et al, 1997). The first characterizd receptor was Toll-like receptor 
4 (TLR4) which was shown to induce activation of the NF-κB pathway, and by 
doing so, induce the expression of cytokines and co-stimulatory molecules that are 
necessary for adaptive immune responses. Following the discovery of Toll-like 
receptor 2 (TLR2), it became apparent that mice with a mutation in this protein 
had a normal response to LPS but were resistant to peptidoglycan and lipoproteins, 
which are key components of the cell wall of Gram-positive bacteria (Takeuchi, 
O., et al, 1999; Takeuchi, O., et al, 2000). The study by Wright and others, 
described CD14 as one of the accessory proteins required for the interaction of 
LPS with TLR4 and lipopolysaccharide-binding protein (LBP) (Wright, S., et al, 
1990). 
 
Soon came the discovery that double-stranded viral RNA was recognised 
specifically by TLR3 (Alexopoulou, L., et al, 2001) and that unmethylated 
bacterial DNA is recognized by TLR9 (Hemmi, H., et al, 2000), these allowed for 
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diversity of the system to be recognized as well as the role of the interplay in its 
member proteins. Data also began to emerge suggestin  collaboration among 
different receptors in order to recognise and mount an inflammatory response 
against invading pathogens. Further research provided evidence that TLR1, TLR2 
and TLR6 form an heterodimer to aid the recognition of Gram-positive bacteria 
(Ozinsky, A., et al, 2000) as well as a wider range of pathogens such as Borrelia 
burgdorferi, Treponema pallidum and Mycoplasma fermentans (Khor, C., et al, 
2007). More specifically, tri-acylated bacterial lipoproteins are recognized by 
TLR1/TLR2 (Takeuchi, O., et al, 2002), whereas diacyl ted lipopeptides and 
zymosan (a component of the fungal cell wall) are recognized by TLR2/TLR6 
(Kataoka, K., et al, 2002 and Underhill, D., et al, 1999). Other researchers such as 
Sugawara, I., et al, in 2003 have linked the TLR2 response to Mycobacterium 
tuberculosis and West, A., et al, 2006 to Neisseria spp and Trypanosoma cruzi. 
TLR5 recognizes flagellin from Gram-negative bacteria (Zhang, Z., et al 2005), 
and TLR7 and 8 recognise single stranded RNA (Mogensen, T. and Paludan, S., 




Receptor Localization Ligand Microorganism 
TLR1/2 Cell surface Triacyl lipopeptides Bacteria 
TLR2/6 Cell surface Diacyl lipopeptides 
Lipoteichoic acid 
Mycoplasma 
Gram positive bacteria 
















TLR3 Cell surface / 
endosomes 
dsRNA Viruses 
TLR4 Cell surface LPS Gram-negative bacteria 
TLR5 Cell surface Flagellin Flagellated bacteria 
TLR7/8 Endosome ssRNA RNA viruses 
TLR9 Endosome CpG DNA Bacteria 
Viruses 
 
Table 1.1 Toll like receptors and ligands recognised by the innate immune system. 
dsRNA: double stranded RNA, ssRNA: single stranded RNA. Modified from 
Mogensen, T., 2009. 
 
 
A much clearer picture of how the immune system as a whole functions has now 
emerged. The innate arm provides physical and chemical barriers to infection, 
effector cells able to act in a short period of time and circulatory or mucosal 
proteins which serve as amplifiers and perform the fin tuning of the response. 
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Environmental pressure has allowed for a relatively limited number of receptors 
able to recognize evolutionarily conserved structures of pathogens called 
pathogen-associated molecular pattern (PAMPs) which ave in common the fact 
that they are invariant among entire classes of pathogens, essential for survival 
and distinguishable from the host’s own patterns (Medzhitov, R., 2007). These 
characteristics allow an early and timely recognitio  of dangerous pathogens, in 
order that they be neutralised and killed. 
 
On the other hand, the adaptive immune arm provides elimination of pathogens 
in the late phase of infection and the generation of immunological memory; this 
is achieved by clonal rearrangements from a broad repertoire of antigen-specific 
receptors on lymphocytes which provide specificity. These two systems work 
together orchestrating early pathogen recognition with the beneficial long term 
effects of immunological memory. This was particularly noted after the 
observation by Unanue, E., in 1997 that although innate immunity was crucial 
for controlling an infection, it is insufficient in order to achieve pathogen 
clearance. Although this might be true for symptomatic infections, in contrast, 
asymptomatic infections pose a challenge since little is known about the 
physiological aspects of incomplete clearance of the colonising organism by 
innate host-defence mechanisms. 
 
Other more recently discovered components of the innate immune system 
include retinoic acid-inducible gene I (RIG-I)–like receptors (RLRs), and 
 8 
nucleotide-binding oligomerization domain (NOD)-like receptors among others, 
but their mechanisms of action are out of the scope of the current discussion. For 
further information about these please refer to the review by Mogensen, T., 2009. 
Since the main focus of this research is in the innate immune response to 
bacterial pathogens, I will focus further on the TLRs that are primarily involved 
in this part of the immune response. 
 
1.1.1 TLR2 signalling 
The original clue about the role of TLR2 in the host response to staphylococcal 
infection was given when TLR2 knockout mice were noted to be highly 
susceptible to S. aureus (Takeuchi, O., et al, 2000). During a model of intra asal 
infection, Gonzalez-Zorn, B., et al, 2005 noted that TLR2 deficient mice had a 
10-fold higher nasal carriage of S. aureus when compared to wild type mice. 
 
Human TLR2 is a type I transmembrane protein composed of an intracellular 
(Toll/Interleukin-1 receptor homology domain,-TIR domain), a transmembrane 
and extracellular domains, in which the N-terminal domain is represented in the 
extracellular portion. It is different from the other TLRs because requires 
heterotypic interaction with TLR1 and TLR6  which accounts for the recognition 
of a wide range of PAMPs (Ozinksky, A., et al, 2000 and Takeuchi, O., et al, 
2002). 
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When Jin, M., et al, 2007 resolved the crystal structure of TLR2 and TLR1, they 
showed that, the high content of leucine rich repeats (LRR) gives the receptor its 
concave surfaces and that TLR1 and TLR2 were formed as two parts of a m-
shape complex with the lipopeptide Pam3CSK4 in the middle binding the two 
receptor proteins together, the two N-terminal domains extending outwards in 
opposite directions and the LRRCT molecules converging at the centre (Jin, M., 
et al, 2007 and Jin, M., and Lee, J., 2008). The TLR1/TLR2 dimer recognizes 
triacylated lipopeptide (Miyake, K., 2007). Triantafillou, M., et al, 2006 showed 
using fluorescence techniques that the TLR2/TLR1 heterodimers and 
TLR2/TLR6 pre-exist and internalize with the ligand as their formation is not 
induced by agonists to the complex or PAMPs. The situation differs with 
TLR2/6, as they recognise diacylated lipopeptide and there are important 
changes in the dimerization interface that promotes heterodimerization, and the 
interaction of the complex with the lipid scavenger r ceptor molecule CD36 is 
not preformed but induced by the ligand (Triantafilou, M., et al, 2006), they also 
respond to stimulation with zymosan, a component of the fungal cell wall 
(Underhill, D., et al, 1999; Zahringer, U., et al, 2008; Miyake, K., 2007 and 
Kataoka, K., et al, 2002).  
 
Activation by the ligand promotes dimerization of the receptor and the TIR 
domains of TLR2 and MyD88 bind. The presence of the adaptor protein MyD88 
(myeloid differentiation protein) and TIRAP/Mal (TIR associated protein and 
MyD88-adaptor like protein) are crucial for the transduction of the signal since 
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Takeuchi, O., et al in 2000, noted that mice deficint in MyD88 were more 
susceptible to systemic infection with S. aureus in comparison to wild type mice 
(Figure 1.1). Further explanation of the responses associated with the MyD88 


















Figure 1.1 Mechanism of TLR-2/1 signalling.  
Interaction of S. aureus with TLR2/1 heterodimer is followed by binding of the 
TIR portion of the receptor with MyD88, which subsequ ntly recruits IRAK and 
associates with TRAF. TRAF ubiquitinates itself and activates TAK1. TAK1 
mediates the activation of IKK complex which result in the phosphorylation  of 
the inhibitor IκB protein which is followed by the translocation to the nucleus 
and activation of NF-κB, inducing the release of pro-inflammatory cytokines IL-
8 and IL-6.  
TIR domain, Toll/Interleukin-1 receptor homology domain; IRAK, IL-1 
Receptor associated kinase; Tollip, toll-interacting protein; TRAF6, TBF-
receptor associated factor 6; TAK1, transforming growth factor-activated 
protein kinase 1; IKK, IκB kinase. 
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Infection with S. aureus is also highly associated with sepsis and septic shock 
(Ammerlaan, H., et al, 2009 and Artero, A., et al 2010). This response happens 
when some of the main components of its outer membrane enter in contact with 
cells of the innate immune system. Under these circumstances and particularly 
due to the actions of TLR2, the peptidoglycan (PGN) and lipoteichoic acid 
(LTA) from this bacterium activate a pro-inflammatory cascade which is then 
associated with the release of pro-inflammatory cytokines into the bloodstream 
such as IL-1 and TNF-α which cause the increase in temperature (fever), 
recruitment of white blood cells (leukocytosis), increase of cardiac rate and 
respiratory rate that give the clinical presentation of sepsis. 
 
1.1.2 TLR4 signalling 
Janeway proposed LPS as the key molecule being recognised from pathogenic 
microorganisms due to its potent stimulatory properties in immune cells 
(Janeway, C., 1989). TLR4 was the first characterized receptor shown to induce 
activation of the NF-κB pathway, in response to LPS, this discovery was 
followed by Schumann’s and coworkers in 1990 when they noted that a serum 
protein they called LPS binding protein (LBP) had the ability to solubilise LPS 
from the bacterium (Schumann, R., et al, 1990) and transfer it onto the leukocyte 
external membrane protein CD14 (Wright, S., et al, 1990). CD14 increases the 
sensitivity of leukocytes to LPS and reduces the binding affinity to picomolar 
concentrations. This allows transfer of LPS to the accessory molecule MD-2 
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which is associated with the extracellular domain of TLR4 (Gioannini, T., et al, 
2004 and Gruber, A., et al, 2004). Recent studies have established that the TRL4 
extracellular domain forms a rigid curved solenoid-like structure with MD-2 
bound at two conserved sites in the amino-terminal region of TLR4 (Kim, H., et 
al, 2007 and Ohto, U., et al, 2007). The binding of the LPS ligand is followed by 
conformational changes in the receptor and homodimerization of the two 
cytoplasmic Toll interleukin-1 receptor domains (TIR) (Bryant, C., et al, 2010 
and Saitoh, S., et al, 2004). The association of the TIR domains provides a 
scaffold for the recruitment of adaptor proteins to form an active signalling 
complex. The TLR4 pathway is particularly complex and requires the 
involvement for four different adaptors: MyD88, Mal, TIR domain-containing 
adaptor inducing IFN-β (TRIF) and TRIF-related adaptor molecule (TRAM) 
(Mogensen, T., 2009). The final outcome is two major signalling pathways, one 
involving MyD88, which induces the activation of NF-κB and mitogen-activated 
protein kinases (MAPK), as well as the activation of the transcription factor 
activator protein1 (AP1) (Chang, L., and Karin, M., 2001), these control the 
induction of proinflammatory cytokines. The second pathway is independent 
from MyD88 but dependent on TRIF, this event activates the transcription factor 
interferon regulatory factor 3 (IRF3), which then promotes the transcription of 
Interferonβ  and the chemokine regulated upon activation normal T cell 
expressed and secrete (RANTES), as well as of Interferon inducible genes 
(Bryant, C., et al, 2010). This pathway also appears to mediate a late phase NF-
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κB activation which potentiates the on-going inflammatory response that the 






























Figure 1.2 Mechanism of TLR-4 signalling.  
Interaction with LPS is followed by binding of the TIR portion of the receptor 
with MyD88, which signals as described earlier and is associated with the 
production of proinflammatory cytokines. The TRAM dependent pathway 
stimulates the activation of IRF3 which induces interferon production and 
interferon associated genes  
IRAK, IL-1 Receptor associated kinase; Tollip, toll-interacting protein; TRAF6, 
TBF-receptor associated factor 6; TAK1, transforming growth factor-activated 
protein kinase 1; IKK, IκB kinase; TRAM, TRIF-related adaptor molecule; 
TRIF, TIR domain-containing adaptor inducing IFN-β; IRF3, interferon 
regulatory factor 3; IFN, interferon. 
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1.1.3 TLR9 signalling 
The original observation of the role of bacterial DNA on the inflammatory 
response was performed in 1984 by Tokunaga, T. and coworkers, when they 
observed that bacterial DNA isolated from Mycobacterium bovis strain BCG had 
strong antitumor effects given by the regression and prevention of metastasis of a 
carcinoma in CDF-1 mice and line 10 tumor of strain 2 guinea pigs. They went 
further and synthesized oligonucleotides derived from the same strain and 
observed that specific oligonucleotide sequences were associated in inducing the 
activation of natural killer cells (NK) and also stimulated mouse spleen cells to 
produce interferon (IFN) alpha and gamma (Tokunaga, T., et al, 1992). These 
observations triggered a great interest in the potential use of bacterial DNA 
synthetic oligonucleotides as potential antitumour agents. Further studies 
demonstrated in detail the stimulatory effects that b cterial DNA has on 
mammalian immune cells and attributed these activities o the presence of 
unmethylated CpG dinucleotides which are highly abundant in prokaryotic DNA. 
Finally by 2000, Akira’s group published the sequence of TLR9 (Hemmi, H., et 
al, 2000). In their study they created TLR9-/- mice which were completely unable 
to respond to stimulation with CpG DNA, but yet retained the ability to increase 
cytokine production in response to LPS challenge. Whilst wild type mice died 
after a lethal injection of CpG DNA, the TLR9 deficient mice not only showed 
resistance, but also failed to increase serum pro-inflammatory cytokine levels, in 
addition it was also noted that the CpG DNA induced TH1 response was 
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abolished. They also determined that TLR9 signals through the use of the adaptor 
molecule MyD88. Using wild type mouse macrophages they observed that 
stimulation with CpG DNA increased the DNA binding activity of NF-κB, in 
contrast, mutant mice showed no increase in NF-κB activity after CpG DNA 
stimulation, whilst both strain’s macrophages responded to LPS stimulation. 
Furthermore, when using an i  vitro kinase assay, it was observed that wild type 
macrophages activated c-Jun N-terminal kinase (JNK) and IRAK in response to 
stimulation with CpG DNA, whilst activation of both kinases was completely 
abolished in TLR9 null macrophages.  
 
Establishing the actual localization of the receptor proved challenging but the 
observation that inhibitors of endosomal maturation such as bafilomaycin A or 
chloroquine abolish CpG mediated cell activation, suggests that endosomal 
maturation precedes cell activation (Hemmi, H., et al, 2000). It appears that the 
intracellular localization of the receptor acts a self protection mechanism as other 
receptors implicated in the recognition of DNA such as TRL7 and TLR8 are also 
located intracellularly as a manner to avoid auto-immunity (Christensen, S., et al, 
2005 and Christensen, S., et al, 2006). The exact localization of the receptor and 
the kinetics involved with it, still remain to be defined since multiple reports 
colocalize it within the early and late endosomes, lysosomes and the endoplasmic 
reticulum (Barton, G. and Kagan, K., 2009).  
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The TLR9 pathway appears to behave similarly to the ot r TLRs in that it also 
signals through a MyD88 dependent route as demonstrated by the observation 
that dominant negative versions of MyD88, IRAK and TRAF inhibit CpG 
mediated cellular activation, furthermore, mutant mice lacking TLR9 or MyD88 
fail to mount an immune response after exposure to CpG (Hacker, H., et al, 
2000). The final outcome is the activation of the transcription factor NF-κB with 
















Figure 1.3 Mechanism of TLR9 signalling 
CpG oligonucleotides are internalised through endocytosis, TLR9 is located 
within the endosomal vesicles and this transduces an intracytoplasmic activation 





1.2 Mechanism of action of the TLR pathway 
Once the TLR has engaged its ligand, it starts triggering a cascade of events using 
different adaptors which modulate the specificity of the response. The pathways 
can be classified according to the use of specific adaptors (dependent or 
independent of MyD88 or TRIF and also on the activation of different 
transcription factors (NF-κB, mitogen-activated protein kinases (MAPKs) and 
interferon regulatory factors (IRFs) (Medzhitov, R., 2007 and Mogensen, T., 
2009). 
 
Numerous studies by Hemmi, H., et al, 2002, Horng, T., et al, 2002 and 
Yamamoto, M., et al, 2002, Yamamoto, M., et al, 2003 and Yamamoto, M., et al, 
2003 inferred that MyD88 is the main adaptor molecul  sed by most TLRs, 
except TLR3 (Akira, S. and Takeda, K., 2004). Specifically for TLR4, other 
adaptors such as Mal, TRIF and TRAM are involved in signal transduction. For 
the purposes of this thesis I will focus on the MyD88 dependent pathway. 
 
In response to stimulation, MyD88 is associated with the cytoplasmic tail of the 
TLR and recruits members of the interleukin-1 receptor associated kinase (IRAK) 
family (Burns, K., et al, 1998). Subsequently, IRAK4 and IRAK1/2 are 
phosphorylated sequentially allowing the association with TNF-receptor-
associated factor 6 (TRAF6) (Suzuki, N., et al, 2002). A key step follows when 
TAK-1 binding protein 2 (TAB2) and TAB3 are recruited to the ubiquitinated 
 18 
TRAF6, bringing TAK1 into proximity to the signalling complex, allowing its 
activation. TAK1-mediated activation of the IκB kinase (IKK) complex results in 
site specific phosphorylation of the inhibitory protein IκB (Wang, C., et al, 2001). 
Once phosphorylated, IκB undergoes proteasomal degradation allowing activation 
and translocation of the transcription factor NF-κB to the nucleus, where it binds 
to κB sites present in promoters and enhancers of a range of pro-inflammatory 
genes, which start being transcribed. NF-κB plays a pivotal role in the induction of 
inflammation given its ability to induce pro-inflammatory cytokines such as IL-1, 
IL-6, tumour necrosis factor-alpha (TNF-α) and chemokines such as IL-8 and 
regulated upon activation, normal T cell expressed an  secreted (RANTES) 
(Mogensen, T., 2009). The final result is the activation and recruitment of 
leukocytes to sites of inflammation, enhanced phagocytosis of microbes, and 
cellular lysis through complement or NK cell activaon and enhanced antigen 
presentation. 
 
The inflammatory cytokines are produced by many cell types, particularly by 
macrophages and mast cells, their roles include activation of the endothelium and 
leukocytes as well as the induction of the acute-phase response. In addition 
chemokines which have been demonstrated to be produced by several cell types 
control leuckocyte extravasation and chemotaxis towards affected tissues 
Medzhitov, R., 2008). For a list of the cytokines involved in innate immunity in 
which I will focus during this work please see Table 1.2. 
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Cytokine Principal cell source Cell target Biological effects 
TNF Macrophages, T & B 































 Migration into tissues 
IL-6 Macrophages, 
endothelial cells, T 




Synthesis acute phase proteins 
Proliferation of antibody 
producing cells 




 T cells 
TH1 differentiation 
IFN-γ synthesis, increased 
cytolytic activity 
IL-10 Macrophages, T cells 
(mainly TH2), Treg 
cells 
Macrophages,  
T & B cells 
Dendritic cells 
Inhibition of IL-12 production 
Expression of costimulators 
and class II MHC molecules 
 
Table 1.2 Summary of some of the cytokines involved in the innate immune 
response. 
Modified from Tedgui, A., and Mallat, Z., 2006. 
 
As the main focus of this research is the innate immune response to bacterial 
pathogens in the respiratory system, I will focus on this system. 
1.3 Innate immunity in the respiratory system 
The respiratory system has been divided for its study in upper and lower tracts.  
The upper tract includes the nose, nasopharynx and larynx; is lined by mucous 
membranes on a vascular bed with ciliated epithelium in the surface. The lower 
respiratory tract includes the trachea and bronchi, w ch are lined with ciliated 
epithelium up to the terminal bronchioles that branch further leading to clusters of 
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alveoli. The alveoli are composed of two specialized cell types: the flattened 
squamous type I epithelial cells, which constitute approximately 93% of the 
alveolar epithelial surface area and type II epithelial cells which are cuboidal in 
shape, produce surfactant and also have the ability to proliferate and reconstitute 
the type I cells after lung injury (Crapo, J., et al, 1982 and Crompton, G., et al, 
1999). 
 
Although these anatomical divisions are useful for its study, functionally and 
immunologically, the respiratory system can be divided into: conducting airways 
and lung parenchyma; due to the different cell populations residing as well as to 
the differing levels of exposure to inhaled antigens throughout (Holt, P., et al, 
2008). The conducting airways are lined with ciliated cells and secretory goblet 
cells that produce IgA and allow the mucocilliary clearance of inhaled antigens. 
The mucosa contains dendritic cells, T cells, B cells and macrophages. The airway 
mucosal dendritic cells are specialized for surveillance but lack the ability to 
efficiently present antigen (Stumbles, P., et al, 1998) T cells are also found in 
relatively high numbers in both: within the mucosa and in the underlying lamina 
propia. Furthermore, the airway mucosa also contains s tes known as bronchial-
associated lymphoid tissue (BALT) which resemble th tonsillar tissue or Peyer’s 
patches in that they are discrete lymphoid cell aggre ates underlying specialised 
epithelium (Moyron-Quiroz, J., et al, 2004). 
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The upper conducting airways are chronically exposed to pathogenic bacteria as 
well as to non-pathogenic environmental antigens, i order to avoid a continuous 
state of immunological activation, a specific clone of T cells with positive markers 
for Forkhead box P3 (FOXP3)+CD4+CD25+ regulatory T (TReg) cells, have been 
demonstrated to play a key role in the protection against the inflammatory 
consequences of airway infections and in protection against the development of 
allergies (Chen, C., et al, 2006; Holt, P., et al, 2008) 
 
Because of its proximity to the exterior, the upper r spiratory tract provides an 
attractive route to deliver medications to the lung compartment, for the study of 
the local response to pharmacological compounds, several cell lines have been 
used for the study of the cellular behaviour of the upper respiratory tract (Schmidt, 
M., et al, 1998). The cell line RPMI 2650 derived from an anaplastic squamous 
cell carcinoma of the nasal septum has been describd as a suitable model for 
study of nasal cell behaviour since it closely resembl s the nasal epithelium with 
respect to karyotype and cytokeratin polypeptide expr ssion pattern (Salib, R., et 
al, 2005 and Bai, S., et al, 2007). This cell line has been reported to produce the 
cytokine transforming growth factor-β (TGF-β) as an autocrine growth factor. 
The identification of potentially pathogenic antigens is facilitated by TLRs. 
Several groups have established the presence of TLRs in nasal epithelial tissue and 
primary cells in relation to primary nasal pathology (Wang, J., et al, 2007; Lane, 
A., et al, 2006; VanderMeer, J., et al, 2004). 
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The lung parenchyma comprises the alveoli which are separated by thin walls of 
interstitium containing pulmonary capillaries located in close contact with the 
alveolar space. During homeostasis, the main leukocyte population is made of 
alveolar macrophages (more than 90%) and the remainder are dendritic cells and T 
cells (Holt, P., et al, 2008). Airway epithelial cells constitute the first line of 
defence, not only do they form a physical barrier, but actively secrete into the 
interstitial fluid molecules such as mucins, surfactant, complement and 
complement cleavage products as well as antimicrobial peptides such as defensins, 
secretory leukocyte protease inhibitor (SLPI), elafin mong others (Holt,  P., et al, 
2008). The production of antimicrobial peptides has l o being noted as 
respiratory secretions possess antimicrobial activity (Travis, S., et al, 1999). SLPI, 
has been noted to have antimicrobial activity against Gram-negative and Gram-
positive bacteria which is dependent on its N-terminal domain (Hiemstra, P., et al, 
1996).  
 
In addition, the lung epithelium also modulates airw y smooth muscle activity, 
amplifies the host response to microorganisms through the secretion of 
chemokines and cytokines among other functions (Mayer, A. et al, 2007 and Holt, 
P., et al, 2008). 
 
For its study, several researchers have used in-vitro models with cell lines from the 
lower respiratory tract, the most commonly used model constitutes the A549 cell 
line, which was established in 1972 by Lieber and coworkers from a human 
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alverolar cell carcinoma (Lieber, M., et al, 1976). Burvall, K., et al, 2003 
determined that A549 cells constitutively produced the cytokines IL-8 and IL-6. 
Stimulation with TLR ligands has been associated with an increase in the cytokine 
secretion by these cells. Further work (Droemann, D. et al, 2003) identified the 
presence of TLR2 in these cells and (Guillot, L. et al, 2004) provided the evidence 
for a LPS-TLR4 dependent signalling pathway arguing the in the respiratory tract 
this receptor is sequestered in the cytosol as a way to maintain homeostasis. 
Although cell lines have helped greatly to the understanding of basic cellular 
behaviour, they have limitations related particularly in the case of cancer derived 
cell lines with the fact that their precursors are far from normality and therefore 
establishing assumptions of normal physiological using these models is 
inappropriate.  
The establishment of primary cell culture techniques for the study of human cells 
of the respiratory tract has proven challenging but it has been achieved by several 
groups (Dobbs, L., 1990; Witherden, I., et al, 2004 and Fuchs, S., et al, 2003). 
  
1.4 Negative regulation of the TLR pathway 
The innate immune system can act as a double edged sword: on one hand it is 
necessary to detect, neutralise and kill invading microorganisms by the induction 
of inflammatory responses. On the other, an excessiv  inflammatory state will be 
detrimental for the host. There are several lines of evidence that determined the 
existence of an extensive negative regulator mechanism of the inflammatory 
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cascade in which the TLRs are involved (Cario, E., and Podolsky, D., 2005; Liew, 
F., et al, 2005; Shibolet, O. and Podolsky, D., 2007). These can be classified by 
their site of action: 1) extracellular: soluble decoy TLRs (Iwami, K., et al, 2000; 
LeBouder, E., et al, 2003); 2) membrane: reduced expression of TLRs (Otte, J., et 
al, 2004 and Otte, J. and Podolsky, D., 2004); 3) intracellular: short spliced forms 
of MyD88(MyD88s) (Burns, K., et al, 2003; Janssens, S., et al, 2002), interleukin-
1 receptor-associated kinase-M (IRAK-M) (Kobayashi, K., et al, 2002; Wesche, 
H., et al, 1999), suppressor of cytokine signalling (SOCS-1) (Kinjyo, I., et al, 
2002; Nakagawa, R., et al, 2002), NOD2 (Watanabe, T., et al, 2004; Watanabe, T., 
et al, 2005), Toll-interacting protein (Tollip) (Burns, K., et al 2000; Cario E., and 
Podolsky, D., 2005), the ubiquitin modifying enzyme A20 (Boone, D., et al, 2004; 
Krikos, A., et al, 1992; Opipari, A., et al 1990) and 4) nuclear: inhibitors affecting 
transcriptional output such as peroxisome proliferators-activated receptor-γ 
(PPARγ) (Dubuquoy, L., et al, 2003; Dubuquoy, L., et al, 2006), activating 
transcription factor 3 (ATF3) (Gilchrist, M., et al, 2006) and the tumour 
suppressor cylindromatosis (CYLD) (Yoshida, H., et al, 2005). 
 
The gastrointestinal tract is a good example of a system constantly being 
challenged by exogenous and endogenous bacterial products. Furthermore, its role 
in the induction of immunological tolerance has been stablished by the discovery 
by Melmed and colleagues in 2003 that human intestinal cells are unresponsive to 
TLR-2 bacterial ligands. There are two reasons for these findings: first, the fact 
that intestinal epithelial cells express low levels of TLR2 and TLR6 and second, 
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the fact that these cells display high expression levels of tollip. These findings 
were corroborated by Otte, J., et al, 2004 when they also noted that intestinal 
epithelial cells responded to a short-term stimulation with LPS or lipoteichoic acid 
(LTA) by displaying a pro-inflammatory phenotype, whereas prolonged 
incubation with the same ligands was associated with an hyporesponsive state of 
the cells with no reactivation after a second challenge with bacterial products 
(nevertheless, the cells remained responsive to stimulation with TNF). On closer 
examination of the hypo-responsive cells they also noted a decrease in TLR 
surface expression but more markedly an increase in tollip mRNA and protein 
expression which seems to be likely to contribute to the tolerant state of these 
cells. 
 
1.5 Tollip (Toll-interacting protein) 
 
Tollip could possibly be best described as an endocytic adaptor protein (Brissoni, 
B., et al, 2006). Endocytic adaptors are proteins with domains for protein-protein 
or protein-lipid interactions and sites that lack catalytic ability for inducible post-
translational modifications. They act at the junction between signalling and 
endocytosis (Katoh, Y., et al, 2004; Maldonado-Baez, L., and Wendland, B., 
2006) and have a modular design consisting of combinations of discretely folded 
domains and unstructured regions that contain multiple peptide-binding motifs and 
it is this property that allows them to simultaneously interact with numerous 
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partners in an apparently synchronized fashion. The interactions can be classified 
depending on the interacting partner as lipid-adaptor, cargo-sorting-signal adaptor 
and accessory protein-adaptor interactions. The regulation of these adaptors 
happens through two main mechanisms: phosphorylation nd ubiquitination. 
 
First identified in 2000 by Burns and coworkers, through a yeast-two hybrid 
screen using the IL-1R accessory protein, in mice, tollip is a small protein 
consisting of 274 amino acids (a.a.). Using database searches, they identified 
homologues of tollip in humans and the nematode Ca norhabditis elegans which 
share 97% and 41% sequence identity respectively. Tollip messenger RNA 
(mRNA) species have been detected in a variety of tissues in mice including heart, 
lung, brain and testis (Burns, K., et al, 2000). 
 
In humans, the Tollip gene is located on chromosome 11p15 and it comprises 6 
exons that can be transcribed in at least four different isoforms (Schimming, T., et 
al, 2007). The gene codes for the full length tollip, which is a 274 a.a. protein. It 
appears to be a highly alternatively spliced gene generating several coding and 
non-coding variants. Alternate transcription of TLR pathways is a mechanism for 
generating combinatorial expansion of possible signalling outcomes, including 
repression of signalling at multiple points in the cascade (Jaresova, I., et al, 2007). 
The study from Wells, 2006 performed a systematic analysis of the FANTOM3 
mouse data set, they found that as well as the adaptor molecules, the kinases in the 
TLR pathway produced multiple variant protein products through alternate 
 27 
splicing. Their data set found a novel 220 a.a. tollip isoform generated from an 
alternate terminating exon that lacks the amino-terminal CUE domain. They 
predict that this amino-terminal truncated variant could exacerbate inflammatory 
signalling through TLR and IRAK pathways (Wells, C.et al, 2006)  
 
Lo and coworkers, identified four variants: the human canonical form Tollip A 
transcribed from six exons, translating into a 274 a.a. protein with 94% a.a. 
identity to mouse Tollip a; Tollip B transcribed from five exons, (skipping exon 2) 
translated into a 224 a.a. protein with no Tom1 binding domain; Tollip C also 
transcribed from five exons, (skipping exon 3) transl ted into a 213 amino acid 
protein that lacks the C2-like domain; and Tollip D  initiated from an alternate 
exon 1, transcribed across six exons, translated into a protein product of 205 
amino acids (Lo, Y., et al, 2009).  Three Tollip variants are detected in human 
peripheral blood monocytes and the four variants were also detected across a range 
of tissues with a brain-enriched profile which shows abundant expression of Tollip 
A (2.5 times more abundant than Tollip B and Tollip C). Analysis of Tollip 
transcripts in human and mouse has demonstrated rapi  diversification of exon 
usage in this locus. A high proportion of macrophages expressed the canonical 
variant A as well as the human-specific variant Tollip B and only a small subgroup 
of the human monocytes in the population expressed Tollip C. These findings 
reveal that expression of Tollip variants in different macrophages provides a 
mechanism for diversifying innate immune signalling. All of the human tollip 
protein isoforms studied by this group retained the C-terminal regions including 
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the coupling of ubiquitin conjugation to endoplasmic reticulum degradation (CUE) 
domain. (Lo, Y., et al, 2009) 
 
1.5.1 Tollip protein structure 
Three main functional domains have been described in tollip: the Tom1 binding 
domain (TBD), a C2-like domain in the N-terminal porti n and a CUE domain at 





















Figure 1.4 Tollip protein domains. 
TBD: Tom1 binding domain, C2, C2 domain and CUE coupling of ubiquitin (Ub) 
binding to endoplasmic reticulum domain. Adapted from Lo, Y., et al, 2009. 
 
 
1.5.1.1 Tom1 binding domain (TBD) 
The TBD was identified by Yamakami and colleagues who also described 
Tom1 as a novel ubiquitin binding protein. It was noted that Tom1 interacts 
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with Tollip forming a high molecular mass complex both in vivo and in vitro 
(Yamakami, M., et al, 2003). They also found that the N-terminal portion is 
required for the interaction with the GGA and Tom1 domain (GAT) domain of 
Tom1. It has been observed that there are direct interactions of Tom1 and tollip 
with ubiquitin chains and that the ubiquitin binding capacity of Tom1 is not 
suppressed by the presence of tollip or vice versa suggesting that both Tom1 
and tollip in the complex can bind with the ubiquitin chains simultaneously. 
They also propose a model in which a complex of Tom1 and tollip, (both of 
which are capable of binding with polyubiquitin chains) recruits 
polyubiquitinated proteins to clathrin, one of the main proteins involved in 
endocytosis (Yamakami, M., et al, 2003). 
 
1.5.1.2 The C2 domain 
The C2 domain, in the central and most conserved region, is responsible for 
association with endosomal membranes. The C2 domain is a calcium binding 
domain and by selectively binding phosphatidylinositol-3’-phosphate 
(PtdIns(3)P) and phosphatidylinositol-3,4,5-phosphate (PtdIns(3,4,5)P) which 
are downstream products of PI3 kinase, it has been shown to be involved in 
multiple signalling events and trafficking (Li, T., et al, 2004). Treatment with 
the PI3 kinase inhibitor wortmannin alleviated tollip mediated suppression of 
NF-κB. It was noted that the disruption of the C2-like domain of tollip disrupts 
the negative regulation that tollip exerts on LPS induced NF-κB activation, 
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implying that this domain plays a vital role in controlling TLR4 mediated 
signalling events (Li, T., et al, 2004). 
 
1.5.1.3 The coupling of ubiquitin binding to endoplasmic reticulum (CUE) 
domain 
The CUE domain is situated at the C-terminal end of tollip (Brissoni, B., et al, 
2006)  and is crucial for its interaction with the IL-1R. The CUE domain is also 
found in proteins involved in endosomal functions (Katoh, Y., et al, 2004).  
 
The importance of this domain was observed by Brissoni and colleagues: they 
were aware that following stimulation with IL-1, the type I interleukin-1 receptor 
(IL-1RI) is rapidly internalised and conjugated by multiple monoubiquitin 
moieties. After they generated of a tollip mutant at the MFP (methionine-
phenylalanine-proline) motif (residues 240-242) in the CUE domain (which is 
also a high affinity ubiquitin binding site), they observed that the mutation 
rendered tollip incapable of binding IL-1RI. They also showed that tollip is 
necessary for sorting of IL-1RI in late endosomes since it was noted in tollip 
deficient cells that significant levels of IL-1RI remained present in late 
endosomes after 3-6 hours post-stimulation. This accumulation of IL-1RI could 
be reversed by stable reconstitution of tollip-defici nt cells with tollip but was 
not observed when empty vector was used, indicating that tollip and its capacity 
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to act as an ubiquitin receptor for IL-1RI is required for efficient sorting in late 
endosomes.  
 
Tollip’s CUE domain is also required for efficient degradation of IL-1RI. Tollip 
has specificity for endocytic cargo, which includes IL-1RI and other 
ubiquitinated TIR-family receptors (TLR2,4) with whic  it interacts through this 
domain (Zhang, G., and Ghosh, S., 2002). The regions around the CUE domain 
of tollip bind to unphosphorylated IRAK under resting conditions and also 
associate transiently with the TLRs and IL-1R upon stimulation. The same 
region can also be phosphorylated by IRAK. After activation, IRAK 
phosphorylates tollip, which leads to the dissociation of tollip from the complex. 
Exposing the CUE domain on tollip led to subsequent degradation by 
ubiquitination. The removal of tollip allows signalling to continue by freeing 
activated IRAK to bind to downstream TRAF6 (Zhang, G. and Ghosh, S., 2002).  
 
1.5.2 Mechanism of action of tollip 
Tollip seems to block ligand-independent Toll signalli g. Immunoprecipitation 
experiments using HEK293T cells by Burns et al, showed that tollip is associated 
with type I interleukin-1 receptor (IL-1RI) and IL-1R-associated protein (IL-
1RAcP) during the resting state. They also showed that ollip binds to IL-1 
receptor associated kinase (IRAK) only in unstimulated cells, suggesting that 
Tollip-IRAK complexes are preformed in the cells. 
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Stimulation with IL-1β induces the aggregation of IL-1RI and IL-1RAcP, as well 
as the independent recruitment of MyD88. The binding of MyD88 and the tollip-
IRAK complex, allows the death domains of MyD88 and IRAK to interact 
inducing progressive autophosphorylation of IRAK and causes dissociation of 
the complex. The inability to co-immunoprecipitate tollip and MyD88 suggests 
that they exist in distinct protein complexes, these findings are consistent with 
previous observations that both molecules are recruit d independently to the IL-
1R after stimulation (Burns, K., et al, 2000). 
 
It has also been shown that the tollip-IRAK association takes place with the N-
terminus side of IRAK and not with other death domain (DD) containing 
proteins (Burns, K., et al, 2000). The observation hat tollip translocates to the 
membrane after stimulation with IL-1β, suggests that IRAK and tollip could be 
recruited in a complex and following IRAK phosphorylation, the complex may 
be disrupted. Furthermore, when tollip was co-expressed after IRAK over 
expression, IRAK activation was blocked suggesting hat spontaneous activation 
of IRAK could be blocked once it is complexed with tollip (Burns, K., et al, 
2000). 
 
In addition to undergoing autophosphorylation, IRAK also phosphorylates tollip. 
Phosphorylation of tollip by activated IRAK may facilitate the dissociation of 
IRAK from tollip thereby allowing IRAK to escape the inhibitory effect of tollip 
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and subsequently modifying downstream signalling comp nents (Burns, K., et al, 
2000). 
 
Studies by Li and coworkers using IRAK-deficient cells have shown that 
phosphorylation of IRAK is required for it to dissociate from the receptor and 
transduce signals to downstream molecules leading to NF-κB activation (Li, X., 
et al, 1999). Moreover, it is possible that phosphorylation of tollip may facilitate 
its dissociation from IRAK and subsequent degradation by ubiquitination as 
demonstrated by the fact that tollip contains a highly conserved CUE domain at 
the C terminus (230-270). As mentioned previously, imilar domains in other 
proteins recruit ubiquitin conjugating enzymes, leading to proteosome dependent 
degradation (Zhang, G., and Ghosh, S., 2002). 
 
Tollip has the ability to associate with TLR2 and TLR4. This was demonstrated 
by Bulut, Y., et al, 2001, when it was co-immunoprecipitated with TLR2 and 
TLR4 in human dermal and endothelial cells. Furthermore, Zhang et al showed 
that HA (haemagluttinin) tagged-tollip coprecipitates efficiently with TLR2 and 
TLR4 but it was significantly enhanced with the latter by the presence of MD-2, 
this suggests that structural changes in the cytoplasmic domain of TLR4 induced 
by MD2 are necessary for efficient binding to tollip (Zhang, G., and Ghosh, S., 
2002). When Bulut, over-expressed tollip, they showed that it inhibits TLR2 and 
TLR4 mediated NF-κB activation in a dose-dependent manner in 293 T cells. 
This suggests that this molecule is also shared among the IL-1R, TLR4 and 
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TLR2 signalling pathways and that it limits proinflammatory signals from the 
innate immune system (Bulut, Y., et al, 2001). Moreover, in a study by Zhang, 
using dominant negative TLRs (truncated versions of TLRs that lack the 
intracellular signalling TIR domain) it was demonstrated that the sensing of 
Pseudomonas aeruginosa by human airway epithelial cells (HAECs) was 
specifically mediated by TLR5 (Zhang, Z., et al, 2005). After cloning tollip from 
a human cDNA library and over-expressing it in the same cells they found that 
significant blocking of TLR5 occurred. A dominant negative of TIR-domain 
containing adaptor protein (TIRAP) had no effect on P. aeruginosa-induced NF-
κB activation. These results revealed a common initial part of the IL-1R 
signalling pathway involving MyD88, IRAK and its regulating protein tollip and 
TRAF6, which were utilized by TLR5 in response to P. aeruginosa.   
 
So far, there is no evidence of tollip executing an inhibitor role in relation to the 
TLR9 activation pathway. The study from Yeo, S., et al, 2003 failed to 
demonstrate up-regulation of tollip after stimulation of RAW264.7 cells with 
CpG DNA, although IRAK was degraded and inhibited. 
 
When Piao and colleagues studied primary human monocytes they observed that 
the over-expression of tollip successfully inhibited LPS-mediated activation of 
NF-κB and RANTES but did not affect TNF-induced NF-κB reporter activity 
(Piao, W., et al, 2009). 
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The generation of tollip knockout mice by Didierlaurent, provided valuable 
insight into how this protein interacts in the immune system. Tollip null mice 
exhibited normal IκB degradation and phosphorylation of MAPK by IL-1R, 
TLR2 and TLR4. There were no differences in the degradation of IRAK and the 
activation of dendritic cells and lymphocytes was not affected. However, it was 
noted that IL-6 and TNF-α production was decreased in tollip-deficient cells 
after stimulation with IL-1β or LPS and there were no differences in the 
production of the IFN-inducible genes RANTES or ISG15 after poly (I-C) or LPS 
stimulation in tollip deficient mice. The above find gs suggest that tollip 
controls the fine tuning of the inflammatory cytokine production in response to 
IL-1R and TLR pathways that are dependent on MyD88 signalling 
(Didierlaurent, A., et al, 2006). 
 
Tollip is capable of self association or oligomerizat on to allow signals to be 
transduced efficiently (Zhang, G., and Ghosh, S., 2002). When they performed 
mutations in tollip they found that all tollip mutants associated efficiently with 
full length tollip except for the construct containing only the C2 domain (a.a.s 
53-178). Therefore they concluded that self-associati n of tollip is mediated by 
both the N and C terminal regions of the protein and may result in formation of a 
stable protein complex. 
 
More recent work by Ciarrocchi and colleagues has implicated tollip as a 
mediator of protein sumoylation (Ciarrocchi, A., et al, 2009). Sumoylation is a 
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post-translational modification of proteins that are involved in various cellular 
processes such as nuclear-cytosolic transport, transc iptional regulation, 
apoptosis, protein stability, response to stress and finally, progression through the 
cell cycle (Hay, R., 2005 and Zhao, J., 2007). Ciarrocchi found that tollip is 
sumoylated in more that one lysine residue by its as ociation with the 
sumoylation enzyme SUMO-1 since they co-immunopreciitated together. The 
most studied role of SUMO-1 modification on proteins is that of nuclear 
translocation. In cells that constitutively express the IL-1RI tollip deposited itself 
in small aggregates in the cytoplasm, in the perinuclear region in a position that 
may correspond to the Golgi apparatus, and/or to endosomes, and also in the 
nuclear bodies, where it also co-localises with SUMO-1 and the death domain 
interacting protein (DAXX) repressor. This finding suggests that tollip together 
with SUMO-1 are translocated into the nucleus and internalized into nuclear 
bodies (Ciarrocchi, A., et al, 2009).  
 
1.5.3 Localisation of tollip: 
Tollip appears to be a highly abundant intracellular protein. Brissoni and 
coworkers found it localised on early as well as in late endosomes and they think 
that is likely that the localisation of tollip in the different endosomal 
compartments is a dynamic and highly regulated process controlled in part 
through its internal C2 domain which is abundant on endocytic vesicles (Brissoni 
et al, 2006). This finding was also supported by the observation from Katoh 
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when they noted that HA tagged-tollip was localised on punctate structures 
distributed throughout the cytoplasm which partially overlapped with an early 
endosomal marker EEA-1; but not significantly with t e cation-independent 
mannose-phosphate receptor, which tends to cycle between the trans-Golgi 
network and late endosomes, suggesting that tollip localises on part of the 
population of early endosomes (Katoh, Y., et al, 2004). Tollip mutants lacking 
the TBD, the CUE domain and both domains, all retain d the ability to associate 
with endosomal structures. Therefore it is highly probable that the C2 domain 
determines endosomal localisation.  
 
The fact that tollip has been recently implicated in sumoylation suggests a 
nuclear role for tollip as well as its involvement in nuclear cytoplasmic 
trafficking (Ciarrocchi, A., et al, 2009).  
. 
1.5.4 Role of Tollip in the adaptive immune response 
Tollip is not only a key player in the modulation of the innate immune response, 
but there is evidence that it also provides a link to adaptive immunity. This was 
observed by Ohnuma, K., et al, 2005 when using proteomic analysis they 
identified tollip and IRAK-1 as caveolin-1 interacting proteins in monocytes. 
Adenosine deaminase-binding protein (CD26) is a 110 kD type II 
transmembrane molecule which was originally characterised as a T cell 
activation antigen, preferentially expressed on a specific population of T 
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lymphocytes, particularly the subset of CD4+ memory T cells (Dang, N., et al, 
1990 and Dang, N., et al, 1991). Ohnuma observed that after stimulation with 
CD26 tollip and IRAK1 dissociated from caveolin-1 and IRAK 1 was 
phosphorylated in the cytosol, leading to the upregulation of the costimulator for 
T lymphocyte activation molecule CD86 via the activation of NF-κB. It is likely 
that the result of this interaction is associated with T cell activation and 
proliferation of T memory cells. 
  
The clinical demonstration of tollip’s actions in the adaptive immune system was 
provided by Kimman and colleagues who found an associati n between 
interacting genes in the TLR signalling pathway and the antibody response to 
Bordetella pertussis vaccination. They collected data from 490 children for 
genotyping and single nucleotide polymorphisms (SNPs) selection and compared 
it to the levels of pertussis toxin (PT-IgG) titres. Using multifactor 
dimensionality reduction analysis they showed significant genetic interactions of 
SNPs in tollip, TLR4 and IRAK-1. Children with wild type genotypes of both 
tollip and TLR4 had a high chance of PT-IgG in the highest 33rd percentile. When 
an IRAK-1 SNP was added to the combination (tollip and TLR-4 SNPs) further 
increased the accuracy and was also significantly associated with high PT-IgG 
titres (Kimman, T., et al, 2008).  
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1.5.5 Role of Tollip in clinical medicine 
Although not studied extensively in a clinical setting yet, some groups have 
started to look for the clinical relevance that tollip’s multiple actions have. A 
study by Schimming, T., et al, 2007 found two polymorphisms in the tollip gene 
which appear to have an association with atopic dermatitis, a chronic 
inflammatory skin disease of multifactorial origin in which the evidence supports 
an inverse relationship between its development and the exposure to endotoxin 
(Kabesch, M., et al, 2003 and Kabesch, M., et  al, 2004). 
 
 Hu demonstrated that tollip could be a negative regulator during the 
development of cardiac hypertrophy in C57BL/6 mice, as well as in vitro in 
neonatal cardiomyocytes, through the down regulation of the MyD88-dependent 
NF-κB activation pathway, suggesting a broader role of this protein in the 
myocardium (Hu, Y., et al, 2009). 
 
Septic shock has been recognized as one of the main results of an uncontrolled 
inflammatory response, and there is evidence to support the concept that sepsis 
syndrome may be mediated by TLRs (Poltorak, A., et al, 1998). The group led by 
dib-Conquy could not demonstrate a difference betwen tollip m-RNA in sepsis 
patients and with healthy controls, however (dib-Conquy, M., et al, 2006). 
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1.6 Staphylococcus aureus epidemiology 
Septic shock accounts for high morbidity and mortality, and the Gram-positive 
bacterium Staphylococcus aureus is one of the main species associated with this 
life-threatening disease (Artero, A., et al, 2010). The SEPIA study group 
(Ammerlaan, H., et al, 2009) found S. aureus bacteraemia to be significantly 
associated with 30-day mortality. Furthermore, the association between S. aureus 
and nosocomial infection, particularly ventilator-associated pneumonia VAP) has 
received increasing attention during the last decad (DeRyke, C., et al, 2005; 
Lynch, J., 2001 and Rello, J., et al, 1994). North American national surveillance 
programs have identified S. aureus as the second most common causative agent in 
hospital-acquired infections (Hidron A., et al, 2008). 
 
Staphylococcus aureus is a Gram-positive bacterium. It is considered a very 
successful colonising agent and pathogen since it is very versatile and possesses 
multiple virulence factors that allow it to adhere, colonise and infect its host. It has 
been well known to cause epidemics (Chambers, H., 2005; Chambers, H. and 
DeLeo, F., 2009; Enright, M., et al, 2002; Robinson, D., et al, 2005 and Stewart, 
G. and Holt, R., 1963). It also has the ability to acquire resistance to antibiotics at 
intimidating speed: the first penicillin-resistant strains were reported in the mid 
1940s and were associated with causes of infections in hospitalized patients 
(Barber, M., et al, 1949; Kirby, W., 1944). Very soon after, and extending up to 
the 1960s, the appearance of the penicillin resistant S. aureus strain phage type 
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80/81 was associated with hospital-acquired diseases  well as with infections in 
the community (Donahue, J. and Baldwin, J., 1966). After the introduction of 
methicillin in 1959, the phage type 80/81 strains di appeared and almost 
immediately were replaced by methicillin resistant Staphylococcus aureus 
(MRSA) strains which are now an increasing problem in current hospital medical 
practice (Chambers, H., 2001; Holt, R. and Stewart, G., 1963). 
 
The prevalence of MRSA has been rising during the last two decades. In the 
United Kingdom, there was a sharp rise in the proportion of MRSA among all 
cases of S. aureus bacteraemia during the 1990s and reached its peak at 40-45% 
during 2001-2005. The implementation of strategies incorporating strict infection 
control measures was associated with a decrease to 36% in the incidence during 
2007 has been seen. The initial increase was due to the successful spread of two 
epidemic MRSA strains EMRSA-15 (ST22-MRSA-IV) and EMRSA-16 (ST36-
MRSA II) which were mostly linked to hospital settings (Enright, M., et al, 2002; 
Johnson, A., et al, 2005).  
 
Simultaneously, in the early 2000s, the emergence was observed of a new MRSA 
strain which affected a completely different population of patients including 
nursery children, teams of contact sportsmen, prisoners, military recruits and 
homosexual men (Diederen, B. and Kluytmans, J., 2006 and Zetola, N., et al, 
2005). This strain was called a community associated-MRSA strain (CA-MRSA) 
and its main characteristic of this emerging strain was the increased virulence due 
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to the production of a toxin able to cause pores in the membranes of white blood 
cells. This is called the Panton-Valentine leukocidin (PVL) (Vandenesch, F., et al, 
2003). 
 
The versatility of S. aureus to develop new antibiotic resistance was evidenced in 
Japan in 1997 at a time when severe MRSA infections were conventionally treated 
with glycopeptides (Hiramatsu, K., et al, 1997). Antibiotic resistance has been 
considered an established issue since 2002 when the first true vancomycin-
resistant MRSA strain was identified from a diabetic foot ulcer which also had a 
vancomycin-resistant Enterococcus faecalis (Sievert, D., et al, 2008). The 
introduction of new antibiotics such as linezolid and daptomycin has not stopped 
the development of antibiotic resistance in MRSA. Whereas linezolid resistance 
has been reported during therapy (Meka, V., et al, 2004; Tsiodras, S., et al, 2001), 
daptomycin (a new lipopeptide) is not far ahead, and the development of 
resistance during treatment has again resulted in therapeutic failure (Hayden, M., 
et al, 2005; Mangili, A., et al, 2005; Marty, F., et al, 2006, Skiest, D., 2006; 
Vikram, H., et al, 2005). Therefore, we are now, more than ever, extremely 
vulnerable to this microorganism which has proven itself superior to all advances 
in modern medicine. 
 
So, what makes these bacteria so special? There is vidence that multiple factors 
account for its success including the ability to adhere to host cells, to persist 
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intracellularly, to evade immune responses, to invade nd penetrate the tissues and 
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Table 1.2 S. aureus virulence factors and their role in human infections.  
PVL, Panton-Valentine leukocidin; CHIPS, chemotaxis inhibitory protein of 
staphylococci; ACME, arginine catabolic mobile element; MSCRAMMs, microbial 
surface components recognizing adhesive matrix molecules. Adapted from Gordon, R. 
and Lowy, F., 2008. 
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Staphylococcus aureus has a great repertoire of virulence factors which share 
two main characteristics: a virulence factor may have several functions in 
pathogenesis and multiple virulence factors may perform the same function 
(Gordon, R. and Lowy, F., 2008).  Some of the main virulence factors include 
the formation of an antiphagocytic microcapsule that allows staphylococci to 
evade the innate immune system and which has also been associated with the 
ability to cause abscesses (O’Riordan, K. and Lee, J., 2004). The production of 
protein A (binds to the Fc portion of immunoglobulins, therefore preventing 
opsonisation) and the ability to adhere to tissues and prosthetic materials helps to 
evade the immune system and to cause infections at distant and more difficult 
sites. In addition to the capacity to remain within the “slime” around prosthetic 
materials provides a reservoir which is inaccessible to both cells of the innate 
immune system and to antimicrobial treatment. The production of toxins such as 
toxic shock syndrome toxin-1 (TSST-1) has been associated with increased 
virulence and pathogenicity, as well as the presence of pathogenicity islands in 
some of the more virulent strains of S. aureus. 
 
1.6.1 Structure of the Staphylococcus aureus cell wall 
The bacterial cell wall is a key component of the cell; it provides structural 
rigidity, with-holds the high osmotic pressure of the cytoplasm, gives shape to 
the cell and is also a physical barrier to the external environment. Bacterial cell 
walls differ importantly between Gram-positive and Gram-negative bacteria. 
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Whereas the Gram-positive bacterial cell wall lies at the outermost layer of the 
cell, in Gram-negative bacteria it is covered under and additional layer: the outer 
membrane (Washington, W., et al, 2006). 
Gram-positive bacteria have cell walls with a thick peptidoglycan (PGN) layer, 
in which teichoic acids are anchored and lipoteichoi  acids are linked to the 
cytoplasmic membrane (Draing, C., et al, 2008; Zahringer, U., et al, 2008).  
 
1.6.1.1 Peptidoglycan 
The component that gives the most rigidity to the cell wall is PGN. It is 
composed of a backbone of alternating carbohydrate moieties of N-
acetylglucosamine and N-acetylmuramic acid in β-1,4 linkage (Beveridge, T., 
1981). Short tetrapeptides which are composed of identical short chains of D and 
L aminoacids are attached to the N-acetylmuramic acd residues through a 
peptide bond to the lactyl group on C3. Some of these t tra peptides are linked to 
one another by short peptides forming cross-bridges b tween adjacent PGN 
strands. The degree of this cross-linking determines whether the cell wall 
structure is “tight” (highly cross-linked) or loose. There are variations in the 
cross-linking of the peptidoglycan among bacteria (Vollmer, W., et al, 2008). 
 
In S. aureus, most of the N-acetylmuramic acid residues are cross-linked to 
adjacent peptidoglycan strands by a cross bridge of five glycine residues 
providing a rigid cell wall structure. The biosynthesis of the bacterial cell wall is 
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a continuous process; new peptidoglycan polymers are exported from the cell 
and linked to pre-existing cell wall polymers at the inner aspect of the cell wall 
by penicillin binding proteins (PBP) (Paul, T., et al, 1995). These proteins 
catalyse the elongation of the glycan strands (glycos ltransferase activity) and 
the interconnection of the glycan strands by peptid cross-linking (transpeptidase 
activity) (Goffin, C. and Ghuysen, J., 2002; Massova, I. and Mobashery, S., 
1998; van H., 2006). The loss of this catalytic activity impairs the ability of the 
bacterium to control the integrity of the cell wall nd the end result is cell lysis. 
β-lactam antibiotics exert their bactericidal activity by binding to the PBPs and 
inhibiting polymer renewal at the inner core of the cell wall (Sugai, M., et al, 
1997).  
 
Staphylococcal peptidoglycan has been shown to stimulate the production of pro-
inflammatory cytokines and chemokines (TNF-α, IL-1β, IL-6 and IL-8) in 
human monocytes and macrophages (Heumann, D., et al, 1994; Timmerman, C., 
et al, 1993). The glycan strands are crucial for cytokine production, whereas the 
stem peptide structure is not (Myhre, A., et al, 2004; Yoshimura, A., et al, 2000).  
 
Studies by Iwaki and colleagues demonstrated that saphylococcal peptidoglycan 
binds strongly to the soluble recombinant form of the extracellular domain of 
TLR2 suggesting that the extracellular TLR2 domain d rectly interacts with 
peptidoglycan (Iwaki, D., et al, 2002). 
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1.6.1.2 Teichoic acids:  
Teichoic acids are highly charged polymers; they concentrate cations at the cell 
wall surface. They are involved in activities such as cation balance at the cell 
surface, cell division and regulation of PGN autolysis. Lipoteichoic acid (LTA) 
is the main teichoic acid and protrudes from the cytoplasmic membrane through 
the peptidoglycan layer. It consists of 25 poly (1-3)-glycerol phosphate linked to 
a diacylglycerolipid anchor (Draing, C., et al, 2008; Zahringer, U., et al, 2008). 
 
S. aureus LTA has been shown to induce the secretion of cytokines and 
chemokines such as TNF, IL-1β, IL-10, IL-8, IL-12 from monocytes and 
macrophages (Danforth, J., et al, 1995; Standiford, T., et al, 1994; von AS, et al, 
2004; von AS, et al, 2007). Von Aulock and colleagues found that LTA from S. 
aureus was a more potent inducer for the chemokine IL-8 in 160 healthy 
individuals in comparison to LPS from Salmonella abortus equi (von AS, et al, 
2006). When comparing the potency of LTA and LPS from Gram-negative 
bacteria Kusunoki and coworkers noted that very large amounts of LTA were 
needed to induce inflammatory responses in vitro. Concentrations of 1 to 
10µg/ml of LTA produced responses equivalent to those produced by LPS 
concentrations in the ng/ml range (Kusunoki, T., et al, 1995). Nevertheless, 
comparison of the activity of LPS and LTA demonstrated by Von Aulock, 
showed that staphylococcal LTA promotes the same strong induction of 
chemoattractants (IL-8, MIP-1α, MCP-1) as LPS, whereas it was a weaker 
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inducer of TNF-α, IL-1β and IL-6. They also noted that the cytokine pattern 
produced by LTA is similar to that induced by the whole bacterium (Von AS, et 
al, 2004; Von AS, et al, 2007). 
 
1.6.2 Nasal colonisation by S. aureus 
Undoubtedly one of the main reasons why S. aureus is such a successful organism 
is its ability to colonise its host. There is evidenc  that colonisation is the 
preceding step to infection and patients who are colonised usually develop 
infection with their same colonising strain (Dall’antonia, M., et al, 2005; Von E., 
et al, 2001; Watanabe, H., et al, 2000). S. aureus colonisation tends to happen 
predominantly in the anterior nares, although other sites such as the axilla, 
perineum, throat and gastrointestinal tract are also important reservoirs for the 
bacterium and should be considered for infection control purposes (Boyce, J., et al, 
2005; Gordon, R. and Lowy, F., 2008; Wertheim, H., et al, 2005). 
 
The best studied, has been the role of nasal colonisation. Staphylococcus aureus 
nasal carriage tends to happen in the anterior nares in the vestibulum nasi, which 
consists of fully keratinised epithelium, apocrine sweat glands, sebaceous glands 
and hair follicles (Gluck, U. and Gebbers, J., 2000; Wertheim, H., et al, 2005). 
Several studies have reported the epidemiology of S. aureus nasal carriage: 20% 
of the population are persistent carriers (range 12-30%), 30% are intermittent 
carriers (range 16-70%) and 50% are non-carriers (range 16-69%). There is 
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evidence that persistent carriers tend to have a higher bacterial load and are at 
higher risk of S. aureus infection (Wertheim, H., et al, 2005). The increas in the 
prevalence of MRSA infections and the fact that the bacterium can also be carried 
asymptomatically in the nose have attracted a great d l of interest due to the 
implications for clinical practice as well as for the infection control arena (Hidron, 
A., et al, 2008; Woodford, N. and Livermore, D., 2009). 
 
A recent study by Datta and Huang has shown that persist nt carriers who have 
carried MRSA for more than one year are at high risk for subsequent infection and 
associated MRSA mortality, particularly within the first three months after 
colonisation (14%) after which the risk decreases approximately to 4% for the 
subsequent months (Datta, R. and Huang, S., 2008). In addition the same 
investigators have previously shown a 33% increase in the risk of developing new 
MRSA invasive disease within one year, followed by 27% during the second year 
and 16% thereafter (Huang, S., et al, 2006). 
 
Multiple host factors as well as organism-related factors play a role in 
colonisation. Host factors include local nasal phenotypic differences: a study by 
Cole et al demonstrated differences in antimicrobial activity in the nasal secretions 
of colonised versus non-colonised subjects (Cole, A., et al, 1999). The actual state 
of competence of the immune system also seems to play a key role in colonisation 
status, since there is evidence of increasing carriage rates in groups of patients 
who are considered immunocompromised such as patients with renal impairment 
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on haemodialysis (Kaplowitz, L., et al, 1988; Kluytmans, J., et al, 1997; Pujol, M., 
et al, 1996), diabetes mellitus, end-stage liver disease and cancer (Datta, R. and 
Huang, S., 2008; Kluytmans, J., et al, 1997), as well as infection with HIV 
(Kluytmans, J., et al, 1997; Weinke, T., et al, 1992). Genetic studies looking for a 
relationship with the colonisation state have provided conflicting data. Whereas 
Moore could not find an association between TLR2 gene polymorphisms and 
susceptibility to severe staphylococcal infections (Moore, C., et al, 2004), the 
study by Gonzalez-Zorn found that TLR-2 deficient mice developed persistent 
nasal colonisation (Gonzalez-Zorn, B., et al, 2005). Studies in monozygotic twins 
have also failed to demonstrate a clear genetic relationship, indicating once more 
the multifactorial nature of this highly dynamic process (Aly, R., et al, 1974; 
Hoeksma, A. and Winkler, K., 1963). Other implicated factors are ethnic origin 
(demonstrating higher carriage rates in white people) (Cole, A., et al, 2001; 
Williams, R., 1963), age (Armstrong-Esther, C., 1976; Parnaby, R., et al, 1996; 
Peacock, S., et al, 2003) and previous skin infections with S. aureus as well as skin 
diseases such as eczema and psoriasis (Wertheim, H., et al, 2005; Williams, J., et 
al, 1999). Host factors are still in need of furthe r search, if we are to improve 
current clinical practice. This was demonstrated by the study from Wertheim et al 
in which nasal S. aureus carriage and the development of bacteraemia and 
mortality were followed in non surgical hospitalized patients. They showed that 
among bacteraemic patients, the non-carriers had higher mortality in comparison 
to carriers and since most infections in the colonised patients happened with their 
own colonising strains, therefore, the colonisation status itself seemed to provide 
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some protective immunity (Wertheim, H., et al, 2004).  Humoral immunity also 
appears to have a protective effect particularly in the case of staphylococcal toxic 
shock syndrome, which appears to occur only in patients who lack antibodies 
against the particular toxin during the time of their acute illness (McCormick, J., et 
al, 2001). 
 
Staphylococcus aureus is very versatile and therefore possesses an arsenal of 
bacterial factors that support its role as a successful colonising microorganism. 
Microbial surface components recognising adhesive matrix molecules 
(MSCRAMMs) are important in colonisation efficacy (Van, B., 2006). Their 
expression occurs during logarithmic growth, whereas the secretion of proteins 
happens during the stationary phase. During the infctive process, the early 
expression of MSCRAMMs helps initial colonization ito tissues, whereas toxin 
production allows the spread of the bacterium (Gordon, R. and Lowy, F., 2008). 
Recent research looking into this aspect of bacterial colonisation has demonstrated 
the presence of two Staphylococcal proteins implicated in adherence to nasal 
epithelial cells: clumping factor B (ClfB) and the S. aureus surface protein G 
(SasG). For ClfB in particular, there is evidence of specific binding to human 
cytokeratin 10 from desquamated nasal epithelial cells (O’Brien, L., et al, 2002). 
When Wertheim inoculated volunteers with a wild-type S. aureus strain and its 
isogenic strain lacking the ClfB gene, they found that the mutant strain was 
eliminated faster in comparison to the wild-type strain and persisted up to the end 
of the follow up in their study. This research highli ted ClfB as a potential 
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therapeutic target for future decolonisation studies (Wertheim, H., et al, 2008). 
Roche also showed that SasG promotes bacterial adherence to human 
desquamated nasal epithelial cells, contributing to establishment of nasal 
colonisation (Roche, F., et al, 2003). 
 
The increasing rate of MRSA infections prompted thedevelopment of new 
research into nasal colonisation with MRSA. The study by Dall’antonia 
highlighted the competition for the niche that occurs between MRSA and MSSA 
strains (Dall’antonia, M., et al, 2005) while Huang and Platt have also observed a 
28% rate of relapse within 18 month period after previous infection or colonisation 
with MRSA (Huang, S. and Platt, R., 2003). The whole dynamics of the 
colonisation process remains poorly understood, especially due to the lack of study 
into primary epithelial cells in the subjects who are colonised and their reaction to 




The respiratory tract is exposed to a multitude of infective, as well as, non 
infective antigens on a daily basis. Looking more sp cifically into the infective 
process, there is evidence that the upper respiratory p rtion is colonised with 
bacterial microorganisms such as S. aureus, without eliciting an immune response 
(Watanabe, H., et al, 2000). On the other hand, the presence of the very same 
pathogen in the lower portion: alveolar compartment is associated with an 
exuberant pro-inflammatory response which is clinically observed during the 
development of pneumonia. Furthermore, the presence of S. aureus in the nasal 
compartment is considered a risk factor for developing lower respiratory tract 
infection with the same bacterial strain. In this manner, the upper respiratory tract 
acts as a bacterial reservoir (Watanabe, H., et al, 2000).  
Although the precise mechanism for this phenomenon has not been researched 
before, the hypothesis that I want to test is that: “there are differences in innate 
immune regulation, which are responsible of the development of tolerance to S. 
aureus in the human nasal epithelium, but induce a florid inflammatory 
response in human alveolar epithelium”.  
 
From this main hypothesis I will attempt to address further specific aspects such 
as: 
 55 
• “nasal epithelial cells have a lower intrinsic capacity than alveolar 
epithelial cells to mount an inflammatory response to S. aureus” 
• “Tollip is expressed in the human respiratory tract” 
• “The nasal epithelium plays an active role in the surveillance of 
microorganisms” 
 
1.8 Aims and Objectives of thesis 
Arising from the clinical observation described above: that the upper respiratory 
tract particularly its nasal compartment allows thegrowth of bacteria, whilst its 
lower portion reacts with an exuberant inflammatory response to the same 
microorganisms, the main question is to assess if these differences can be 
reproduced in an in vitro system; using first cell lines representative of bth cell 
types and then to try to translate the findings onto primary cells of the respiratory 
system in an effort to elucidate the molecular mechanisms underlying these 
responses. 
 
To assess if tollip is present in the respiratory system, to characterise its role and to 
try to establish compartmental differences that could explain the induction of 
tolerance in the upper portion of the respiratory tract 
 










2 Materials and Methods 
2.1 Cell lines 
 
2.1.1 RPMI 2650 cells 
The human nasal cell carcinoma RPMI 2650 was obtained from LGC Promochem 
(ATCC Number: CCL-30). This cell line was established in 1962 by Moore and 
Sanberg from a patient with an anaplastic squamous cell carcinoma of the nasal 
septum (Moore, G., and Sandberg, A., 1964). They report d to have grown it for 
35 passages without alteration of the karyotype. Thcell line was submitted to the 
American Type Culture Collection in the 15th passage in 1963 and was grown up 
to passage 22nd. The karyotype was analyzed and it was noted to be nearly-normal 
with a stable chromosomal number (Moorhead, P., 1965), characteristic which 
makes this cell line unique among the human cell lines available at present. 
 
The cells were cultured in Minimum Essential Medium Eagle (MEM) (Sigma Cat 
No. M2279) with Earle’s Balanced Salt Solution adjusted to contain 1.5 g/L 
sodium bicarbonate supplemented with 10% foetal bovine serum, 1% L-
glutamine, 1% non essential amino-acids, 1% sodium pyruvate. Cells were split 
every three days or when confluence was reached using trypsin/ethylene diamine 
tetra-acetic acid (EDTA) solution. For experiments, cells were seeded at 2 x 106 in 
6-well plates and not used until confluent. Once th monolayer was established, 
cells were exposed either to a) live Staphylococcus aureus (wild-type strain 
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Newman or isogenic mutant strains deficient for thegenes clumping factor B 
(clfB) and protein A) or to b) bacterial products derived from Staphylococcus 
aureus such as peptidoglycan (PGN; Fluka – Sigma Aldrich Cat No.77140), 
lipoteichoic acid (LTA; Sigma Aldrich Cat No L2515), ultrapure Pseudomonas 
aeruginosa lipopolysaccharide (a kind gift from Professor IanPoxton, University 
of Edinburgh) and recombinant human tumor necrosis factor Alpha (TNF-α R&D 
Systems Cat No.210-TA). 
 
2.1.2 T84 cells 
The human colon cell carcinoma T84 was obtained from LGC Promochem  
(ATCC Number: CCL-248). This cell line was derived from a lung metastasis of a 
colon carcinoma in a patient. The tumour tissue was transplanted in BALB/c nude 
mice and the cell line was established after 23 passages (Murakami, H. and Masui, 
H., 1980). Dharmsathaphorn and colleagues noted that the cells form tight 
junctions and desmosomes and suggested it, as a model for the study of electrolyte 
transport (Dharmsathaphorn, K., et al, 1984). 
 
The cells were cultured in a 1:1 mixture of Dulbecco's Modified Eagle's Medium 
(DMEM) / Nutrient Mixture F-12 Ham (Sigma Aldrich Cat No. D6421); 
supplemented with 5% foetal bovine serum. Cells were cultured and split every 
four days or when confluent and subcultured using trypsin/EDTA solution and 
subcultured. For experiments, the cells were seeded at 5 x 105 in a 24-well tissue 
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culture plate (Costar) and allowed to reach confluece. They were then lysed prior 
to RNA extraction (see below). 
 
2.1.3 A549 cells 
The human type II pneumocyte-like cell line A549, was established in 1972 by 
Lieber and colleagues from a human alveolar cell carcinoma. They propagated it 
in vitro continuously for more than three years and observed similarities with type 
II alveolar epithelial cells (Lieber, M., et al, 1976). 
 
The cells were cultured in DMEM (PAA Laboratories Cat No.E15-009) 
supplemented with 10% foetal calf serum and 1% L-glutamine. A549 cells were 
split every two to three days and split using trypsin/EDTA as described above. For 
experiments the cells were seeded at 2 x 106 in 6 well plates and once the 
monolayer was established, they were exposed to live bacteria or bacterial 
products as described above. 
2.2 Isolation of Primary epithelial cells: 
2.2.1 Isolation and culture of Primary nasal epithelial cells: 
 
Healthy volunteers and elective patients undergoing pulmonary lobectomy or 
pneumonectomy in the Cardiothoracic Surgery Departmen  of the Royal 
Infirmary of Edinburgh Hospital were approached. Those providing informed 
written consent were enrolled. Ethical approval was granted by the Lothian NHS 
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Research Ethics Committee (Ref 08/S1102/32). Volunteers or patients were 
asked to blow their nose before starting the procedure. A nose swab was 
obtained, using a sterile cotton bud lightly moistened in 0.9% sterile saline 
(Baxter). Under direct visualisation using a nasal speculum (Instrapac Thudicum 
Cat No.7861, Medisave, Dorset, UK), the inferior tubinate of the nose was 
gently brushed using a sterile cytology brush (Surgipath, Cat No. 01970, 
Peterborough, UK). Both nostrils were brushed. The material obtained was 
disaggregated and suspended in 2ml of Bronchial Epithelial Growth Medium 
(BEGM, Lonza, Clonetics) supplemented with 0.1% hydrocortisone, 0.1% 
recombinant human insulin, 0.1% recombinant human epidermal growth factor, 
0.4% bovine pituitary extract, 0.1% retinoic acid, 0.1% gentamicin sulphate and 
amphotericin B, 0.1% triiodothyronine (T3), 0.1% transferrin and 0.1% 
epinephrine (Lonza, Clonetics Cat No.CC-3170), and seeded within a single well 
of a 6-well culture plate previously coated with type I rat-tail collagen (Sigma-
Aldrich Cat No.C3867-1VL). After 24 hours, the supernatant and unattached 
cells were removed and replaced with fresh medium. The removed supernatant 
was seeded into a second collagen-coated plate to encourage further attachment 
and growth. Culture media was changed every three days and cells were 
incubated at 37oC in 5% CO2 and cultured until 90-100% confluent. Upon 
reaching confluence, cells were washed with 2ml of 4-(2-hydroxyethyl)-1-
piperazineethanesulphonic acid (HEPES)-buffered saline solution (Lonza, 
Clonetics Cat. No CC-5022), detached using 2 ml of trypsin-EDTA solution 
(Lonza, clonetics Cat No.CC-5012) and incubated for 10 minutes at 37oC. 
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Trypsin activity was quenched using 4ml of trypsin neutralising solution (Lonza, 
Clonetics Cat No. CC-5002). The cell suspension was centrifuged at 279g for 5 
minutes at 20oC. The resulting pellet was resuspended in 6 ml of BEGM. Cells 
were counted and seeded at a density of approximately 6 x 105 cells/ml onto an 
uncoated 6-well plate (costar). All further assays were performed on cells at 
second passage. If cells were unsuccessful in reaching confluence by the third 
week, acquired an infection with bacteria or fungi, or if they failed to attach to 
the collagen within two weeks, they were discarded. 
 
2.2.2 Isolation and culture of primary bronchial epithelial cells: 
 
Cells were obtained from the same group of consented patients as described 
above, ie undergoing partial lobectomy or pneumonectomy at the Cardiothoracic 
Surgery Department of the Royal Infirmary of Edinburgh Hospital. After the 
induction of anaesthesia and endotracheal intubation a broncoscopy brush 
(Olympus BC-202D Cytology brush Cat No. BC-202D-2010) was inserted 
blindly through the lumen of the endotracheal tube corresponding to the lung on 
which no surgery was to be performed. Blind brushings were performed and the 
material obtained was inoculated immediately in 6ml of BEGM culture medium 
and transported to the laboratory. Three ml of the cellular suspension were then 
seeded onto wells coated with type I collagen as described previously in section 
2.2.1 and allowed to grow and achieve confluence. All further assays were 
 62 
performed under identical conditions as for the primary nasal epithelial cells. All 
the cells were used at passage two. 
 
2.2.3 Isolation and culture of primary type II alveolar epithelial cells 
 
Patients undergoing pulmonary lobectomy or pneumonect my in the 
Cardiothoracic Surgery Department under the surgical team led by Mr. William 
Walker were consented. Ethical approval was given by the Lothian NHS 
Research Ethics Committee (Ref 08/S1102/32). 
 
Immediately after surgical removal, tissue was transported to the Pathology 
Department based at the Royal Infirmary of Edinburgh where the duty 
pathologist removed an appropriately considered portion of macroscopically non 
diseased lung tissue under strict aseptic technique. Th  tissue was then immersed 
in transport medium (0.9% NaCl, 0.5% gentamicin, 1%penicillin/streptomycin 
and 0.5% amphothericin B). The tissue was allowed to refrigerate overnight and 
processed the next day. The following day the tissue was injected with 0.9% 
saline to remove alveolar macrophages, followed by two digestion steps using 
0.25% trypsin (Sigma Aldrich Cat No. T8003) in Hanks Balanced Salt Solution 
(HBSS)(PAA Cat No.H15-009) at 37oC for 15 minutes (10ml per 5 cm3 of 
tissue). Once the digestion was completed, the tissue was cut into small pieces of 
approx 1-2 mm3 in the presence of newborn calf serum (Invitrogen, Cat No, 
SKU#26010-074), DNAse I (Sigma Aldrich Cat No DN25) was added to the 
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suspension at 250µg/ml in 7 ml of HBSS and shaken vigorously for 5 minutes 
before filtering through a large sterile metallic mesh (approx 500µm), followed 
by a 40µm Falcon cell strainer (BD Biosciences). The filtered suspension was 
centrifuged at 300g for 10 minutes at 4oC. After centrifugation, the resulting 
pellet was resuspended in 15ml HBSS / 15ml DCCM-1 (Biological Industries 
Cat No. 05-010-1) without serum containing 100µg/ml of DNAse I. The 
suspension was incubated in a T-75 flask (Costar) for two hours at 37oC in a 5% 
CO2 atmosphere to allow residual contaminating macrophages to adhere. After 
two hours, the supernatant containing non-adherent c lls was removed and 
centrifuged at 300g for 10 minutes at 4oC. The pellet was resuspended in 
complete medium (DCCM-1, 10% Newborn Calf Serum, 1%glutamine, 1% 
penicillin and streptomycin). This suspension was incubated for two hours at 
37oC to allow contaminating fibroblasts to adhere. After wo hours incubation 
the non-adherent cells were removed and centrifuged at 300g for 10 minutes at 
4oC. Cells were resuspended in complete medium at 2 x 106 cells/ml and seeded 
in 6- or 12-well dishes pre-coated with type I bovine collagen Purecol (Nutacon 
Cat No.5409). The cells were allowed to adhere at 37oC for 24 hours, the 
medium and any remaining contaminating cells were rmoved and new fresh 
medium was added. Cells were re-incubated at 37oC/ 5%CO2 and after 16 hours 
the medium was removed and the cells were washed with HBSS. Fresh medium 
was added and the cells were incubated further to allow establish confluent 
monolayers with type II pneumocyte morphology. All cells were used at passage 
1. 
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2.3 Bacterial strains 
 
The Gram positive bacterium Staphylococcus aureus strain “Newman” was a kind 
gift from Dr. Ross Fitzgerald from the Centre for Infectious Diseases (CID), 
University of Edinburgh. This strain was originally isolated from a case of 
osteomyelitis from a man (Duthie, E. and Lorenz, L., 1952), and has been fully 
sequenced recently by Baba and colleagues (Baba, T., et al, 2008).  
 
Staphylococcus aureus strain Newman was cultured on tryptic soya broth (TSB), 
brain heart infusion (BHI) broth and MEM culture media; a growth curve showed 
that the bacterium grows optimally in TSB and BHI media, but growth on MEM 
was slightly reduced. Isogenic mutants of this strain were also given by Dr. Ross 
Fitzgerald, such as a strain lacking clumping factor B (δClfB) (Walsh, E., et al, 
2008) and a strain deficient in protein A (δProt A) (Guss, B., et al, 1985) were 
used in order to investigate the role of these virulence factors in establishing 
infection. The MRSA strain 252 was also used, this is a representative strain of the 
epidemic MRSA-16 clone (EMRSA-16), which has sequenced by Holden and 
collaborators (Holden, M., et al, 2004). The mentioed strains were cultured in 
identical conditions to those described for the Newman strain. 
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2.4 Characterisation of the cell line RPMI 2650 
2.4.1 Confocal Microscopy 
 
Confocal microscopy was used to characterise the cell line RPMI 2650. 
Antibody staining was used to assess the phenotype of the cell line. Antibodies 
used included those against cytokeratin 7-17 (Zymed Invitrogen Cat No.39-
4500), cytokeratin 10 (Zymed Invitrogen Cat No.39-5300), cytokeratin 18 
(Zymed Invitrogen Cat No18-0158), and vimentin (Zymed Invitrogen Cat No.18-
0052). See Table 2.1. 
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Antibody Species Cat No Supplier Concentr 
µg/ml 
Cytokeratin 7-17 Monoclonal mouse anti-human 
IgG1 
39-4500 Invitrogen 20 
Cytokeratin 18 Monoclonal mouse anti-human 
IgG1 
18-0158 Invitrogen 20 
Cytokeratin 19 Monoclonal mouse anti-human 
IgG2a 
08-0190 Invitrogen 6.5 
Cytokeratin 10 Monoclonal mouse anti-human 
IgG1 
39-5300 Invitrogen 20 
Vimentin Monoclonal mouse anti-human 
IgG1-kappa 
18-0052 Invitrogen 1 
Tollip Polyclonal rabbit anti-human 
IgG 
Ab37155 Abcam 1 
Isotype control 
mouse  





Rabbit IgG SKU# 08-
6199 
Invitrogen 0.5 










TLR-4 Rabbit polyclonal anti-human 
IgG 
36-3700 Invitrogen 10 
TLR-6 Monoclonal mouse anti-human 
IgG1-kappa 
39-0800 Invitrogen 20 
TLR-9 Monoclonal mouse anti-human 
IgG1 
OP185 Calbiochem 20 
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Alexa Fluor 488 Goat anti-rabbit IgG SKU#A-
11008 
Invitrogen 0.005 
Alexa Fluor 488 Goat anti-mouse IgM (µ chain) SKU#A-
21042 
Invitrogen 0.005 
   
Table 2.1 List of antibodies used for immunocytochemistry and confocal 
microscopy 
 
Cells were seeded at 5 x 105 in glass coverslips in individual wells of a 6-well 
plate and allowed to adhere for 15 minutes prior to adding 2ml of culture 
medium and incubated overnight. The following day, 1 ml of medium was 
removed, 1 ml of ice cold methanol was added, and the plates were incubated on 
ice for 10 minutes. The coverslips were washed three times with phosphate 
buffered saline (PBS) and blocked with 2ml of 2% goat serum for 30 minutes. 
The coverslips were dried and placed in an incubation chamber and incubated 
with the corresponding antibody at appropriate concentration overnight, taking 
care to avoid evaporation of the antibody solution. The next day, the coverslips 
were washed three times with PBS, and the secondary antibody (see Table 2.1) 
was added at a 1:200 dilution, and incubated at room temperature for 1 hour. The 
coverslips were washed again three times with PBS and dried and mounted using 
50µl of Vectashield with 4’,6-diamidino-2-phenylindole (DAPI) (Vector 
Laboratories Cat No. H-1500). The coverslips were visualized the following day 
using the Leica TCS SP5 confocal microscope (Leica Microsystems CMS 
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GmbH) based at the Confocal and Advanced Light Micros opy (CALM) facility 
in the Queen’s Medical Research Institute (QMRI). 
2.5 Characterisation of primary epithelial cells: 
2.5.1 Primary nasal cells: 
Primary nasal epithelial cells were characterised by immunocytochemistry. Once 
cells reached confluence they were detached using 2ml of trypsin/EDTA solution 
applied at 37oC for 10 minutes followed by centrifugation. Cells were resuspended 
then, seeded onto sterile glass coverslips and processed as described above in 
section 2.4.1. Cells were tested for cytokeratin 7-17, 18 and 19, as well as 
vimentin, using the same antibodies described in section 2.4.1 and table 2.1. 
2.5.2 Primary type II alveolar epithelial cells: 
Type II alveolar epithelial cell phenotype was confirmed by positive staining for 
alkaline phosphatase (Dobbs, L., 1990) and reverse transcriptase – polymerase 
chain reaction (RT-PCR) for Surfactant Protein-C (SP-C) and aquaporin 3 (AQP3) 
(Fuchs, S., et al, 2003; Armstrong, L., et al, 2004). 
2.5.2.1 Alkaline Phosphatase Stain 
Primary type II alveolar epithelial cells were phenotyped by staining for alkaline 
phosphatase (ALP). Ten mg of naphthol-AS-bisphosphate (Sigma Aldrich Cat 
No. N2125) was dissolved in 40µl of dimethyl sulphoxide (DMSO) and added to 
10ml of alkaline phosphatase buffer (0.625M magnesium chloride and 0.125M 
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2-amino-2-methyl-1- propanol; pH: 8.9). Then 10mg of fast red violet LB salt 
(Sigma Aldrich Cat No.F3381) was added and the solution was mixed for 5 
minutes at room temperature. This was then filtered through a 0.22µm filter and 
used immediately. 1ml was added to the monolayers and the cells were incubated 
for 20 minutes at 37oC. Photographs were taken using a light microscope.  
 
 
2.5.2.2 Reverse transcriptase-Polymerase Chain Reaction for Surfactant 
Protein-C (SP-C) and Aquaporin 3 (AQP3) 
 
Total RNA was extracted as it will be described in detail in section 2.8 and 1µg 
was reverse transcribed. Primers used were described from the paper from 
Armstrong et al, 2004 for SP-C: forward primer: 
AGCAAAGAGGTCCTGATGGA; reverse primer 
CTAGTGAGAGCCTCAAGACT, for AQP-3: forward primer: 
CCTTTGGCTTTGCTGTCACTC and reverse primer: 
ACGGGGTTGTTGTAAGGGTCA.  
 
PCR was performed under the following conditions: DNA was denatured at 94oC 
for 3 minutes, followed by 30 cycles of 94oC for 20 seconds, annealing at 54oC for 
45 seconds and extension for 72oC for 45 seconds. Final extension was performed 
at 72oC for 5 minutes. Samples were then run on a 2% agarose gel and then 
visualised using the Molecular Imager Versadoc MP4000 System PC (Bio-Rad 
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Laboratories, Inc). Negative controls for the PCR reaction included a non reverse 
transcriptase control as well as RNA extracted from the cell line A549 (Witherden, 
I., et al, 2004; Armstrong, L., et al, 2004). GAPDH was the house keeping gene 
used for this, primers used were the same as the ones that will be described in 
section 2.8. 
2.6 Constitutive cytokine production in cultured supernatant by cell lines 
 
The cell lines RPMI 2650 and A549 were seeded at 5 x 105 cells/ml on a 24-well 
plate (Costar) once confluent, supernatants  were rmoved at 0, 2, 4, 6 and 24 
hours. Supernatants were stored at -80oC prior to enzyme-linked immunosorbent 
assays (ELISAs). Cytokines measured included transforming growth factor-β2 
(TGF-β2) (R&D Systems Cat No.DY302), interleukin-8 (R&D Systems Cat No. 
DY208), interleukin-6 (R&D Systems Cat No DY206) and i terleukin-10 (R&D 
Systems Cat No.DY217B), following the manufacturers instructions.  
Total protein concentration was measured in cell lysates using the BCA TM® 
protein assay kit (Thermo scientific USA, Cat No 232 7), following the 
manufacturer instructions. This was done in order to permit normalisation of the 
ELISA assay to the total protein content for each individual sample. 
2.7 Bacterial co-cultures:  
 
The cell line RPMI 2650 was seeded at a density of 1 x106 cells per well in a 24-
well plate. The same day 5ml of MEM were inoculated with one colony of 
Staphylococcus aureus strain Newman and incubated overnight at 37oC, rotating at 
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250 revolutions per minute (rpm). The following day  fresh 1:200 dilution of the 
overnight bacterial culture was inoculated in 5ml of MEM and allowed to grow for a 
further 3 hours in order to ensure that the bacteria used were in the logarithmic 
phase of growth. After 3 hours in culture, the bacterial suspension was washed 3 
times with MEM and resuspended in MEM to achieve an O.D. approximately of 
0.1. Appropriate volumes were added to the cells according to the desired 
multiplicity of infection (MOI) dose and bacterial suspensions were also plated on 
to tryptic soy agar (TSA) to perform viable counts the following day for further 
assessment of the bacterial dose used. 
 
The cells were washed twice with MEM and infected with two different doses of 
bacteria: 1 x 105 cfu/ml and 1.6 x 105 cfu/ml. After infection, the cells were 
incubated for a further 4 or 24 hours at 37oC/5% CO2 and samples were processed 
for cell lysis and RNA extraction (as will be described in section 2.9). Experiments 
were performed using the cell line A549 under identical conditions as described 
above. 
2.8 Development of an in-house tollip ELISA 
 
Recombinant human tollip protein was purchased from Abnova Cat No. 
H00054472-P01 Taiwan: Full length protein (275 a.a.) with a GST tag in a buffer 
with 50mM Tris-HCl, 10mM reduced glutathione, pH8.0. The recombinant 
protein was produced by a wheat germ cell-free protein synthesis system. The 
purity of the received protein was 90%. Ten microlit es of a stock solution of 
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tollip (initial concentration 100µg/ml) were diluted in 990µl PBS and serial 
dilutions performed to give an eight point standard curve (1000ng/ml, 500ng/ml, 
250ng/ml, 125ng/ml, 62.5ng/ml, 31.25ng/ml, 15.6ng/ml and 0ng/ml).  Four 
different anti-tollip antibodies were tested in order to develop the assay: antibody 
1: mouse, anti-human tollip monoclonal antibody (MO1), unconjugated, clone 
1A5-2A3 (Abnova corporation, Cat No.H00054472-MO1), antibody 2: rabbit anti-
human polyclonal antibody to tollip (Abcam, Cat No.ab56202), antibody 3: mouse 
anti-human tollip monoclonal (Kimmy-2) (Abcam, Cat No. ab16089) and finally 
antibody 4: rabbit anti-human polyclonal to tollip (Abcam, Cat No. ab37155). Best 
results were achieved using antibody four.  
 
A 96- well plate (Nunc) was coated with 100µl of either standard (human 
recombinant tollip as described above), or cell lysate and incubated overnight at 
room temperature. The following day the plate was washed with wash buffer 
(0.05% Tween 20 in PBS) three times and blocked with 1% bovine serum albumin 
(BSA)  (R&D Systems, Cat No. DY995) for one hour at room temperature. The 
plate was washed again three times with wash buffer and rabbit polyclonal 
primary antibody to tollip (Abcam, Cat No. ab37155-100) was diluted in PBS and 
added at a concentration of 10µg/ml to incubate for 2 hours at room temperature. 
 
The plate was then washed three times with wash buffer and goat anti-rabbit IgG 
complexed to horseradish peroxidase HRP (Zymax Cat No.62-6120) was added at 
1:2000 dilution in PBS with 1% BSA and incubated for 30 minutes at room 
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temperature. The plate was washed three times and 100µl of Sureblue 
tetramethylbenzidine (TMB) Microwell Peroxidase Substrate (KPL, Cat No. 
520001) reagent were added and incubated for 20 minutes, followed by 100µl of 
the stop solution 2N H2SO4. The plate was then read using the microplate data 
collection and analysis software, Biotek (Biotek instruments incorporated, 
Vermont, USA) optical densities were determined at 450nm with a reference filter  
of 540nm. Results were normalised to total protein co tent in the samples as 
previously mentioned in section 2.6. 
2.9 Rt-PCR for tollip in cell lines 
Total RNA was extracted from T84, RPMI 2650 and A549 cell lines using the 
Trizol extraction method (Chomczynski, P., and Sacchi, N., 1987). After each 
experiment, supernatant media was removed and monolayers were washed with 
PBS, 1 ml of Trizol (Invitrogen Cat No.15596-026) was added and cell lysates 
were stored at -80oC until assayed. After defrosting, 200µl of chloroform was 
added and incubated on ice for 5 minutes, followed by centrifugation at 12500g 
for 15 min at 4oC. After centrifugation 600µl of the clear top aqueous phase were 
aspirated gently and isopropanol was added. The tub was mixed and placed at -
80oC for 1 hour. Tubes were thawed on ice for 10 minutes and centrifuged at 
12500g for 20 minutes at 4oC. The supernatant was discarded and 300µl of ice 
cold 70% ethanol was added and vortexed for 5-10 seconds, followed by 
centrifugation at 12500g for 10 minutes at 4oC. The supernatant was removed 
taking care not to disrupt the pellet which was then allowed to dry for 15 minutes 
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at room temperature. Forty-three µl of RNAse-free water was added to the pellet 
and the mixture vortexed gently for 20 seconds at room temperature. Samples 
were then assayed for reverse transcription of RNA using the Improm-IIIM  System 
(Improm-IITM Reverse Transcriptase Cat No. A3802, Promega, Madison, USA).  
 
The reverse transcriptase polymerase chain reaction (RT-PCR) was performed 
using the following primers for tollip: forward primer: 
OM1:TACAGGCAAAGTTGGCCAA (which binds a region of the tollip gene 
between the second and third exons), reverse primer: 
OM2:AAGCAGCGCGTAGGACAT, (which binds to a region betw en the fourth 
and fifth exons). The expected product size was 347 base pairs (bp). Primers were 
designed with the help of Dr. Thomas Wilkinson using the software Primer3® 
(Whitehead Institute for Biomedical Research, Steve Rozen and Helen Skaletsky, 
USA).  
 
Complementary DNA (cDNA) was denatured at 94oC for 3 minutes, annealed at 
58oC for 1 minute and extended at 72oC for 1 minute for 35 cycles, and then 
allowed a final extension step at 72oC for 5 minutes. Samples were run using the 
PTC-100 Programmable Thermal Controller (MJ Research, Inc, Watertown, MA, 
USA). After PCR was completed, PCR products were then run on a 2% agarose 
gel and visualised using ethidium bromide staining on the Molecular Imager 
Versadoc MP4000 System PC (Bio-Rad Laboratories, Inc).  
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For the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping 
gene. Primers were designed using the Primer3 software as above. Forward 
primer: 5’-CGAGATCCCTCCAAAATCAA-3’ and reverse primer: 5’-
TGCTGTAGCCAAATTCGTTG-3’. Predicted product size was 727 base pairs. 
The PCR was performed in the same conditions as per tollip, but run for 20 cycles 
only.  
 
A second PCR reaction was performed using primers published in the literature by 
Otte, J., et al, 2004. The expected product size was 74 base pairs. The PCR 
conditions used were the same as above. 
 
2.10 Real-time PCR for Tollip 
Total RNA was extracted from primary nasal, bronchial and alveolar type II cells 
using the total RNA Isolation kit NucleoSpin RNA II(Macherey-Nagel Cat 
No.740955.50). A total of 1µg of RNA was reverse transcribed using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems Cat No.4368814) 
following the manufacturer’s instructions. Real-time PCR primers and probe for 
tollip were designed with the assistance of Dr. Thomas Wilkinson using the 
software Primer3® as mentioned previously in section 2.9. Forward primer: 5’-
TGGAATAAGGTCATCCACTG-3’, reverse primer: 5’-
AGAAGGCTCTCTCATCGAA-3’, Probe: 5’-CCCAGGCGTGGACTCTTTCTA-
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3’.  Dissociation curves were used to assess the quality of the primers and to rule 
out the possibility of having primer dimmers (Vandesompele, J., et al, 2002).  
 
Primers and probe were also designed for the housekeeping gene GAPDH using 
the same software. Forward primer: 5’-GAAGGTGAAGGTCGGAGTC-3’, 
reverse primer: 5’-GAAGATGGTGATGGGATTTC-3’ and probe: 5’-
CAAGCTTCCCGTTCTCAGCC-3’. Primers were tested and dissociation curves 
were performed to assess specificity and to rule out the presence of primer 
dimmers as described above. A second house keeping gene for PCR was chosen in 
order to perform normalisation of the gene of interest results: 18S, using a 
TaqMan® endogenous control (Eukaryotic 18S rRNA endogenous control Cat No. 
4352930E, Applied biosystems) 
 
Diluted cDNA (1:100) was used as a template for the PCR reaction and samples 
were loaded onto the Applied Biosystems 7500 Fast Real-Time PCR System. The 
specificity of the reactions was controlled by using “ o-template” and “no-reverse 
transcription controls”. Results were normalised to the human 18S gene using the 
standard curve method (Applied biosystems, 2008).  
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2.11 Comparison of the Cytokine profile between the cell-line RPMI 2650 
and A549 
RPMI 2650 and A549 cells were seeded in 6 well plates at 2 x 106 cells/ml and 
allowed to reach confluence. After the monolayers were established, cells were 
washed with medium (MEM and DMEM, respectively), 3 times and stimulated 
with 100ng/ml Pseudomonas aeruginosa ultrapure LPS (kind gift from Professor 
Ian Poxton from the Centre for Infectious Diseases), 10µg/ml of S. aureus PGN 
(Fluka, Sigma-Aldrich), 10µg/ml of S. aureus LTA or 10ng/ml of human 
recombinant tumor necrosis factor-alpha (Hr-TNF-α). Cells were incubated for 24 
hours and supernatants were removed and stored at -80oC until assayed. Enzyme-
Linked Immunosorbent Assay (ELISA) was used to measure cytokines in cell 
supernatants. Levels of IL-8, IL-6,IL-10 were determined using commercially 
available ELISA kits (R&D Systems), SLPI levels were determined using the 
SLPI quantikine ELISA kit (R&D Systems Cat No. DP100). Tollip levels were 
determined in cell lysates using the in-house ELISA developed protocol as 
described in section 2.8 above.  
 
2.12 Bacterial identification 
 
2.12.1 Identification of nasal carriage of Staphylococcus aureus 
Healthy volunteers and patients (as described in section 2.2.1 above) had a nasal 
swab performed prior to the isolation of primary nasal epithelial cells. A sterile 
cotton wool swab was moistened in sterile 0.9% saline and then the anterior 
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portion of the right nostril was swabbed, followed by inoculation on two separate 
horse blood agar plates (Oxoid). Plates were incubated t 37oC, on 5% CO2 
atmosphere for 18 to 24 hours. Multiple colonies were separated further into blood 
agar and chocolate agar plates (Oxoid) and re-incubated. Once plates appeared to 
have a single predominant type of colony, bacterial identification was performed 
primarily to investigate the growth of the bacterium S. aureus. 
All Gram-positive colonies were tested for catalase production, Staphytect test and 
coagulase production (please see below).  
2.12.1.1 Catalase Test: 
In order to exclude growth of streptococci (catalase negative), a full colony of 
the bacterium being grown onto chocolate agar was tested was transferred onto a 
glass slide and one drop of 3% hydrogen peroxide (Sigma Aldrich Cat No.H-
1009) was added. The slide was then observed for “bubble formation”: the rapid 
and sustained appearance of bubbles /effervescence was interpreted as a positive 
test. The appearance of small bubbles after 20 to 30 seconds was not considered 
a positive test. Staphylococcus aureus strain Newman was used as a positive 
control and a Streptococcus strain was used as a negative control was every time 
that the test was performed. 
2.12.1.2 Latex agglutination test 
This diagnostic test for the differentiation of Staphylococcus aureus utilises the 
detection of clumping factor, protein A and some polysaccharides found in 
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methicillin resistant Staphylococcus aureus (MRSA) from those staphylococci 
that do not possess these properties. It uses latexbeads coated with plasma. 
Fibrinogen bound to the latex detects clumping factor. In addition, 
immunoglobulin molecules also present in the beads detect protein A (Staphytect 
plus, Oxoid, Cat No. DR0850 and M43 MicrogenTM STAPH, Microgen 
bioproducts, Surrey, UK). Briefly, a drop of the test reagent and the control 
reagent were added onto the reaction card, followed by the inoculation of a 
loopful of a colony to be tested, the suspension was mixed with a sterile loop and 
then mixed by rocking the test card by hand for 60 seconds observing the 
development (or not) of agglutination in the sample. Each single reaction was 
also tested with a known strain of S. aureus strain Newman as a positive control.  
2.12.1.3 Tube coagulase test 
Free coagulase is a thrombin-like substance present in culture filtrates. Once a 
suspension of coagulase-producing organisms is prepared in plasma in a test tube, 
a visible clot forms as a result of the coagulase reacting with a serum substance 
(coagulase reacting factor) to produce the fibrin clot. Eighteen to twenty four hour 
cultures were tested by adding a loopful of the test strain to a tube containing 
500µl of rabbit plasma with EDTA (Animal Biologicals Cat No. IRB-N). The tube 
was then incubated at 37oC for 4 hours at which time clot formation was observed 
by gently tilting the tube. If no clot was observed at that time point, the tube was 
re-incubated at room temperature for a further 18 hours and read again. The test 
was considered to be positive if a visible clot was ob erved either at 4 or 24 hours. 
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A positive control (S. aureus strain Newman) was used and a negative control 
(coagulase negative Staphylococci) were tested each time.  
 
2.13 Toll-Like Receptors in Primary nasal epithelial cells 
The expression of TLRs in primary nasal epithelial cells was assessed by 
immunocytochemistry and confocal microscopy. Primary nasal epithelial cells 
were seeded into sterile coverslips and processed a escribed above in section 
2.5.1. Antibodies were used against TLR-1, 2, 4, 6 and 9. Primary human 
monocytes were used as positive controls. They were obtained from consented 
healthy donors after a separation protocol; they were a kind gift from Dr. HiSin- 
Ni Li from the Davidson’s group, Lung Inflammation group, Centre for 
Inflammation Research, (CIR), University of Edinburgh. For antibody 
concentrations and further details please refer to the table 2.1. 
2.14  Flow Cytometry of Nasal Brushings 
This work is the result of collaboration with Dr. Paul Fitch from the 
Schwarze/Immunity and chronic inflammation group based at the QMRI, 
University of Edinburgh.  
 
Healthy volunteers were consented for performing nasal brushings analysed by 
flow cytometry. Volunteers were asked to clean their nose and a sterile wool swab 
lightly moisturised in 0.9% saline was used to perform a nasal swab. The swab 
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was inoculated on a horse blood agar plate as describ d above in section 2.2.1. 
Under direct vision of the inferior nasal turbinate  sterile cervical brush was used 
to obtain nasal cells. The material obtained was reuspended in PBS and 
centrifuged at 275g for 5 minutes at 4oC. It was then resuspended in ice cold 
FACS wash fluid (CellWASH, Cat No. 349524, Becton Dickinson biosciences) 
containing 1% mouse serum, using a syringe and a 19g or 20g needle, the sample 
was mixed gently until it was deemed to be a homogeneous cellular suspension. 
The suspension was centrifuged at 275g for 5 minutes a  4oC and the supernatant 
was discarded, followed by vortexing of the pellet. The cells were resuspended in 
a final volume of 200µl with FACS wash fluid containing 1% mouse/rat serum 
and a cell count was performed. A 50µl of cell suspension was added to a black 
bottom low adherence 96-well plate (Nunc® FluoroNunc™ Cat No. P8741, 
Sigma), kept on ice and 1:10 dilution of the relevant ntibody was added and 
mixed well. The plate was incubated for 30 minutes on a gently rocking platform 
at 4oC. After which the plate was centrifuged at 300g for 5 minutes and the 
supernatant was removed. Two hundred µl of FACS-lysing solution (Becton 
Dickinson, Cat No349202) was added to the samples and mixed gently. The plate 
was incubated in the dark for a further 8 minutes at 4oC. After incubation, it was 
centrifuged at 300g for 5 minutes at 4oC and washed three times with FACS wash 
solution. Cells were resuspended in 200µl FACS wash, protected from light and 
stored at 4oC until run in the BD FACScalibur flow cytometer (Becton Dickinson 
and company©) held at the cytometry facility based at the CIR in the Queen’s 
Medical Research Institute, University of Edinburgh. Once ready for assay, 
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samples were transferred onto FACS tubes (BD biosciences) containing 100µl 
PBS. The forward scatter (relative size) verses side catter (relative granularity) 
gates were defined using a heat and UV killed Propidium Iodine stained cell 
control to exclude dead cells.  
  
The antibody panel included antibodies raised against CD16 (FITC labelled-BD 
Pharmingen, Cat No. 555406), epithelial cell adhesion molecule (EPCAM) (PE 
labelled-BD Pharmingen Cat No.347198), CD14 (PERCP labelled-BD 
Pharmingen Cat No. 345786) and CD3 (APC labelled-BD Pharmingen Cat No. 
345767). 
2.15  Cytokine response by primary nasal epithelial cells  
Primary nasal epithelial cells from healthy volunteers and patients were cultured to 
confluence as described above in section 2.2.1. The cells were used at passage 
two, once confluent. Monolayers were washed 3 times with fresh BEGM and non 
stimulated or stimulated with 100ng/ml of Pseudomonas aeruginosa ultrapure 
LPS (kind gift from Professor Ian Poxton from the Cntre for Infectious Diseases), 
10µg/ml of S. aureus PGN (Fluka, Sigma-Aldrich), 10µg/ml of S. aureus LTA, 
1µM of the oligonucleotide CpG-C DNA prototype ODN 2395 (Hycult 
biotechnology b.v., Cat No. HC4041) and 10ng/ml of Hr-TNF-α. Cells were 
incubated for 24 hours at 37oC/5% CO2. Supernatants were removed and stored at 
-80oC until assayed using the BDTM Cytometric Bead Array (CBA) Human 
Inflammatory Cytokine kit (BD Biosciences Cat No.551811), which measures IL-
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8, IL-6, IL-1β, IL-10, TNF and IL-12p70 using the BD FACSarray at the CIR 
Flow Cytometry Facility in the QMRI. The results were analysed using GraphPad 
Prism (Version 5 GraphPad Software, Inc. La Jolla, CA). For S. aureus 
colonization experiments the cytokine concentration was related to the particular 
colonisation status of each individual subject. 
 
2.16  Cytokine response by primary bronchial epithelial cells 
Primary bronchial epithelial cells from patients undergoing pulmonary lobectomy  
or pneumonectomy were grown to confluence as described above  in section 2.2.2 
and supernatants were assayed using identical conditions as for the primary nasal 
epithelial cells. 
 
2.17 Cytokine response by primary type II alveolar epithelial cells 
Type II alveolar epithelial cells were harvested as de cribed above in section 2.2.3 
and plated onto plates pre-coated with bovine type I collagen. Cells were allowed 
to adhere to the collagen and then washed with HBSS. Once they achieved 
confluence (approximately after 5 days), they were washed 3 times with DCCM-1 
medium supplemented with L-glutamine, 10% foetal calf serum, 1% 
penicillin/streptomycin and then stimulated with 100ng/ml Pseudomonas 
aeruginosa ultrapure LPS, 10µg/ml of Staphylococcus aureus PGN, 10µg/ml of 
Staphylococcus aureus LTA, 1µM of the oligonucleotide CpG-C DNA prototype 
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ODN 2395 and 10ng/ml of Hr-TNF-α. Cells were incubated for 24 hours at 37oC 
and supernatants were removed and stored at -80oC until assayed using the BDTM 
Cytometric Bead Array (CBA) Human Inflammatory Cytokine kit (BD 
Biosciences Cat No.551811), which includes IL-8, IL-6, IL-1β, IL-10, TNF and 
IL-12p70 using the BD FACSarray at the Flow Cytometry Facility in the QMRI. 
Statistical analysis was performed using the GraphPd rism software (Version 5 
GraphPad Software, Inc. La Jolla, CA). 
2.18 TLR-9 stimulation experiments in primary nasal epithelial cells and 
primary type II alveolar epithelial cells 
In order to try to elucidate the role of TLR9 in the innate immune response to 
bacterial DNA, primary nasal epithelial cells were s eded in a 12-well plate 
(Costar) until confluence. Once confluent, cells were washed three times with 
fresh BEGM and then exposed to 1µM of the oligonucleotide CpG-C DNA 
prototype ODN 2395 (Hycult biotechnology b.v., Cat No. HC4041), 10µM of the 
inhibitory oligonucleotide ODN TTAGGG (Invivogen Cat No.tlrl-hinhodn) or left 
unstimulated for 24 hours at 37oC/5% CO2. Cells were challenged further for 24 
hours by the addition of 100ng/ml P. aeruginosa LPS, 10µg of S. aureus LTA, 
1µM of CpG-C DNA or 10µM of ODN TTAGGG. After a total incubation of 48 
hours at 37oC supernatants were removed and stored at -80oC for cytokine assays 
and cells were harvested and lysed for protein analysis. 
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Type II alveolar epithelial cells were seeded onto wells pre-coated with bovine 
type I collagen in a 12-well plate and cultured until confluence around day 5 and 
exposed to bacterial DNA and bacterial products under i entical conditions to 










3.1. Comparison of differences between cells from the respiratory tract 
3.1.1. Introduction 
 
The vocal cords represent a landmark demarcating the upper and lower 
respiratory tract. The lower respiratory tract can be conveniently divided again 
into the conducting airways (as far as the terminal bronchioles) and gas-
exchanging regions of the lung (from the respiratory bronchioles to the alveoli). 
The use of epithelial cell lines has been widespread in the research into the 
respiratory tract, particularly since epithelial cel lines are easily accessible, easy 
to store and have so far provided valuable information regarding the cellular 
behaviour of nasal as well as lung epithelium. On the other hand, cell lines may 
not be representative of primary cells from the corresponding region. For 
example the nasal epithelial cell line RPMI 2650 is derived from a human nasal 
cell carcinoma (Moorhead, P., 1965) and the type II alveolar epithelial cell line 
A549 is derived from a lung adenocarcinoma (Lieber, M., et al, 1976) Cancerous 
cells grow at a very high speed, lack the contact inhibition that normal cells 
possess and are metabolically more active (Hanahan, D., and Weinbergh, R., 
2000, Pan, C., et al, 2009). They are also good at disguising themselves from the 
immune response in order to be able to proliferate. Wistuba and coworkers have 
compared 12 types of human non-small cell lung cancer (NSCLC) cell lines with 
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their corresponding original tumours and found that NSCLC cell lines retain the 
properties of their parental tumours for long periods of time (Wistuba, I., et al, 
1999). In contrast, primary cells are difficult to obtain, very fragile during culture 
and not easily stored, and have a limited lifespan. Nevertheless these cells are the 
preferred material in order to establish normal physiological epithelial cell 
behaviour.  
The hypothesis that I would like to test are: 
1. “nasal epithelial cells have a lower intrinsic capacity than alveolar 
epithelial cells to mount an inflammatory response to S. aureus” 
2. “nasal and alveolar epithelial cell lines mimic poorly primary nasal and 
alveolar epithelial cells” 
In view of these considerations, my aim was to characterize the phenotype and 
cytokine response of cell lines considered representative of the upper and lower 
respiratory tract, and to compare them to primary human epithelial cells of the 
respiratory tract. For this I used the cell line RPMI 2650 and compared it against 
primary human nasal epithelial cells. In addition I studied the cell line A549 and 
compared it against primary human type II alveolar epithelial cells.  
 
3.2. Characterisation of the upper respiratory tract 
3.2.1. The cell line RPMI 2650 
The human nasal epithelial cell line RPMI 2650 has been described in the past to 
closely resemble the normal nasal epithelium, especially regarding karyotype 
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(Moorhead, P., 1965) and cytokeratin polypeptide pattern. It typically grows in 
clusters both horizontally as well as vertically and does not form neat 
monolayers in vitro (Figure 3.1) (Salib, R., et al, 2005; De Fraissinette, A., et al, 
1995; Kasper, M. and Stosiek, P., 1990). On light microscopy the cells were 
observed to be small in size, with a granular appearance. Rapid growth with a 
high mitotic rate was also observed, in accordance with the findings of Bai, S., et 
al, 2008. Although it has been reported by Moore and Sandberg (1963) and 
Moorhead (1965) that this cell line exhibits the prsence of mucoid material at 




Figure 3.1. Morphology of the human nasal cell line RPMI 2650.  
Cells were cultured in MEM supplemented with L-glutamine, non-essential aminoacids, 
sodium pyruvate and 10% foetal bovine serum in 24 well plates. Cells were plated at 
5x105 cells/ml, and photomicrographs were taken 24 hours after initial inoculation of the 
plate. 650x magnification. 
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3.2.1.1. Cytokeratin pattern 
 
After establishing the basic culture conditions forthe cell line, I proceeded to 
characterise the cells according to their cytokeratin expression pattern. This was 
done using immunocytochemistry techniques and confocal microscopy. RPMI 
2650 cells displayed low expression of cytokeratin 10 and high levels of 
cytokeratin 7-17, cytokeratin 18 and vimentin. These findings are in keeping 
with previous observations (De Fraissinette, A., et al, 1995; Moll, R., et al, 















         
   
 
 Figure 3.2. Cytokeratin polypeptide pattern of the RPMI 2650 cell line.  
RPMI 2650 cells were plated at 2.5 x105/ml in coverslips, fixed with methanol, blocked 
with 2% goat serum and subsequently incubated with murine monoclonal antibodies 
against a) Cytokeratin 7-17, b) Cytokeratin 18, c) Cytokeratin 10, d) Vimentin e) Isotype 
control. Nuclei were stained with DAPI (blue). Secondary antibody was anti-mouse IgG 
Alexa 488(green). Images were analysed using confocal microscopy. Scale bar equals 
25µm in detailed images, 50µm for the isotype control. The typical morphology of 
cytokeratin filaments is observed. 






3.2.1.2. Constitutive cytokine production 
 After the cytokeratin expression confirmed the epithel al phenotype of the cell 
line, I proceeded to perform functional studies on its constitutive behaviour. The 
RPMI 2650 cell line has been reported to produce the cytokine TGF-β2 (Salib, 
R., et al, 2005, Carey, B., et al, 1993). The secretion of TGF-β2 into cell-free 
supernatants appears to be an active process, levels of this cytokine at 4 hours 
were 193.6 pg/mg of lysate protein (+73.21) and rose significantly to 516.1 

































Figure 3.3. TGF-β2 production by the human nasal cell line RPMI 2650 
(n=3).  
The cells were plated at 5 x105 cells/ml in a 24 well plate. Once they achieved 
90% confluency, supernatants were removed at different time points and TGF-
β2 levels were measured by ELISA and normalised to total protein content in 
cell lysates. Negative control: cell-free medium 
Data are presented as mean (columns) +SD (error bars). Data analyzed using 
ANOVA, post test: Dunn’s test. 
Statistical significance (*) determined when p<0.05. 
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Constitutive levels of the pro-inflammatory cytokines IL-8, IL-6, TNF-α were 
non detectable in RPMI 2650 cells by ELISA. 
Since the characterisation of the cell line RPMI 2650 was in agreement with the 
findings in the current literature, I proceeded to try to establish an infection 
model to provide important information regarding the interaction between 
Staphylococci and nasal epithelium that happens early during the colonisation 
process.  
 
3.2.1.3. Bacterial and eukaryotic co-culture experiments 
Bacterial and eukaryotic co-culture experiments provide useful and valuable 
information on the real dynamics of eukaryotic-prokaryotic interactions. Since 
one of the main objectives of this work was to try to investigate how S. aureus 
interacts with the respiratory epithelium and to try o dissect fundamental 
differences between the responses, eukaryotic and prokaryotic cultures were 
performed using the nasal cell line RPMI 2650 and the bacterium Staphylococcus 
aureus strain Newman. 
 
S. aureus was grown in TSB and MEM culture media. A growth curve showed 
optimal growth in TSB. Growth on MEM, despite being slightly lower, was 


















MEM + Staph 
 
Figure 3.4. Growth curve of Staphylococcus aureus in TSB and MEM media.  
S. aureus strain Newman was grown overnight in TSB medium or MEM medium 
rotating at 250 rpm, at 37oC in air. The following day a 1:200 dilution solution was 
prepared using both media and aliquots of medium were taken hourly to measure the 
optical density (O.D.). Data are presented as mean + standard error of the mean (SEM) 
of four consecutive experiments. 
 
Once I established that the growth of Staphylococci was comparable in cell 
culture medium and TSB, I went on to design a model to mimic the early stages 
of colonisation, for which the infecting doses were at a ratio of approximately 1 
bacterium per 10 cells (1. x 105 colony forming units (cfu)/ml) or approximately 
1 bacterium per 6 cells (1.6 x 105 cfu/ml). RPMI 2650 cells were cultured in 
MEM media in the absence of antibiotics and infected with S. aureus strain 





Figure 3.5. Co-culture of S. aureus strain Newman with the cell line RPMI 
2650.  
Cells were plated at 1 x 106 cells/ml and infected with 1.1 x 105 cfu of S. aureus, 
microphotographs were taken prior to infection a) and at 3 hours (b). 






After infection with S. aureus strain Newman, within 2 hours it was possible to 
observe rapid growth of the bacterium, by three hours there was evidence of 
microcolony formation by the bacteria within the cell monolayer. The normal 
cellular architecture was destroyed at 3 hours with loss of the cellular 
morphology and invasion of the monolayer by the bacterium. Beyond 4 hours the 
cellular layer was barely discernible. 
During these cultures it was possible to observe the rapid proliferation of the 
bacteria among the eukaryotic cells. These experiments were performed in the 
absence of antimicrobials in the culture medium in order to provide a 
physiological environment to model the colonisation status. Establishing how the 
dynamics of bacterial colonisation happen is difficult, since it is a highly 
complex process. On one hand, if the infective dose is too high, a severe immune 
response will be initiated and the pathogen will be cleared. Therefore, I assumed 
that the infective dose should be small enough to avoid immunological clearance, 
but at the same time large enough to ensure the survival of the pathogen. 
Unfortunately, S. aureus proved to behave in an aggressive way with the cells, 
with formation of Staphylococcal micro-colonies within the epithelium at 3 
hours, and loss of architecture by 4 hours. Several approaches were attempted in 
order to delay the onset of cellular death, such as shortening the time points and 
decreasing the infective dose to a ratio of 1 cfu per 100 cells. Despite this it was 
not possible to improve the performance of the model. 
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3.2.1.3.1. Quantitative PCR during S. aureus infection 
 
During the work with prokaryotic and eukaryotic cell cultures, quantitative PCR 
(QPCR) was performed to assess individual eukaryotic gene responses during 
infection.  
The cell line RPMI 2650 was infected as described above and QPCR for the gene 
of interest and for the housekeeping genes GAPDH was performed. It was 
observed that after a 4 hour infection of RPMI 2650 cells with S. aureus, 
multiple gene changes happened simultaneously, particul rly when assessing 
housekeeping genes. Housekeeping genes are genes that are required for the 
maintenance of basal cellular function and are constitutively found in all human 
cells (Eisenberg, E., and Levanon, E., 2003)  It is expected that these genes 
should be transcribed at a constant rate and that they should provide a baseline to 
establish further comparisons. I expected to find no variation in the 
quantification of these transcripts. On the contrary, GAPDH mRNA transcripts 
were constitutively expressed at a low level and appe red to be up-regulated after 
infection. In view of this finding I went onto asse a different housekeeping 
gene and performed QPCR for the 18S gene which is involved in protein 
synthesis and which according to the literature is a commonly gene used for 
establishing a baseline. Contrary to expectation, in these experiments it was 
possible to observe that the 18S gene also displays great variability during 



























Figure 3.6. Expression of GAPDH and 18S mRNA in the human nasal 
epithelial cell line RPMI 2650 before and after 4 hours infection with S. 
aureus strain Newman.  
RPMI 2650 cells were plated at 1 x 106 per well.  
Once the cells achieved 90% confluence, they were infected. RNA extraction 
was performed followed by QPCR using the primers and probes described in 




























S. aureus low dose S. aureus high dose 
S. aureus high dose S. aureus lo  dose 
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To my knowledge there is no current evidence in the li erature of the effects of S. 
aureus infection on housekeeping genes in human cells. In the case of viral 
infections, Nystrom, K., et al, 2004 demonstrated that GAPDH levels varied by 
several orders of magnitude during herpes simplex virus type-1 (HSV1) infection 
of human embryonic lung fibroblasts, although they found less variation in 
comparison with 18S mRNA. In addition to this, Dheda, K., et al, 2004, 
demonstrated a high variability of GAPDH in peripheral blood mononuclear cell 
culture from healthy individuals and patients with tuberculosis. Moreover, 
Zhong, H., et al, 1999 have reported variability in GAPDH among cell types 
during cell proliferation and development, as well as in response to various 
stimuli such as hypoxia, insulin, dexamethasone and mitogens as well as to 
experimental treatments.  
The role of 18S has also been questioned as a housekeeping gene. A study by 
Araya, M., et al, 2008, demonstrated 18S as highly unstable when comparing 
nine candidate housekeeping genes during the study of haemocytes from soft-
shell clams challenged with Vibrio splendidus. Furthermore, the effects of 
adenovirus infection on 28S and 18S rRNA synthesis and maturation in HeLa 
cells were described in 1983 by Castiglia, C. and Flint, S. They observed that 
after adenoviral infection protein synthesis was inhibited rapidly.  
The overwhelming effect that the bacterial infection had on the cellular 
monolayers was documented when real-time PCR was performed in the 
monolayers. The detection of the genes GAPDH and 18S showed an alteration in 
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their expression which might be explained by alterations in the consumption of 
energy and ribosomal protein synthesis as a result of the bacterial infection. The 
results may indicate that during an in vitro bacterial infection, and without an 
innate immune system that would assist in controlling the infection, the cells are 
overwhelmed by the injury and multiple cellular processes happen 
simultaneously, making this model a very difficult one in order to establish 
mechanisms. In addition, cytokine measurements in supernatants could not be 
performed by conventional ELISA methods, due to theint rference of the 
Staphylococcal virulence factor protein A, which binds with high avidity the Fc 
fraction of IgG (Kessler, S., 1975). Prokaryotic and eukaryotic co-cultures were 
also attempted with the methicillin-resistant Staphylococcus aureus (MRSA) 
strain 252 and with isogenic mutant strains with deletions in clfb and protein A, 
with similar results to those previously described. Due to these difficulties it was 
considered that this was a highly complex model in which it would not be 
possible to establish single differences involved in the epithelial recognition of, 
and response to, Staphylococcal antigens, and it was decided to change the 
approach to using a sterile microenvironment model in which variables could be 
controlled in a better manner.  
 
The advantage of using a sterile model that mimics exposure to single virulence 
factors was demonstrated in primary human nasal epithelial cells, where it was 
shown that  bacterial ligands did not change expression of the housekeeping gene 
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18S. After implementing a sterile method in which cells were stimulated with 
bacterial ligands such as Pseudomonas aeruginosa LPS, Staphylococcus aureus 
PGN and LTA and the pro-inflammatory cytokine TNF-α, 18S transcripts were 
measured over a 24 hour period (Figure 3.7). Althoug  baseline levels of 18S 
appeared lower in comparison to the baseline levels found in the RPMI 2650 cell 
line (shown in Figure 3.6), it was noted that they r mained constant throughout 


























Figure 3.7. Expression of 18S mRNA in the human primary nasal epithelial 
cells after 24 hours stimulation with TLR ligands  
Primary human nasal epithelial cells were plated onto u coated plastic plates.  
Once the cells achieved 90% confluence, they were stimulated with bacterial 
ligands. RNA extraction was performed followed by QPCR using the primers 
and probe as described in section 2.10 of Materials and Methods.  
Results are presented as a mean of replicates from one representative 
experiment. 
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3.2.1.4. Cytokine production by the cell line RPMI 2650 after 
stimulation with TLR ligands 
 
RPMI 2650 cells were cultured and stimulated with bacterial ligands such as P.
aeruginosa LPS at 10ng/ml and 100ng/ml, S. aureus PGN at 10µg/ml and 
100µg/ml, S. aureus LTA at 10µg/ml and TNF-α at 10ng/ml for 24 hours. Cell 
viability was assessed using trypan blue exclusion. Cell viability was not 































Figure 3.8 Viability counts in RPMI 2650 cells after stimulation with TLR 
ligands 
Cells were seeded in 6 well plates at 2x106 cells/ml and stimulated with 
bacterial ligands as described above. Cells were trypsinised and viability counts 
were performed using trypan blue exclusion method. 




LPS activity was assessed using the Limulus amoebocyte lysate (LAL) assay. P. 
aeruginosa PAO1 LPS activity was comparable in activity to E. coli LPS (data 
courtesy of Dr. Hsin- Ni Li, University of Edinburgh). 
 
RPMI 2650 cells were stimulated with TLR ligands as well as with the pro-
inflammatory cytokine TNF-α as described above. Despite of being viable, 
median constitutive levels of IL-8 and SLPI were non detectable by ELISA in 
supernatants; neither did these cells respond to stimulation. The secretion of IL-6 
was very low; just at the limit of detection of the ELISA assay and it was not 
affected by stimulation. Constitutive median production of the anti-inflammatory 
cytokine IL-10 by the cell line RPMI 2650 was 32.8 pg/ml  (range: 0-118). This 
was not increased after incubation with bacterial ligands such as LPS, PGN or 
LTA, nor by stimulation with the pro-inflammatory ctokine TNF-α. 
 
3.2.2. Characterisation of the primary nasal epithelial cells 
3.2.2.1. Description of healthy volunteers and patients 
A total of 44 subjects were consented for the isolation of primary nasal epithelial 
cells. Of these 22 were healthy volunteers (HV) and22 were patients undergoing 
partial lobectomy or pneumonectomy in the Department of Cardiothoracic 
Surgery, Royal Infirmary of Edinburgh. Regarding the HV group; there were 16 
males and 6 females, mean age was 31 years (range: 24-42), and there were 3 
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smokers. Successful cultures were achieved for 12 subjects (54%). Cultures were 
deemed unsuccessful if the cells failed to attach to the collagen matrix (7 
subjects) or if the cells failed to achieve confluenc  in culture after three weeks 
(3 subjects).  
 
The patient group consisted of 11 males and 11 females who provided consent 
for nasal brushings to be performed The mean age of this group was 65 years 
(range: 53-76), and 17 were smokers. Successful cultures were achieved for 10 
subjects (45%). Twelve cultures were unsuccessful: one due to fungal 
contamination and eleven due to failure of the cells to attach to the collagen 
matrix (Table 3.1). 
Median time to confluence was 1 week for the first passage and subsequently 
cells were sub-cultured in separate wells for the sp cific experiments, in which 
the median time to confluence was 2 weeks. All the experiments were performed 




Subject Age Sex Smoker Culture 
Successful 
Reason for no success 
HV1 42 M N Y  
HV2 31 M N Y  
HV3 34 M N N Failed to attach 
HV4 35 F N Y  
HV5 34 M N Y  
P1 75 M Y N Fungal infection 
P2 53 F Y N Failed to attach 
HV8 26 F N Y  
P3 66 M Y Y  
HV10 33 M N Y  
HV11 26 F N Y  
HV12 28 M N N Failed to attach 
P4 76 M N N Failed to attach 
HV14 28 M N N Unable to reach 
confluence 
HV15 30 M N N Failed to attach 
HV16 30 M N Y  
HV17 28 M N Y  
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HV18 32 M N Y  
HV19 34 M N N Failed to attach 
P5 59 F Y N Failed to attach 
P6 57 M Y Y  
HV22 35 M N N Unable to reach 
confluence 
HV23 33 F Y N Unable to reach 
confluence 
P7 70 F Y N Failed to attach 
P8 63 F N N Failed to attach 
P9 64 F Y Y  
HV27 32 F Y N Unable to reach 
confluence 
HV28 34 M N N Failed to attach 
P10 71 M Y Y  
HV30 24 M N Y  
HV31 32 F Y Y  
HV32 36 M N N Failed to attach 
P11 59 F N N Failed to attach 
P12 60 F Y N Failed to attach 
P13 67 M Y Y  
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P14 77 F N N/A Did not consent 
P15 61 M N Y  
P16 60 F N Y  
P17 69 F Y N Failed to attach 
P18 73 F Y N Failed to attach 
P19 72 M N Y  
P20 57 M Y Y  
P21 59 M Y N Failed to attach 
P22 71 M Y N Failed to attach 
P23 69 F Y Y  
Total    22 22 
Table 3.1. Demographic data for healthy volunteers and patients from whom 
primary nasal epithelial cells were obtained. 
HV, Healthy Volunteer; P, Patient; N/A, non applicable. 
 
 
3.2.2.2. Flow cytometry in primary nasal epithelial cells 
In order to establish the phenotype of the cells obtained during nasal brushings, 
cells from 20 healthy volunteers whom already had consented for nasal brushings 
were used for flow cytometry. For further details about the phenotype of the cells 




3.2.2.3. Morphological appearance of the primary nasal 
epithelial cells 
Immediately after the brushings were performed the cell suspension was plated 
onto pre-coated type I collagen wells and it was posible to visualise ciliated 
cells. After the culture was established and reached 90% confluence it was 
possible to visualise the typical “cobblestone” morphology under light 
microscopy as described by McDougall, C., et al, 2008. Some cells exhibited 
slight prolongations (Figure 3.9)  
 
Figure 3.9 Morphology of human primary nasal epithelial cells.  
Cells were obtained after brushing of the inferior turbinate of the nose and seeded onto 
plastic plates pre-coated with type I rat-tail collagen. Cells reached confluence after 
approximately 7 days. Magnification 650x. Cells display the typical cobblestone 







3.2.2.4. Phenotyping of primary nasal epithelial cells 
Phenotyping of primary nasal epithelial cells showed a high content of 
cytokeratin 18 and cytokeratin 19. I was unable to detect cytokeratin 10 
expression in these cells. Vimentin staining of the cells was variable - 80% of the 
cells stained positive for vimentin with 27% of the c lls staining strongly to it, 
whereas all cells (100%) stained positive for the epith lial markers CK18 and 
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b) CK 19 













Figure 3.10 Phenotyping of human primary nasal epithelial cells.  
Primary human nasal epithelial cells were plated on coverslips, fixed with 4% 
paraformaldehyde solution, blocked with 2% goat serum, and subsequently incubated 
with murine monoclonal antibodies against a)Cytokeratin 18, b)Cytoketatin 19, 
c)Vimentin, d)Cytokeratin 10 and e)Isotype control. Nuclei were stained with DAPI 
(blue). Secondary antibody was anti-mouse IgG linked to Alexa 488(green).  
Images were analysed using confocal microscopy. Scale bars: 50µm for low 
magnification images and 25µm for high magnification.  The typical morphology of 




e) Isotype control 
d) CK 10 
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3.2.2.5. Cytokine production by primary nasal epithelial cells 
Culture and isolation of primary human nasal epithelial cells was difficult due to 
problems in obtaining volunteers and because it is a demanding, skilled 
technique. In addition the attachment and proliferation of cells during culture 
varies form subject to subject. Cell-free supernatats were removed and assayed 
by ELISA initially and then standardised using the CBA kit in order to avoid 
operator error which could occur during ELISA.  
 
The cytokines assayed included IL-8, IL-6, IL-1β, IL-12p70, IL-10 and TNF-α. 
Within this selective group of cytokines IL-8, IL-6 and IL-1β were chosen as 
there is evidence that these are secreted in response t  stimulation with TLR 
ligands by respiratory epithelial cells (Cheon, I., et al, 2008; Burvall, K., et al, 
2003; Berube, J., et al, 2009). TNF-α and IL-12p70 were chosen as they are 
predominantly secreted by macrophages, T cells and de ritic cells (particularly 
the latter one), and in this way it would be possible to demonstrate functionally 
that the monolayers were predominantly composed by epithelial cells and that 
there was no contamination with the previously mentioned cell types 
(Bekeredjian-Ding, E., et al, 2006 and Barkman, C., et al, 2008). Finally, IL-10 
was chosen as a cytokine known by its anti-inflammatory properties. Whilst it 
would have been ideal to report the levels for the cytokine TGF-β2 and the 
antimicrobial peptide SLPI, it was not possible to pr duce these results due to 
lack of supernatant. It would be of great interest to include these molecules in 
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future research studies. It is also relevant to mention that due to limited numbers 
of cells obtained during the preparations, the cell lysates were used for 
performing RNA extraction and PCR, therefore cytokine correction in 
supernatants to total protein content in cell lysate  was not performed. For this 
analysis, cells from five patients were included (Table 3.2) 
 
 
Subject Age Sex Smoker 
Patient 3 66 M Y 
Patient 6 57 M Y 
Patient 9 64 F Y 
Patient 20 57 M Y 
Patient 23 69 F Y 
 





Primary nasal epithelial cells produced constitutive levels of all of the cytokines 
assayed (IL-8, IL-6, IL-1β, TNF-α, IL-10 and IL-12p70). There were differences 
in constitutive production among patient’s cells, particularly for IL-8, IL-6 and 
IL-1β. Stimulation with S. aureus PGN and the pro-inflammatory cytokine TNF-
α, were associated with an increase in the secretion of the cytokines IL-8 and IL-
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6. Stimulation with P. aeruginosa LPS or S. aureus LTA were not associated 
with an increase in the levels of IL-8 or IL-6. There was not an associated 
increase in the secretion of the cytokines IL-1β, TNF-α, IL-10 or IL-12p70 after 
stimulation with TLR ligands or TNF-α. For further details, please refer to table 
3.7, page 143 in which the data are presented. 
 
 
3.2.3. Characterisation of cells from the airway 
3.2.3.1. Primary bronchial epithelial cells  
Primary bronchial epithelial cells were obtained using blind brushings through an 
endotracheal tube as described in the Materials and Methods section. A total of 
nine sets of primary bronchial epithelial cells were obtained from nine consented 
patients, of whom only one set was successfully cultured. These cells were used 
in immunocytochemistry studies (see Chapter 4). Oneculture was contaminated 
with a fungal infection and the remaining seven failed to attach to the collagen 
matrix. Due to the lack of success of this technique it was discontinued after 
patient number 9 was recruited into the study. It is likely that one of the main 
limitations in these cultures was that the bronchial brushings were performed 













Final diagnosis Smoker Cultures 
Successful 
1 75 M RL Squamous lung cell Ca Y N 
2 53 F RL Aspergilloma Y N 
3 66 M LL Non small cell lung Ca Y Y 
4 76 M RL Single lung metastasis 
from bowel Ca 
N N 
5 59 F LU Squamous cell Ca Y N 
6 57 M LL Non small cell lung Ca Y N 
7 70 F RU Bronchogenic Ca Y N 




9 64 F L* Squamous cell Ca Y N 
 
Table 3.3 List of patients from whom primary bronchial epithelial cell cultures 
were attempted.  
Patients who underwent lung resection were consented. After induction of  anaesthesia, 
a bronchoscopy brush was inserted blindly through the endotracheal tube and bronchial 





3.3. Characterisation of the cells of the lower respiratory tract 
3.3.1. Characterisation of the cell line A549 
The cell line A549 has been characterised in the lierature (Lieber, M, et al, 1976; 
Foster, K., et al, 1998) as a type II alveolar epithel al cell model for metabolic 
studies and also as a model for in vitro characterisation of human alveolar 
epithelial cell functions.  
A549 cells have been reported to produce a cobbleston  morphology under light 
microscopy. (Figure 3.11, courtesy of Dr. Tom Wilkinson) 
 
  
Figure 3.11 Light microscopy of the cell line A549 
A549 cells were cultured in DMEM supplemented with L-glutamine and 10% foetal calf 
serum. Cells were seeded in 6 well plastic Costar pl tes at  2.5 x 106  per well and 




3.3.1.1. Constitutive cytokine production 
Mean production of TGF-β2 by A549 cells was 50.94 (+44.19) pg/mg of lysate 
protein in cell free cultured supernatant after four hours of culture and these 
levels rose to 185.3 (+121.2)pg/mg protein after 24 hours, this increase was 




























Figure 3.12 TGF-β2 production in supernatants by the human alveolar type 
II cell line A549 (n=3).  
The cells were plated at 5 x105 cells/ml in a 24 well plate. Once they achieved 
90% confluence, supernatants were removed at different time points and TGF-
β2 levels were measured by ELISA and normalised to total protein content in 
cell lysates. Negative control: cell-free medium 
Data are presented as mean (columns) +SD (error bars) and analysed using 
ANOVA. Post-test: Dunn’s test 
Statistical significance (*) determined when p<0.05 
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Burvall, K., et al, 2003 have shown that A549 cells constitutively produce low 
levels of IL-6 (11 + 4 pg per 106 cells) and higher levels of IL-8 (167 + 25 pg per 
106 cells). 
 
3.3.1.2. Cytokine production by the cell line A549 after 
stimulation with TLR ligands 
3.3.1.2.1. IL-8  
IL-8 levels were measured in cell-free supernatant and normalised to total protein 
content in the cell lysate. Median constitutive levels of IL-8 were 394.8 pg/mg of 
lysate protein (range: 205.5 – 560.6). These levels increased significantly after 
stimulation of the cells with S. aureus PGN as well as after stimulation with the 
pro-inflammatory cytokine TNF-α. The cells remained unresponsive to two 
different concentrations of P. aeruginosa LPS. Stimulation with S. aureus LTA 















































Figure 3.13 IL-8 levels in the A549 cell line after stimulation with TLR 
ligands (n=5).  
RPMI 2650 cells were seeded in 6 well plates at 2 x106 cells/ml. After 
achieving confluence, cells were washed and stimulated with 10ng/ml and 
100ng/ml P. aeruginosa LPS, 10µg/ml and 100µg/ml S. aureus peptidoglycan, 
10µg/ml of S.aureus LTA and 10ng/ml of TNF-α for 24 hours. Data are 
presented as individual data points and median (line) for five consecutive 
experiments.  
Statistical analysis was performed using the Kruskal-W llis test with Dunn’s 
post hoc analysis using GraphPad Prism software.  
Statistical significance was determined when p<0.05. 
 
 
3.3.1.2.2. IL-6  
Median constitutive production of IL-6 by the A549 cell line was undetectable. 
Levels rose significantly after stimulation with S. aureus PGN at the higher dose 
as well as after stimulation with TNF-α. As observed with IL-8, stimulation of 
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the cells with P. aeruginosa LPS or S. aureus LTA did not induce an increase of 











































Figure 3.14 IL-6 levels in the cell line A549 after stimulation with TLR 
ligands (n=5).  
A549 cells were seeded in 6 well plates at 2 x 106 cells/ml. After achieving 
confluence, cells were washed and stimulated as describ d in Figure 3.23.  
Data are presented as individual data points and meian (line) for five 
consecutive experiments.  
Statistical analysis was performed using the Kruskal-W llis test with Dunn’s 
post hoc analysis using the GraphPad Prism software.  
Statistical significance was determined when p<0.05. 
 
Median baseline levels of IL-10 in the A549 cell line were 4.9 pg/mg of protein 
(range: 0 – 137.8). Median baseline levels of the antimicrobial peptide SLPI in 
supernatants were 8132 pg/mg of protein (range: 406 – 9423). Stimulation with 
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TLR ligands such as LPS, PGN and LTA or with TNF-α was not associated with 
an increase in the secretion of IL-10 or SLPI. 
 
3.3.2. Characterisation of primary cells from the lower respiratory 
tract 
3.3.2.1. Description of patients 
Thirteen patients that underwent partial lobectomy or pneumonectomy in the 
Cardiothoracic Surgery Department at the Royal Infirmary of Edinburgh 
consented to donate a suitable size of lung tissue for the purposes of this 
research. In one case, during surgery it was noted that the primary tumour was 
not suitable for resection. The total number of tissue samples processed therefore 
corresponds to twelve patients. Due to a small size of the tissue corresponding to 
patient 14, it was not possible to perform the cytokine production experiments 
with the cells isolated from this patient.  
 
Four cultures were unsuccessful: two due to infection and a further two due to 
failure of attachment of the cells onto the collagen matrix. 
 







Final diagnosis Smoker Cultures 
Successful 
1 75 M RL Squamous lung cell Ca Y N 
2 53 F RL Aspergilloma Y N 
3 66 M LL Non small cell lung Ca Y N 
4 76 M RL Single lung metastasis 
from bowel Ca 
N N 
5 59 F LU Squamous cell Ca Y Y 
6 57 M LL Non small cell lung Ca Y Y 
7 70 F RU Bronchogenic Ca Y Y 
8  63 F L* Single lung metastasis 
from malignant Melanoma 
N Y 
9 64 F L* Squamous cell Ca Y Y 
10 71 M RU Squamous cell Ca  
Lung tissue not obtained-unresectable 
Y N/A 
11 59 F RU Single lung metastasis 
from rectal Ca 
N Y 
12 60 F M Non small cell lung Ca Y Y 
14 77 F RL Lung Adenocarcinoma N Y 
Table 3.4 Demographics of patients consented for the isolation of primary type II 
alveolar epithelial cells.  
RL, right lower lobe; LL, left lower lobe; RU, right upper lobe; M, right middle lobe; 
N/A, non applicable; *pneumonectomy 
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3.3.2.2. Cell types isolated from human lungs 
3.3.2.2.1. Primary human fibroblasts 
The lung parenchyma has multiple cell types including type I alveolar epithelial 
cells, primary alveolar macrophages, and Clara cells among many others. 
Another cell type that was isolated in pure culture was primary human lung 
fibroblasts which are shown here to illustrate their differences in comparison to 
primary type II alveolar epithelial cells. On light microscopy they displayed the 
typical filamentous appearance and on immunocytochemistry they stained 
positively for vimentin. (Figure 3.15) 
 
    
 
 
Figure 3.15 Primary human lung fibroblasts.  
Cells were seeded onto coverslips, fixed with 4% paraformaldehyde, blocked 
with 2% goat serum and incubated with monoclonal antibodies against a) 
vimentin or b) with Isotype  control. Nuclei were stained with DAPI (blue). 
Secondary antibody was anti-mouse IgG conjugated with Alexa 488 (green). 
Images were analysed using confocal microscopy. Scale bar equals 25µm. The 
typical filamentous morphology of the fibroblasts is observed. 
 
 
a) Vimentin b) Isotype control 
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3.3.2.2.2. Primary type II alveolar epithelial cells 
3.3.2.2.2.1. Morphology 
After the isolation of type II alveolar epithelial cells, the cells were plated onto 
wells pre-coated with type I bovine collagen and washed several times. Around 
approximately day 3 - 4 it was possible to observe a confluent monolayer of cells 
of cuboidal shape (Figure 3.16), certainly quite different from their carcinoma 
counterpart A549 (Figure 3.11, page 116).  
 
Figure 3.16 Primary human type II alveolar epithelial cells.  
Cells were isolated and seeded onto pre-coated type I collagen plates. Cells were 







3.3.2.2.2.2.1. Alkaline phosphatase stain 
Alkaline phosphatase has been proposed as a maker of alveolar type II cell 
differentiation by Edelson et al (1988). This enzyme is not expressed  by alveolar 
macrophages, therefore its histochemical demonstration allows differentiation 
between type II alveolar epithelial cells and alveoar macrophages.  
After the cells achieved confluence around day 3 - 4 alkaline phosphatase 
staining was performed. The cells took the stain and developed an intense pink 
colour typical of the type II alveolar epithelial cell phenotype as described by 





Figure 3.17 Alkaline phosphatase stain for primary human type II alveolar 
epithelial cells.  
Primary type II alveolar epithelial cells were seedd onto plates pre-coated with 
type I collagen and allowed to reach confluence.  
After four days they were stained for alkaline phosphatase and incubated for 15 
minutes at 37oC. Magnification 2000x.  
 
 
3.3.2.2.2.2.2. Rt-PCR for surfactant Protein-C and 
Aquaporin-3 
 
After demonstrating that the primary type II alveolar monolayers stained positive 
for alkaline phosphatase, I went onto assess if type II markers such as surfactant 
protein-C (SP-C) and aquaporin 3 (AQP3) were found in these cells as described 
by Witherden, I., et al, 2004 and Armstrong, L., et al, 2004. 
 
After the primary type II alveolar epithelial cells achieved a confluent 
monolayer, they were lysed and RNA was extracted as escribed in the Materials 
and Methods section. RT-PCR was performed for SP-C and AQP-3. The type II 
alveolar epithelial cells displayed m-RNA transcripts. The alveolar type II A549 
cell line was used as a negative control and there were no transcripts for these 
genes found. This finding indicates that the cells di played primary type II 
alveolar cell markers. Transcripts of GAPDH were used as the housekeeping 










Figure 3.18 Phenotyping of primary human type II alveolar epithelial cells.  
Cells were isolated and seeded onto plates pre-coatd with type I collagen,. 
Once confluent, cells were harvested, lysed, RNA was extracted and rt-PCR was 
performed for SP-C, AQP3 and GAPDH.  
Bands labelled as 1, 2 and 3 correspond to patient samples, 4 corresponds to the 




3.3.2.2.2.3. Cytokine response by primary type II alveolar 
epithelial cells 
After type II alveolar epithelial cells achieved a confluent monolayer, they were 
stimulated with bacterial ligands for 24 hours. Cell supernatants were collected 
and stored at -80oC until processed, and cells were lysed for RNA extraction, 
therefore, it was not possible to perform a correction of the total cytokine 
concentration in supernatant to the total protein co centration in cell lysates for 
these experiments. Cytokine measurements were performed using the Becton 
Dickinson (BD) Cytometric Bead Array Human Inflammation kit as described in 
the Materials and Methods section. 
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3.3.2.2.2.3.1. Interleukin-8 (IL-8) production 
Median basal production of IL-8 by primary type II alveolar epithelial cell was 
2273 pg/ml (range: 708 – 11226). This was significantly increased after 
stimulation with S. aureus PGN and the pro-inflammatory cytokine TNF-α. 
Stimulation with P. aeruginosa LPS or with S. aureus LTA did not produce an 



















































Figure 3.19 IL-8 levels in primary human type II alveolar epithelial cells 
after stimulation (n=7).  
Cells were seeded in 6 well plates pre-coated with type I collagen. After 
confluence, cells were washed and stimulated with 100ng/ml Pseudomonas 
aeruginosa LPS, 10µg/ml S. aureus PGN, 10µg/ml S. aureus LTA and 10ng/ml 
TNF-α for 24 hours.  
Data are presented as individual points.  
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software.  
Statistical significance (*) was determined when p<0.05. 
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3.3.2.2.2.3.2. Interleukin-6 (IL-6) production 
Median basal levels of Interleukin-6 were 236.3pg/ml (range: 8.3 – 1276). The 
production of this cytokine increased significantly after stimulation with S. 
aureus PGN and the pro-inflammatory cytokine TNF-α.  Stimulation with LPS 
from P. aeruginosa or S. aureus LTA did not induce an increase in the 























































Figure 3.20 IL-6 levels in primary human type II alveolar epithelial cells 
after stimulation (n=7).  
Cells were seeded in 6 well plates pre-coated with type I collagen. After 
confluence, cells were washed and stimulated in a smilar way to Figure 3.31. 
Data are presented as individual points.  
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software.  
Statistical significance (*) was determined when p<0.05. 
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3.3.2.2.2.3.3. Interleukin-1β (IL-1β) production 
 
Median basal IL-1β production by primary type II alveolar epithelial cells was 
5.3pg/ml (range: 2.5 – 8.1). This increased significantly after stimulation with S. 
aureus PGN (p<0.05). There was no significant increase associated with 



























































Figure 3.21 IL-1beta levels in primary human type II alveolar epithelial 
cells after stimulation (n=7).  
Cells were seeded in 6 well plates pre-coated with type I collagen. After 
confluence, cells were washed and stimulated in a smilar way as in Figure 3.31. 
Data are presented as individual points.  
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software.  
Statistical significance (*) was determined when p<0.05. 
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3.3.2.2.2.3.4. Tumour Necrosis Factor-Alpha (TNF-α) 
production 
Median baseline production of TNF-α by primary type II alveolar epithelial cells 
was 10.06pg/ml (range: 3.6 – 21.2). This was significantly increased after 
stimulation with S. aureus PGN. Stimulation with P. aeruginosa LPS or S. 














































Figure 3.22 TNF-α levels in primary human type II alveolar epithelial cells 
after stimulation (n=7).  
Cells were seeded in 6 well plates pre-coated with type I collagen. After 
confluence, cells were washed and stimulated in a smilar way as in Figure 3.31. 
Data are presented as individual points.  
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software.  
Statistical significance (*) was determined when p<0.05. 
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3.3.2.2.2.3.5. Interleukin-10 (IL-10) production 
Median baseline levels of IL-10 produced by type II alveolar epithelial cells were 
15pg/ml (range: 2.6 – 1276). A high degree of variability among individuals was 
noted, with two having particularly high basal secretion of this cytokine. IL-10 
levels increased significantly after exposure of the cells to S. aureus PGN 
(p<0.05) and TNF-α (p<0.05). There was no increase in the production of IL-10 


































































Figure 3.23 IL-10 levels in primary human type II alveolar epithelial cells 
after stimulation (n=7).  
Cells were seeded in 6 well plates pre-coated with type I collagen. After 
confluence, cells were washed and stimulated in a similar manner as per Figure 
3.31. 
Data are presented as individual points.  
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software.  




3.3.2.2.2.3.6. Interleukin-12p70 (IL-12p70) production 
The median baseline production of IL-12p70 by primay type II alveolar 
epithelial cells was 8pg/ml (range: 5.4 – 19.7). Despite stimulation with bacterial 
ligands and the pro-inflammatory cytokine TNF-α, there was not an increase in 
the production of this cytokine. 
 
3.4. Comparison of the cytokine response between cell lines and human 
primary cells of the respiratory tract 
 
As it is important to establish the differences in behaviour between cell lines and 
primary cells, my aim was to compare it using cytokine production as one of the 
outcomes. Due to the small numbers of primary cells obtained from patients, the 
following results display total cytokine concentration in supernatants, without 
protein correction in the lysates as the primary cell lysates were used for RNA 
extraction. All experiments were conducted in identical conditions. 
  
3.4.1. The cell line RPMI 2650 and primary human nasal epithelial 
cells 
Primary human nasal epithelial cells behave in a different manner to the cell line 
RPMI 2650. They grow forming a neat monolayer (see figure 3.9, page 108) 
contrary to the irregular pattern of growth that the cell line displays. Although 
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they share similar cytokeratin patterns, primary human nasal epithelial cells do 
not display the presence of cytokeratin 10. Cytokeratin 18 is strongly expressed 
by both cell types and vimentin expression appears to be stronger in the RPMI 
2650 cell line.  Primary nasal epithelial cells display variable amounts of 
vimentin. 
  
The RPMI 2650 cell line was not able to produce actively the pro-inflammatory 
cytokines IL-8 and IL-6 before or after stimulation with the cytokine TNF-α. On 
the contrary, primary nasal epithelial cells constitutively secreted these cytokines 
and responded actively to TNF-α stimulation. RPMI 2650 cells produced higher 
constitutive levels of IL-10 in comparison to primary nasal epithelial cells and 
this production was increased after stimulation with TNF-α although not in a 
statistically significant manner. (Table 3.5) 





















IL-8 0 (0-50.2) 0 (0) 1 282 (192 – 1004) 2975 (2033-
48688) 
0.0625 
IL-6 6.1(0-16.2) 0 (0-8.4) 0.125 26.2 (13.7 – 167) 452 (67.5 – 
3173) 
0.0625 
IL-10 32.8(0-118) 83(49.6-154) 0.125 10.4(4 - 18.7) 18 (0-67.5 0.3125 
 
Table 3.5 Comparison of cytokine production by RPMI 2650 cells and primary 
nasal epithelial cells 
Statistical analysis was performed using the Wilcoxon matched pairs test to compare 
results for paired samples before and after stimulation using GraphPad Prism software.  
Statistical significance (*) was determined when p<0.05. 
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3.4.2. The cell line A549 and primary human type II alveolar 
epithelial cells 
3.4.2.1. Interleukin-8 (IL-8) 
Median constitutive production of IL-8 by A549 cells was 765pg/ml. These cells 
responded to TNF-α stimulation by increasing their IL-8 release. Constitutive 
median IL-8 production by primary type II alveolar epithelial cells was 
2273pg/ml. These cells responded to stimulation with TNF-α by increasing 




































Figure 3.24 IL-8 production by A549 cells (n=5) and primary type II 
alveolar epithelial cells (n=7). 
A549 cells were plated at 2x106 in 6 well plates. After achieving confluence, 
cells were washed and stimulated with 10ng/ml TNF-α for 24 hours. Primary 
nasal epithelial cells were treated in a similar way. Cell free supernatants were 
collected and processed. 
Data are presented as individual data points for n=5 for A549 graph and n=7 for 
primary type II alveolar epithelial cells. 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 





3.4.2.2. Interleukin-6 (IL-6) 
Median constitutive production of IL-6 from A549 cells was undetectable, 
although cells responded to stimulation with TNF-α by increasing the production 
of this cytokine. In primary type II alveolar epithelial cells, median basal levels 
of IL-6 were 236pg/ml and this increased significantly after stimulation with 




































Figure 3.25 IL-6 production by A549 cells (n=5) and primary type II 
alveolar epithelial cells (n=7). 
A549 cells were plated at 2x106 in 6 well plates. After achieving confluence, 
cells were washed and stimulated in a similar manner as per Figure 3.40. 
Data are presented as individual data points for n=5 i  A549 graph and n=7 in 
primary type II alveolar epithelial cells graph. 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 




3.4.2.3. Interleukin-10 (IL-10) 
Median basal production of IL-10 by A549 cells was 8.4pg/ml. Stimulation with 
TNF-α was associated with variable results. In two experim nts there was a 
decrease in the secretion of Il-10, whereas in three it was raised. On the contrary, 
median constitutive IL-10 production by primary type II alveolar epithelial cells 
was 15pg/ml. This was increased after TNF-α stimulation. It is also important to 
mention that two subjects produced high baseline lev ls of this cytokine, which 





































Figure 3.26 IL-10 production by A549 cells (n=5) and primary type II 
alveolar epithelial cells (n=7). 
A549 cells were plated at 2x106 in 6 well plates. After achieving confluence 
cells were washed and treated in a similar manner as per Figure 3.40. 
Data are presented as individual data points for n=5 i  the A549 graph and n=7 
in the primary type II alveolar epithelial cells graph. 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 














p value Primary type II 




Primary type II 










0.0625 2273 (707-11226) 31721 (9450-78198) *0.0156 
IL-6 0 93(67.5-200) 0.0625 236(8.3-1276) 1205(34.1-029) *0.0156 
IL-10 8.4(0-267) 96(59.6-126) 0.8125 15(2.6-1276) 25.8(3.5-4029) *0.0156 
  
Table 3.6 Comparison of cytokine response between the A549 cell line and human 
primary type II alveolar epithelial cells 
Statistical analysis was performed using the Wilcoxon matched pairs test to compare 
results for paired samples before and after stimulation using GraphPad Prism software.  





3.5. Comparison between primary nasal epithelial cells and type II 
alveolar epithelial cells in response to TLR ligands 
It is interesting that in clinical practice nasal epithelium favours the presence of 
micro-organisms without developing an overt inflammatory response, whereas in 
the lower respiratory tract, and especially in the lung parenchyma, the presence 
of the same organism is associated with a severe inflammation that if not treated 
appropriately could even risk the life of the host. In order to answer this question, 
I have isolated, cultured and performed experiments with primary human 
epithelial cells from the upper respiratory tract and the lower respiratory tract and 




For these experiments, primary nasal epithelial cels were obtained from 5 
patients with neoplastic lung pathology and they were matched to 7 patients who 
underwent partial lobectomy or pneumonectomy as described in the Materials 
and Methods section 2.2.1 page 59 and section 2.2.3page 62 respectively.  
 
3.5.1. Interleukin-8 (IL-8) 
Median constitutive levels of IL-8 in primary nasal epithelial cells were 
282pg/ml, while primary type II alveolar epithelial cells produced higher levels: 
2273pg/ml. Both cell types responded by increasing the production of this 
cytokine after stimulation with TNF-α, although in the alveolar epithelial cells 




































Figure 3.27 IL-8 production by primary nasal epithelial cells and primary 
type II alveolar epithelial cells. 
Primary nasal epithelial cells were plated at 2x106 in 6 well plates, after 
achieving confluence. Cells were washed and stimulated with 10ng/ml TNF-α 
for 24 hours. Primary type II alveolar epithelial cells were treated in a similar 
way. Cell free supernatants were collected and processed by CBA. 
Data are presented as individual data points for n=5 i  the nasal epithelial cells 
graph and n=7 in the primary type II alveolar epithelial cells graph. 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 
Statistical significance (*) was determined when p<0.05 
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3.5.2. Interleukin-6 (IL-6) 
Median constitutive IL-6 production by primary nasal epithelial cells was 
26.2pg/ml, whereas primary type II alveolar epithelial cells produced higher 
baseline levels: 236pg/ml. Both cell types responded by increasing their secretion 
of IL-6 in response to TNF-α stimulation, although alveolar cells displayed a 






































Figure 3.28 IL-6 production by primary nasal epithelial cells and primary 
type II alveolar epithelial cells. 
Cells were treated in a similar way as per Figure 3.43. Cell free supernatants 
were collected and processed. 
Data are presented as individual data points for n=5 for the primary nasal 
epithelial cells and n=7 for primary type II alveolar epithelial cells. 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 
Statistical significance (*) was determined when p<0.05 
 
 
3.5.3. Interleukin-10 (IL-10) 
Median constitutive levels of IL-10 in supernatant from primary nasal epithelial 
cells were 10.4pg/ml, while in primary type II alveolar epithelial cells they were 
15pg/ml. Stimulation with TNF-α was not associated with an increase in the 
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production of this cytokine by primary nasal epithelial cells. On the contrary, 







































Figure 3.29 IL-10 production by primary nasal epithelial cells and type II 
alveolar epithelial cells. 
Cells were treated in a similar manner as in Figure 3.43.  
Data are presented as individual data points for n=5 i  nasal primary epithelial 
cells and n=7 in primary type II alveolar epithelial cells 
Statistical analysis was performed using the Wilcoxon matched pairs test using 
GraphPad Prism software. 
Statistical significance (*) was determined when p<0.05 
 
 
Median constitutive levels of IL-1β, TNF-α and IL-12p70 in supernatants of 
primary nasal and alveolar epithelial cells were low. In both cell types 





For a summary of the cytokine responses between cells from the upper and lower 





















IL-8 282 (192.8-1004) 2975 (2033-48688) 0.0625 2273 (707-11226) 31721 (9450 – 78198) *0.0156 
IL-6 26.2 (13.7-167.8) 452.6 (67.50-3173) 0.0625 236.3 (8.3-1276) 1205 (34.18-4029) *0.0156 
IL-1β 7.1 (0-9.5) 4.2 (0-165) 0.6250 5.2 (2.8-8.1) 11.2 ( . -85.3) 0.1094 
TNF-α 10.3 (1.7-14.9)  N/A 10 (3.6-21.2)  N/A 
IL-10 10.4 (4-18.7) 18 (0-67.5) 0.3125 15.2 (2.6-1276) 25.8 (3.5-4029) *0.0156 




Table 3.7 Comparison of cytokine responses between human primary nasal epithelial cells and primary human type II 
alveolar epithelial cells before and after stimulation with TNF-α 
Statistical analysis was performed using the Wilcoxon matched pairs test to compare results for paired samples before and after 
stimulation using GraphPad Prism software.  




The RPMI 2650 cell line was established by Moore and Sandberg in July 1962 
when it was reported as a permanent cell line derived from the pleural effusion of 
a patient with anaplastic squamous cell carcinoma of the nasal septum. They 
described its quasi-diploid karyotype, which resembles the normal human 
epithelium, as well as similarities in the cytokeratin polypeptide profile and the 
presence of mucoid material on the surface during culture. My findings support 
their observations except that during culture I did not observe the production of 
mucus by the cells. My results also support the report made by Moll, R., et al 
(1983) and De Fraissinette, A., et al, (1995), thatRPMI 2650 cells express high 
levels of CK-18 and CK-7-17, although CK-10 expression was low in my 
experiments. I also demonstrated that as well as their primary counterparts, both 
cell types express CK-18 and vimentin, although the expression of the latter 
appears to be variable in the primary nasal epithelial cells. This finding is also 
consistent with the study from Kasper, M., and Stosiek, P., in 1990 whom 
investigated biopsies of normal nasal tissue showing the dual expression of CK-
18 as well as vimentin in epithelial cells. The authors argue that the co-
expression of cytokeratin and vimentin in epithelial cells is related to the 
secretory function of non-glandular epithelium in cavities which are in contact 
with low-protein body fluids.   
 145 
Electron microscopy studies by Salib, R., et al, 2005, have shown that RPMI 
2650 cells are not fully differentiated since they grow in multiple layers and do 
not possess any cilia. These studies have also been supported by Bai, S., et al, 
2008 which showed that one of the limitations of this model is that RPMI 2650 
cells are not able to form tight junctions during fluid culture and that they need to 
be grown at an air-liquid interface in order to develop them. Schmidt, M., et al, 
1998 have reviewed in vitro models to study nasal mucosal permeability and 
metabolism and have reported that the limitations of this cell line are the poor 
differentiation and the lack of polarisation. Studies by Boucher, R., et al, 1987 as 
well as from Schmidt, M., et al, 1998 have shown that the trans-epithelial 
electrical resistance in the cell line is similar to that in fresh excised nasal 
mucosa and is typical of leaky epithelium. 
 
I have demonstrated that the cell line RPMI 2650 actively produces the cytokine 
TGF-β2 as reported by Carey, B., et al, 1993. This cytokine serves as an 
autocrine growth factor given not only its active scretion, but also by the 
presence of TGF-β2 receptors as detected by flow cytometry in the study by 
Salib, R., et al, 2005.  TGF-β is an important pleiotropic cytokine - its functions 
include the maintenance of tolerance (Schull, M., et al, 1992) through the 
regulation of T and B lymphocyte responses (Gorelik, L., et al, 2000 and Cazac, 
B., et al, 2000), as well as having a role in mucosal immunity given by its ability 
to modulate isotype switching to IgA in mucosal intestinal epithelium (Kim, P., 
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and Kagnoff, M., 1990; Ehrhardt, R., et al, 1992). Fong, C., et al, 2000, have, in 
addition to other groups, shown its role in the release of IL-8 in human airway 
smooth muscle cells and Pelaia, G., et al, 2002, have shown that TGF-β induces 
an approximate nine-fold increase in p38 MAPK activation in airway epithelial 
cells. Of its three isoforms, TGF-β2 appears to be the main isoform expressed in 
the airways (Balzar, S., et al 2005; Puddicombe,S., et al, 2000) and it has been 
noted that in these sites this isoform can modulate subepithelial fibroblast 
function.  
 
 The behaviour of the cell line RPMI 2650 is characterised by its inability to 
constitutively produce the cytokines IL-6, IL-8 and the antimicrobial peptide 
SLPI. IL-10 production was observed at low levels. The fact that these cells 
appeared refractive to stimulation with bacterial TLR ligands such as LPS, PGN 
and LTA, as well as to the pro-inflammatory cytokine TNF-α suggests that they 
could have lost TLRs as well as TNF-α receptors as a result of the multiple 
passages that they had gone through, although upon receipt of the vial, multiple 
frozen aliquots were prepared and the cells were discarded after passage number 
20. My findings agree with those of Lindbom, J., et al, 2006 when studying the 
cytokine release by human macrophages and respiratory cells after exposure to 
particles generated from studded tires and pavement usi g the nasal epithelial 
cell lines (RPMI 2650) and bronchial epithelial cells (BEAS-2B). They reported 
that none of the particle types used in their experim nts were able to evoke a 
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detectable cytokine release from RPMI 2650 cells. They attributed their findings 
to the transformation process of these cells into immortalized cell lines.  Another 
option could be that since RPMI 2650 cells constitutively produce high levels of 
TGF-β2, that the over-expression of receptors for this cytokine could inhibit the 
cellular activation given by TLR ligands, although t is is unlikely since, as 
discussed above, this cytokine favours a pro-inflamm tory phenotype through 
the increase in p38 MAPK activation.  
 
In contrast, primary nasal epithelial cells were able to produce constitutive levels 
of cytokines such as IL-8 and IL-6, and stimulation with the bacterial ligand 
PGN from S. aureus invariably induced an increase in the release of these 
cytokines, as did stimulation with the pro-inflammatory cytokine TNF-α. These 
findings are in accordance with those reported by McDougall, C., et al, 2008, 
which showed a significant increase in the release of these cytokines after 
stimulation with 10ng/ml of TNF-α by primary nasal epithelial cells. Constitutive 
production of the cytokines IL-1β, TNF-α, IL-10 and IL-12p70 was very low, 
just above the detection limit for the assay and I did not observe an increase in 
the secretion of these cytokines after stimulation with TLR ligands or with TNF-
α. It is interesting to note that stimulation of these cells with LPS was not 
associated with an increase in the secretion of IL-8 and IL-6. A study by Wang, 
J., et al, 2007, observed the involvement of TLR in nasal polyp epithelial cells 
from patients with chronic rhinosinusitis. They measured IL-8, RANTES, IP-10 
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and GM-CSF, and found that these cells did not respond significantly to 
stimulation with 10µg/ml of PGN, whereas they responded significantly to 
stimulation with 10µg/ml of E. coli LPS, although they also reported that their 
predominant finding was the high response to double stranded RNA (dsRNA), an 
activator of TLR3. Chronic rhinosinusitis is usually precipitated by viral 
infections and that could explain their results since these patients’ cells could be 
primed by repeated viral infections. In contrast, in my work the primary nasal 
cells were obtained from patients with no previous history of nasal pathology and 
therefore reflect the response of a relatively healt y mucosa, although all of the 
patients had previous exposure to smoking. The increase in the cytokine response 
after stimulation of the cells with PGN from S. aureus (which is a well 
recognised bacterium present in the anterior nasal cavity (Gluck, U., and Jebbers, 
J., 2000)) suggests that the nasal epithelium provides a surveillance mechanism 
for the presence of pathogens. This is supported by the study by Ritz, H., et al, 
1984 in which healthy volunteers colonised with toxic shock antigen(TSA) 
producing strains of S. aureus were found to have high levels of serum 
antibodies to TSA. The lack of response of the cells in my system to LPS in 
comparison to the Wang study could be related to the lower dose of LPS used 
(100ng/ml) as well as to the different concentrations of serum in the different 
culture systems, although they also reported in their study a low expression and 
functionality of TLR2 and TLR4.  To my knowledge this is the first report trying 
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to characterise the cytokine response to bacterial lig nds in primary nasal 
epithelial cells. 
 
Co-culture experiments with S. aureus failed to provide useful information 
regarding how this bacterium establishes colonisation of the nasal epithelium due 
to its aggressive behaviour. They also demonstrated th  need for developing a 
sterile model in order to try to mimic the in-vivo environment in which the 
effector cells of the innate immune system provide support to the epithelial cells 
in order to maintain a low bacterial number which prevents overwhelming 
bacterial growth. Using QPCR it was possible to observe the multiple effects that 
S. aureus infection induces in cellular metabolism.  
 
The dynamics of S. aureus infection in airway epithelial cells have been studied 
by da Silva, M., et al, 2004. Their study shows that after a 24 hour infection 
period with S. aureus, almost 90% of the airway cells exhibited severe damage of 
the cellular membrane. Further experiments demonstrated that the cells 
underwent apoptosis first rapidly followed by necrosis. In their study airway 
epithelial cells exhibited efficient defence mechanisms against S. aureus as 
evidenced by the permeabilisation of the plasma membranes in almost 50% of 
the bacteria detected in cell culture supernatants 1hour post-infection. However 
supernatants retrieved from the cells at 24 hours exhibited a lower capacity to 
inhibit growth of S. aureus, suggesting that during infection the self-defence 
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mechanisms of airway cells may have been overwhelmed. My experiments are 
similar to those of da Silva et al in that the cells were kept continuously exposed 
to S. aureus in suspension in the culture medium and under these conditions 
extracellular bacteria are likely to have replicated and released virulence factors. 
Because I did not wash the cells after 1 hour of infection the effects happened in 
a more speedy manner in my system. Furthermore, the data presented by Bantel, 
H., et al, 2001 showed that in the induction of cell d ath by S. aureus α-toxin, 
necrosis predominated despite the apoptotic activation of caspase 8. Kahl, B., et 
al, 2000, have shown that internalised S. aureus replicates actively inside 
pulmonary epithelial cells inducing apoptosis. Intracellular replication induces 
apoptosis. There is growing evidence that S. aureus may be internalised into 
epithelial cells (Bayles, K., et al, 1998; Kahl, B. et al, 2000). The advantages of 
the intracellular location for the bacteria are theability to avoid host defence 
mechanisms as well as antibiotics. In the study by da Silva and colleagues, they 
found that S. aureus was efficiently internalised by  airway epithelial cells in a 
time and dose dependent fashion. They found that S. ureus replicates actively 
inside pulmonary epithelial cells and they also showed that infected airway 
epithelial cells showed evidence of apoptosis with typical DNA laddering, 
alteration of cellular morphology and annexin V staining occurring at 24h but not 
at 4h after infection. The co-localisation of green fluorescent bacteria inside 
apoptotic cells in these experiments suggests that bacterial replication precedes 
and induces apoptosis. Apoptosis was not induced in cells where internalisation 
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was blocked by cytochalasin D or in cells infected with heat killed bacteria. 
Taken together, these observations illustrate the devastating and multiple effects 
that live infection cause in cellular physiology and support the concept of 
moving onto a sterile model in which processes could be studied in a more 
controlled fashion. 
 
In comparison to the nasal epithelial cell line RPMI 2650, the cell line A549 was 
found to produce constitutively lower levels of TGF-β2, and constitutive 
production of IL-8 was higher than IL-6 as reported by Burvall, K., et al., 2003 
After stimulation with PGN and TNF-α, IL-8 and IL-6 secretion increased 
significantly. Median IL-10 production by this cell line was low but increased 
after TNF-α stimulation in a non-significant manner. These results are in 
accordance with Burvall et al who demonstrated that A549 cells produce 
constitutively low levels of IL-6 and higher levels of IL-8. In comparison to the 
RPMI 2650 cell line, the A549 cell line appears more responsive to TLR and 
TNF-α ligand stimulation, nevertheless, it is interesting to note that this cell line 
failed to respond to stimulation with LPS. This observation has also been 
reported by Guillot, L., et al, 2004 who demonstrated the intracellular 
compartmentalisation of TLR4 using the same cell line, as well as the human 
tracheobronchial epithelial cell lines BEAS-2B and 16HBE. Using flow 
cytometry techniques they demonstrated that TLR4 is not expressed at the 
surface of the cell lines A549 and BEAS-2B. They also provided evidence for 
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intracellular TLR4 localisation in human primary bronchial epithelial cells and 
that the production of the cytokines IL-8 and IL-6 acts is dose-dependent, with 
the highest secretion being found when they were stimulated with 10µg/ml of 
LPS. Previous evidence from Guha, M., and Mackman, N., 2001; Zarember, K., 
et al, 2002, has shown that phagocytic cells are highly sensitive to the LPS dose 
as they respond with increase secretion of proinflamm tory cytokines when they 
are stimulated by 1-10ng/ml of LPS. My results are in agreement with this 
finding since stimulation of the cell line A549 at 10ng/ml and 100ng/ml was not 
associated in an increase in the secretion of cytokines in supernatant. The study 
by Bérubé, J., et al, 2009 also used LPS at 100ng/ml to stimulate BEAS-2B cells, 
a human cell line derived from normal bronchial epithelium. Their results 
showed only a modest increase in IL-8 secretion in supernatants after 24 hours of 
stimulation, the predominant responses being after stimulation with Pam3CSK4 
(an agonist of TLR1/2) poly I:C (a TLR3 agonist) and C12-ie-DAP (an acylated 
derivative from peptidoglycan which binds the intracellular NOD1 receptor). 
Similar results were obtained when I stimulated human primary type II alveolar 
epithelial cells. Taken together these findings suggest that initiation and 
signalling events appear to be less efficient in pulmonary cells. Hornef, M., et al, 
2002, have demonstrated the intracellular distribution of TLR4 in the Golgi 
apparatus, where it co-localises with internalised LPS, and its absence on the 
surface of intestinal epithelial cells, in contrast to its membrane expression in 
monocytes. This intracellular compartmentalisation could be a negative 
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regulation mechanism in order to avoid excessive activation of pulmonary 
epithelial cells due to their regular exposure to low amounts of LPS in the air.  
 
On the other hand, one of the main consistent findings of this research was the 
significant increase of cytokine production by the A549 cell line and by primary 
human nasal and type II alveolar epithelial cells after stimulation with S. aureus 
PGN. Hussain, T., et al, 2008 have shown that PGN up-regulates TLR-2 
expression in mouse primary pleural mesothelial cels. Using the alveolar 
epithelial cell line A549 Cheon, I., and coworkers, (2008) demonstrated that S. 
aureus PGN induces IL-8 mRNA and protein expression in a dose and time 
dependent manner. Furthermore, they also demonstrated that PGN increases the 
DNA binding of the transcription factors AP-1 and NF-κB. Leemans, J., et al, 
2002, studied the differential role of LTA and PGN from S. aureus in the 
induction of lung inflammation in bronchoalveolar lavage (BAL) from IL-6+/+ 
BALB/c mice and IL-6-/- mice on a BALB/C background; their data suggest tha
intrapulmonary administration of LTA provokes an inflammatory response that 
is very similar to that induced by LPS showing an increase in PMN and elevated 
BAL concentrations of TNF-α and IL-6. While inoculation of PGN resulted in 
increase PMN infiltration and cytokine concentration, histologically it induced 
the formation of numerous abscesses centred around small bronchi and mostly 
composed of PMN, quite different from the LTA-induced interstitial 
inflammatory infiltrate in the lungs. Hessle, C., et al, 2005 have shown that PGN 
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enhances the production of pro-inflammatory cytokines to a greater degree than 
LTA in human monocytes. The specific signalling pathways are still 
controversial. The study by Schwandner, R., et al, 1999, suggested that PGN is 
recognised by TLR2, while Travassos, L., and coworkers, (2004) have argued 
that highly purified PGN is not sensed by TL2, TLR1/2 or TLR2/6.  
Furthermore, Strober, W., et al, 2006, have shown that Gram-positive bacterial 
PGN preferentially activates NOD2. Girardin, S., et al, 2003, have shown that 
PGN is identified by NOD2 through the recognition of muramyl dipeptide 
(MDP).. Further work should establish the presence of this receptor in primary 
type II alveolar epithelial cells and aim to dissect the pathways associated with 
the different responses. 
 
Despite several unsuccessful attempts it was possible to isolate and culture 
primary human lung fibroblasts and primary type II alveolar epithelial cells from 
8 patients that underwent lung resection. The phenotype of the primary type II 
alveolar epithelial cells was confirmed biochemically by positive staining for 
alkaline phosphatase which confirmed the purity of the monolayers used for 
further experimentation, and by molecular methods identifying transcripts for 
surfactant protein-C and aquaporin-3.  
 
It was possible to detect the cytokines IL-8, IL-6, IL-1β, TNF-α, IL-10 and IL-
12p70 in supernatants from unstimulated human primary type II alveolar 
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epithelial cells. Upon stimulation with bacterial ligands, particularly with S. 
aureus PGN, there were significant increases in the production of the pro-
inflammatory cytokines IL-8, IL-6, Il-1β, and TNF-α. It is interesting to note that 
in my system the primary type II alveolar epithelial cells did not respond to 
stimulation by the TLR-2 agonist LTA. This result agrees with the report 
published by Mayer, A., et al, 2007, in which they noted that stimulation of 
human bronchial epithelial cells with 10µg/ml of LTA was not associated with an 
increase in IL-8 production, probably related to the low expression of TLR2 by 
bronchial epithelial cells when compared to monocytes. Upon transfection with 
TLR2 responsiveness to LTA was observed. Their results support the concept 
that in airway epithelium low TLR2 expression might play a role in limiting 
uncontrolled activation by inhaled bacteria.  
 
Human primary type II alveolar epithelial cells also responded with a significant 
increase of the pro-inflammatory cytokine TNF-α as expected. It was also 
observed that there were no changes in the production of the cytokine IL-12p70 
and this might reflect the purity of the epithelial cell preparations, since this 
cytokine is mainly produced by myeloid cells particularly human monocytes as 
well as peripheral blood myeloid dendritic cells (Bekeredjian-Ding, I., et al, 
2006). Another observation worthy of mention is the lack of response of primary 
type II alveolar epithelial cells to stimulation with an ultrapure preparation of P.
aeruginosa LPS. As discussed above, this could be due to the intracellular 
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localisation of the TLR4 in these cells. The study by Armstrong, L., et al, 2004, 
has demonstrated functional responses to LPS and LTA, although these depend 
on higher concentrations of these ligands and are of a smaller magnitude than the 
responses in monocytes and macrophages, The differences between my results 
and theirs are probably related to the LPS dose used in their study (10µg/ml 
whereas in my study it was 100ng/ml). The LPS used in my study was also an 
ultrapure preparation of LPS which is highly unlikey to contain contaminant 
lipoproteins. It is also relevant to mention that the cells were obtained from 
previous smokers who underwent resection for lung cancer. MacRedmond,R., et 
al, 2007 have shown a dose-dependent down-regulation of TLR4 mRNA and 
protein expression as a result of stimulation with smoke extracts in A549 cells, 
and it is highly likely that a similar thing happens i  my system. On the contrary, 
the study by Togbe, D., et al (2006) using TLR4 transgenic mice showed that 
over-expression of TLR4 augmented a LPS-induced bronch chostrictive effect 
as well as TNF-α production. They also found increased PMN recruitment and 
microvascular and alveolar epithelial injury depending on the TLR4 gene dose. 
These findings suggest that the down-regulation of TLR4 in the airway 
epithelium is a key regulatory physiological mechanism in order to avoid an 
excessive inflammatory response in the lungs. 
 
 When comparing the A549 and RPMI 2650 cell lines it was observed that RPMI 
2650 cells’ main feature was the inability to constitutively produce cytokines and 
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to respond to stimulation and this could be due to loss of receptors. I also 
observed lack of mucus production as compared with the original report from 
Moorehead, P., 1965. The A549 cell line appears still to retain some of the 
original features of primary type II alveolar epithelial cells. On the other hand 
their inability to express surfactant protein-C and AQP3 suggest that multiple 
passages have altered the original phenotype. This is supported by the work of 
Tetley’s group in which they did not find transcripts for these genes (Witherden, 
I., et al, 2004).  Taken together, these findings support the idea that making 
assumptions of normal physiological behaviour is difficult using these cell lines 
as models. 
 
When comparing the response of the primary nasal epithelium to the alveolar 
epithelium it was observed that the lung epithelium seems to display a pro-
inflammatory phenotype relative to the nose epithelium, since basal IL-8 and IL-
6 levels were significantly higher in alveolar cells. Stimulation with S. aureus 
ligands such as peptidoglycan and lipoteichoic acid was associated with 
significantly higher levels of IL-8 and IL-6 in the alveolar cells, and there was a 
discrete increase also in the levels of IL-1β production, although these were not 
statistically significant. Other cytokines such as TNF-α, IL-10 and IL-12p70 
showed no differences in their profiles when the prima y nasal and alveolar cells 
were compared. A lack of response after stimulation with P. aeruginosa LPS was 
also observed suggesting that the refractivity of these cells appears to be related 
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to their respiratory origin and that this response i  probably the result of 
evolution, in view of the ubiquitous nature of LPS in the environment. Primary 
nasal epithelial cells constitutively produce low levels of pro-inflammatory 
cytokines and these cells are responsive to stimulation. Their baseline production 
levels are lower in comparison to type II alveolar epithelial cells. These latter 
cells not only behave in a more pro-inflammatory pattern but appear mucho more 
responsive to PGN by inducing a significant rise in co centrations of IL−1β, IL-
6, IL-8, IL-10 and TNF. These findings support the hypothesis that the alveolar 
epithelium behaves in a more pro-inflammatory way and that these cells are 
likely to exert not only a higher surveillance mechanism, but also to act as key 
orchestrators of a pro-inflammatory environment as ob erved during clinical 
pneumonia. The nasal epithelium, although able to elicit inflammatory responses 
after stimulation, appears less responsive and therefor  is likely to be more 
tolerant to the presence of bacteria. 
 
Taken together, the findings in primary cells support clinical observations. 
Further work is needed to elucidate the precise molecular mechanism behind 
these responses in order to assess constitutive diff rences in the presence of 
TLRs in both cell types and whether primary nasal epith lial cells express 
repressor proteins or have different requirements for activation of the 














4.1 Toll-like receptors in the respiratory tract 
4.1.1 Introduction 
 
The airways are the first port of entry of microorganisms and foreign matter into 
the respiratory system. Increasing evidence is placing the airway epithelium as a 
key orchestrator of innate immune responses to infection (Xiang, M., and Fan, J., 
2010). Toll-like receptors constitute one of the main sources of surveillance in 
cells of the innate immune system. Upon engagement of the receptors a series of 
signals are followed in order to activate the immune system in response to the 
presence of invading microorganisms. These receptors have been extensively 
characterised in leukocytes (Aderem, A., and Ulevitch, R., 2000 and Mogensen, 
T., 2009) as well as in other organ systems like the gastrointestinal tract (Otte, J., 
et al, 2004 and Melmed, G., et al, 2003). Their presence and function in the 
respiratory tract has been an area of increasing interest, and they have been studied 
and characterised in cells of the lower respiratory ract (Gentry, M., et al 2007, 
Armstrong, L., et al, 2004, Droemann, D., et al, 2003). However, nasal cells have 
received less attention. My objective was to describe the characteristics of the 
main TLRs involved in the response to bacterial infection in human primary nasal 
epithelial cells.  
TLR signalling is at the core of innate immune responses and its regulation 
deserves a great deal of attention since multiple dis ase processes have been 
associated with excessive TLR-driven responses, such as sepsis (Agnese, D., et al, 
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2002, Lorenz, E., et al, 2002) and autoimmunity (Tao, K., et al, 2007). I also 
wanted to explore and characterise the presence of toll-interacting protein (tollip) 
in the respiratory tract. Tollip is a protein involed in the negative regulation of 
TLR-associated responses which has been found to beover-expressed in cells of 
the gastrointestinal tract which are unresponsive to the vast amount of bacteria that 
lie within (Otte, J., et al, 2004 and Melmed, G., et al, 2003). 
The hypothesis that I would like to test are: 
1. Tollip is expressed in the human respiratory tract 




4.2 TLRs in primary human nasal epithelial cells 
The presence of TLRs in human nasal epithelial cells has largely been determined 
looking at nasal polyp tissue (Wang, J., et al, 2007, VanderMeer, J., et al, 2004 
and Lane, A., et al, 2006). Although these studies have made an important 
contribution to the understanding of innate immunity n the nasal cavity, 
nevertheless the tissue used in their experiments is far from normal and therefore I 
wanted to study the presence of these receptors in nasal brushings from healthy 





4.2.1 Toll-like receptor 1 (TLR1) 
 
The presence of Toll-like receptor 1 in primary human nasal epithelial cells was 
determined using confocal microscopy. Previous reports in the literature by 
Wyllie, D., et al, 2000 and Hornung, V., et al, 200, have provided evidence of 
the presence of this receptor on the cell surface of primary human monocytes. 
These cells from healthy donors were therefore used as a positive control and 
subsequently I assessed the presence of TLR1 in primary human nasal epithelial 
cells. In monocytes, the presence of TLR1 was evidenced by membrane staining. 
When primary human nasal epithelial cells were examined, there was a diffuse 
cytoplasmic stain, suggesting that primary nasal epith lial cells express TLR1 







Figure 4.1 Detection of Toll-like receptor 1 (TLR1) in human primary 
monocytes and primary nasal epithelial cells.  
Cells were seeded onto coverslips for 24 hours, then fixed with methanol, 
blocked with 2% goat serum and incubated with a monoclonal mouse antibody 
against TLR1. Nuclei were stained with DAPI (blue). Secondary antibody was 
anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy. a) primary blood monocytes 
and TLR1, b) primary blood monocytes and isotype control, c)primary human 
nasal epithelial cells and TLR1, d) primary human nasal epithelial cells and 
mouse isotype control.  
Scale bar equals 25µm in monocyte images to illustrate the detail of the 
membrane staining with TLR-1, 50µm in primary nasal epithelial cells to 
illustrate the diffuse abundance of the cytoplasmic stain. 
 
b) a) Primary  human 
monocytes  
c) Primary  human 
nasal epithelial cells  d)  
 TLR1 Isotype control 
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4.2.2 Toll-like receptor 2 (TLR2) 
The presence of TLR2 has been described in monocytes by Hornung, V., et al 
(2002) and Parker, L., et al, 2004. I assessed the presence of this receptor in 
primary blood monocytes using confocal microscopy. An abundant cytoplasmic 
stain was observed, when compared to primary human nasal epithelial cells. The 
stain was also cytoplasmic in nasal cells but much less strong in comparison to 





    
 
  
a) Primary human 
monocytes 
d) c) Primary human 
nasal epithelial cells 
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Figure 4.2 Detection of Toll-like receptor 2 (TLR2) in human primary 
monocytes and primary nasal epithelial cells.  
Cells were seeded onto coverslips for 24 hours. They w re then fixed with 
methanol, blocked with 2% goat serum and incubated with a monoclonal mouse 
antibody against TLR2. Nuclei were stained with DAPI (blue). Secondary 
antibody was  anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy: a) primary human monocytes 
and TLR2, b) primary human monocytes and mouse isotype control, c) primary 
human nasal epithelial cells and TLR2, d) primary human nasal epithelial cells 
and mouse isotype control. 
  Scale bar equals 25µm. 
 
4.2.3 Toll-like receptor 4 (TLR4) 
TLR4 was the first receptor of the TLR family to bediscovered by Charles 
Janeway Jr. in 1997. Since then multiple groups have demonstrated the 
distribution of this receptor in multiple cell types and tissues. The presence of 
this receptor in primary human monocytes has been described by Lien, E., and 
Ingalls, R., (2001), Hornung, V., et al, 2002, and Parker, L., et al, 2004, among 
others. 
TLR4 was identified in primary nasal epithelial cells using confocal microscopy. 
It was possible to observe different types of staining within the same sample of 
cells. This suggests that some cells express this protein more strongly than others 
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Figure 4.3 Detection of Toll-like receptor 4 (TLR4) in human primary 
monocytes and nasal epithelial cells.  
Cells were treated in a similar way as described for the previous receptors. After 
fixation and blocking, the cells were incubated with a polyclonal rabbit antibody 
against TLR4. Nuclei were stained with DAPI (blue). Secondary antibody was 
anti-rabbit IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy. a) primary human monocytes 
and TLR4; b)primary human monocytes and rabbit IgG; c)nasal epithelial cells 
and TLR4 stain, d) primary human nasal epithelial cells and TLR4 higher 
magnification, e) primary human nasal epithelial cells and control: rabbit IgG. 
  Scale bar equals 25µm in images a,b and e and 50µm in image c and d. 
 
4.2.4 Toll-like receptor 6 (TLR6) 
 
Toll-like receptor 6 was identified by Akira’s group in 1999 and m-RNA 
transcripts were detected in monocytes, monocyte-derived dendritic cells and 
neutrophils by Hornung, V., et al (2002) and Hayashi, F., et al (2003). In 2005 
Nakao, Y., and colleagues, produced evidence of its expression on the cell 
surface of primary human monocytes.  
In my experiments it was not possible to identify the presence of TLR6 in 












Figure 4.4 Detection of Toll-like receptor 6 (TLR6) in human primary 
monocytes and human primary nasal epithelial cells. 
Cells were treated in a similar way as described for the previous receptors. After 
fixation and blocking, cells were incubated with a mouse monoclonal antibody 
against TLR6. Nuclei were stained with DAPI (blue). Secondary antibody was 
anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy: a)primary monocytes and 
TLR6 stain, b) primary monocytes and mouse isotype control, c) primary human 
nasal epithelial cells and TLR6, d) primary human nasal epithelial cells and 
mouse isotype control. 





a) Primary human 
monocytes  
b)  
c) Primary human 
nasal epithelial cells 
d) 
 TLR6 Isotype control 
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4.2.5 Toll-like receptor 9 (TLR9) 
 
The presence of TLR9 in primary human peripheral blood mononuclear cells was 
demonstrated by Hornung, V., et al, 2002, using quantitative real-time PCR. In 
my study, the identification of TLR9 in primary human monocytes was observed 
as a strong membrane and cytoplasmic stain of different degrees of intensity 
within the same population of cells, suggesting that expression of this receptor 
varies among monocytes. When primary nasal epithelial cells were assessed, the 
stain was abundantly present within all cells in the sample. The stain was 
predominantly cytoplasmic, and it was interesting to observe a granular pattern 
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f) 
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Figure 4.5 Detection of Toll-like receptor 9 (TLR9) in primary human 
monocytes and primary human nasal epithelial cells.  
Cells were treated in a similar manner as described for the previous receptors. 
After fixation and blocking, cells were incubated with a monoclonal mouse 
antibody against TLR9. Nuclei were stained with DAPI (blue). Secondary 
antibody was anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy: a) primary human monocytes  
and TLR9, b)primary human monocytes and TLR9 (higher magnification), 
c)primary human monocytes and mouse isotype control, d) primary human nasal 
epithelial cells and TLR9, e) primary human nasal epith lial cells and TRL9 
(higher magnification), f) primary human nasal epithelial cells and mouse 
isotype control. 





4.2.5.1 Role of TLR9 in primary nasal epithelial cells 
4.2.5.1.1 Immunocytochemistry 
Since the expression of toll-like receptor 9 (TLR9) was so abundant in primary 
nasal epithelial cells, I decided to ask if this expression was affected by 
stimulation of the cells with bacterial ligands such as LPS, LTA, PGN and CpG 
(bacterial DNA), or with the pro-inflammatory cytokine TNF-α. There were no 
significant differences of the cells after stimulation, as assessed by confocal 
















Figure 4.6 Regulation of Toll-like receptor 9 (TLR9) in human primary 
nasal epithelial cells after stimulation with TLR ligands.  
Cells were seeded onto coverslips for 24 hours and were left untreated or 
stimulated for a further 24 hours with bacterial ligands. They were then fixed 
with methanol, blocked with 2% goat serum and incubated with a mouse 
monoclonal antibody against TLR9. Nuclei were stained with DAPI (blue). 
Secondary antibody anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy. a)untreated, b)P. aeruginosa 
LPS, c) S. aureus PGN, d) S. aureus LTA, e)CpG, f)TNF and g)mouse isotype 
control. 
Scale bar equals 50µm. 
 
4.2.5.1.2 Cytokine responses after TLR9 stimulation of primary nasal 
epithelial cells 
 
After the demonstration of strong expression of TLR9 in primary human nasal epithelial 
cells, cells from 5 patients undergoing lung resection were cultured and stimulated with 
the oligodeoxynucleotide (ODN) 2395 CpG-C DNA, a know  agonist of TLR9 
(Vollmer, J., et al, 2004 and Sivory, S., et al, 2006). After stimulation, cell-free 
supernatants were recovered and stored at -80oC until assayed using a CBA kit. The 
cytokines measured include: IL-8, IL-6, IL-1β, IL-10, TNF-α and IL-12p70. Patient 
demographics are included in table 4.1 
g) Isotype control 
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Subject Age Sex Smoker 
Patient 3 66 M Y 
Patient 6 57 M Y 
Patient 9 64 F Y 
Patient 20 57 M Y 
Patient 23 69 F Y 
Table 4.1 Characteristics of the five patients from which primary nasal 
epithelial cells were isolated 
 
 
The cytokine response by primary human nasal epithelial cells after stimulation 
of TLR9 with CpG-C DNA produced variable results: while 2 subjects appeared 
to respond by increasing the secretion of IL-8 and IL-6 in supernatants, the 
remaining three subjects behaved in a different manner by down-regulating the 
secretion of these cytokines. The responses to the o r cytokines produced 
highly variable results.  
 
4.2.5.2 Role of TLR-9 in primary human type II alveolar epithelial cells 
4.2.5.2.1 Immunocytochemistry 
 
Primary human type II alveolar epithelial cells were prepared as described on 
page 62 in the Materials and Methods section 2.2.3. As these cells require a 
bovine type I collagen matrix to be cultured, they were seeded onto pre-coated 
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coverslips. It is possible to observe the strong cytoplasmic uptake of the TLR9 










Figure 4.7 Detection of Toll-Like Receptor 9 in primary human type II 
alveolar epithelial cells. 
Cells were isolated as described in the Materials and Methods section and 
seeded onto glass coverslips pre-coated with type I bovine collagen. Cells were 
then fixed with 4% paraformaldehyde, permeabilised with 0.1% Triton X, 
washed, blocked with 2% goat serum and incubated with a mouse monoclonal 
antibody against TLR-9. Nuclei were stained with DAPI (blue). Secondary 
antibody was anti-mouse IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy: a) TLR9, b)TLR9 and 
c)Isotype control. 
Scale bar equals 10µm in TRL-9 photomicrographs and 25µm in the isotype 
control. 
a)  b)  
c)  
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4.2.5.2.2 Cytokine responses after TLR9 stimulation of primary type II 
alveolar epithelial cells 
After observing that primary type II alveolar epithelial cells expressed TLR9 
strongly in their cytoplasm, I decided to characterise their responses to 
stimulation with CpG-C DNA. Cells from seven patiens who underwent lung 







Final diagnosis Smoker 
5 59 F LU Squamous cell Ca Y 
6 57 M LL Non small cell lung Ca Y 
7 70 F RU Bronchogenic Ca Y 
8  63 F L* Single lung metastasis 
from malignant melanoma 
N 
9 64 F L* Squamous cell Ca Y 
11 59 F RU Single lung metastasis 
from rectal Ca 
N 
12 60 F M Non small cell lung Ca Y 
 
Table 4.2 Characteristics of patients from whom primary type II alveolar epithelial 
cells were isolated.  
RL, right lower lobe; LL, left lower lobe; RU, right upper lobe; M, right middle lobe; 
*Pneumonectomy; N/A, non applicable. 
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The results show a significant increase in the production of IL-8 after stimulation 
with CpG-C DNA (p=0.03). IL-1β secretion displayed a modest increase. There 























Figure 4.8 IL-8 responses by primary human type II alveolar epithelial cells 
after stimulation of TLR9.  
Cells were seeded in 6 well plates pre-coated with bovine type I collagen. After 
confluence, cells were washed and stimulated with 1µM CpG-C DNA for 24 
hours. 
Data are presented as individual data points. 
Statistical analysis was performed using the Wilcoxon matched pairs test to 
compare results for paired samples before and after stimulation using GraphPad 
Prism software. 
Statistical significance (*) was determined when p<0.05. 
 
 
4.2.5.3 Comparison of the cytokine response to TLR9 stimulation in 
primary human nasal and type II alveolar epithelial cells 
The cytokine response varied greatly between cells of the upper and lower 
respiratory tract after stimulation of TLR9 with CpG-C DNA. Type II alveolar 
epithelial cells appeared more responsive to stimulation with CpG-C DNA given 
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the significant increase in the secretion of IL-8 in supernatant and a trend toward 
the increased secretion of IL-1β. The nasal epithelial cells appeared refractive to 
stimulation and results varied greatly among subjects, despite showing a strong 
stain for TLR-9 in their cytoplasm. For a summary of the cytokine responses 
please refer to Table 4.3.  
 
These results suggest that cells from the lower respiratory tract behave in a more 
pro-inflammatory pattern after TLR9 stimulation, whereas cells from the upper 






























IL-8 282 (193-1004) 120 (11.8-2531) 1 2273 (707-11226) 2919 (636 – 40775) *0.0313 
IL-6 26.2 (13.7-
167.8) 
20.2 (4.7-535) 1 236.3 (8.3-1276) 228.3 (12.6–803) 0.57 
IL-1β 7.1 (0-9.5) 4 (0-10.5) 1 5.2 (2.8-8.1) 7.5 (1.7-11) 0.078 
TNF-α 10.3 (1.7-14.9) 5.4 (0–17.5) 0.18 10 (3.6-21.2) 7 (0–15.7) 0.81 
IL-10 10.4 (4-18.7) 6.2 (0–21.1) 0.43 15.2 (2.6-1276) 20.2 (0–803) 0.37 
IL-12p70 12.6 (3.6-19.8) 2.1 (0–26.7) 0.43 8 (5.4-19.7) 12 (2.7-28.6) 0.078 
 
Table 4.3 Comparison of cytokine responses between human primary nasal epithelial cells and primary human type II 
alveolar epithelial cells before and after stimulation of TLR9 
Data are expressed as median (range) for 5 and 7 subjects for primary nasal and type II alveolar epithelial cells respectively. 
Statistical analysis was performed using the Wilcoxon matched pairs test to compare results for paired samples after stimulation 
using GraphPad Prism software. 




 After demonstrating that primary epithelial cells from the upper and the lower 
respiratory tract express TLRs, I wanted to assess whether these cells act under 
negative regulation mechanisms such as the ones that have been identified in the 
gastrointestinal tract. For this, and in view of previous evidence of a recently 
identified protein called toll-interacting protein (tollip), I went on to try to identify 
if this protein could be expressed in the respiratory ract. 
 
4.3 Role of Toll-interacting protein (tollip) in the respiratory tract  
The respiratory tract is continuously challenged by the presence of micro-
organisms and inorganic particulate matter that enters during breathing. Mounting 
an inflammatory response every time that the epithelium is challenged would have 
deleterious consequences for the host, therefore negativ  regulatory mechanisms 
should be in place to avoid the excessive reaction to foreign particulates as well as 
invading micro-organisms. The gastrointestinal tract is an excellent example of 
this, since its large surface area is covered by multiple types of bacteria that live 
within without causing alterations in homeostasis. Furthermore, when the 
tolerance mechanisms are disregulated, pathology ensues (Shibolet, O., and 
Podolsky, D., 2007). One of the negative regulators firstly identified in the 
gastrointestinal tract is tollip, which appears to decrease inflammatory responses in 
colonic epithelium by inhibiting the transcription factor NF-κB (Otte, J., et al, 
2004 and Melmed, G., et al, 2003). 
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Since tollip’s actions could also exert an important effect in the respiratory tract, my 
aim was to assess if this protein is expressed in cell lines representative of the 
respiratory tract and then to characterise its respon es in human primary epithelial 
cells.  
 
4.3.1 Identification of tollip in the Human Colon Carcinoma cell line 
T84 
4.3.1.1 Detection of tollip messenger RNA 
In view of previous published data obtained in intestinal epithelial cells 
(Melmed, G., et al, 2003 and Otte, J., et al, 2004) I used the human colon 
carcinoma T84 cell line as the starting point to prduce primers against tollip, in 
order to use it as a positive control. Two sets of primers were used to achieve the 
detection of tollip mRNA in the cell line T84. An in-house set of primers was 
designed with the help of Dr. Thomas Wilkinson using the software Primer3®: 
the forward primer OM1:TACAGGCAAAGTTGGCCAA, binds a region of the 
tollip gene between the second and third exon, the reverse primer 
OM2:AAGCAGCGCGTAGGACAT, binds a region between the fourth and fifth 
exons. The expected product size was 347 base pairs.  
For the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping 
gene PCR was performed for 20 cycles. Primers used w re designed using 
Primer3 software; forward primer: 5’-CGAGATCCCTCCAATCAA-3’ and 
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reverse primer: 5’-TGCTGTAGCCAAATTCGTTG-3’. The product size 
expected was 727 base pairs. 
A second PCR reaction was performed using primers published by Otte, J., et al, 
2004. The expected product size was 74 bp. The PCR conditions are described in 
the Materials and Methods page 73 section 2.9. 
 








    
 
Figure 4.9 Expression of tollip mRNA analysed by RT-PCR in the human colonic 
cell line T84 using primers OM1 and OM2.  
T84 cells were plated at two different cell densitie : 5 x 105 per well (lanes 1,2); 2 x 106, 
(lanes 3,4) and negative control without the reverse transcriptase (lane 5).  





500 bp 347 bp 
Tollip 
  1      2      3     4        5 
500 bp 
727  bp 
GAPDH 











       
1      2       3       4        5 
 
Figure 4.10 Expression of tollip mRNA  analysed by RT-PCR in the human colonic 
cell line T84 using primers described by Otte et al.  
T84 cells were plated at two different cell densitie : 5 x 105 per well (lanes 1,2); 2 x 106, 
(lanes 3,4) and negative control without the reverse transcriptase (lane 5).  




4.3.1.2 Detection of tollip protein in the Human Colon Carcinoma cell line 
T84 
Once the transcripts for tollip in the human colon carcinoma cell line T84 were 
found, I designed an in-house direct ELISA with theaim to detect tollip protein 
as described in the Materials and Methods page 69 section 2.8. High intracellular 
levels of tollip were found in cell lysates of the T84 cell line. Tollip was not 
detected in cell culture media or in cell-free supernatants. (Figure 4.11) 
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Figure 4.11 Tollip levels in the human colon carcinoma cell line T84.  
T84 cells were seeded at 2 x 106 cells/ml in 6 well plates. Once confluent, cells were 
lysed and cell lysates were assayed for tollip by direct ELISA.  
 
4.3.2 Detection of tollip in the cell line RPMI 2650 
4.3.2.1 Immunocytochemistry 
 
Using confocal microscopy it was possible to find tollip in the nasal epithelial 
cell line RPMI 2650. The cells stained diffusely and strongly in the cytoplasm. In 








Figure 4.12 Detection of tollip in the nasal epithelial cell line RPMI 2650.  
Cells were seeded onto coverslips, fixed with methanol, blocked with 2% goat serum 
and incubated with a polyclonal rabbit antibody against tollip. Nuclei were stained with 
DAPI (blue). Secondary antibody was anti-rabbit IgG conjugated with Alexa 488 
(green).  
Images were analysed using confocal microscopy. a)tollip b)Isotype control.  
Scale bar equals 10µm to appreciate the staining in the cells, the isotype control scale 
bar equals 25µm. 




4.3.2.2 m-RNA tollip levels during infection with S. aureus strain Newman 
I decided to ask whether tollip m-RNA species could be found in the nasal cell 
line RPMI 2650 and if expression was affected after infection with S. aureus 
strain Newman. m-RNA transcripts for tollip were found in the RPMI 2650 cell 
line, which seems to express constitutively high leve s. The levels did not seem 
to be affected after infection with two different doses of live S. aureus, nor were 
they affected after the cells were incubated with the same dose of ultraviolet 
light-killed bacteria after 4 hours of stimulation. The T84 cell line was used as 
the positive control for this experiment and it was interesting to observe 
 Tollip 
b) a)  
Isotype control 
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decreased intensity in the expression of tollip transcripts in this cell line in 







Figure 4.13 Expression of tollip mRNA in the human nasal epithelial cell line RPMI 
2650 before and after 4 hours of infection with S. aureus strain Newman.  
RPMI 2650 cells were plated at 1 x 106 per well. Once the cells achieved 90% 
confluence, they were infected as described previously in the Materials and Methods 
section. RNA extraction was performed followed by RT-PCR using the primers OM1 
and OM2 
Lane 1) positive control for tollip from cell line T84; 2,3)unstimulated RPMI 2650 cells 
4,5) RPMI 2650 cells infected with Staphylococcus aureus strain Newman at a 
concentration of 1.1 x 105cfu/ml 6,7)RPMI 2650 cells infected with S. aureus at 1.6 x 
105 8,9)Cells exposed to UV-killed S. aureus at a concentration of 1.1 x 105cfu/ml 
10,11)cells exposed to υ killed S. aureus at a concentration of 1.6 x 105cfu/ml.  
Transcripts for GAPDH were used as the housekeeping gene 
 
 
These findings suggest that tollip m-RNA expression is constitutive in RPMI 
2650 cells and it does not seem to be affected by infection with Staphylococcus 
aureus at an early stage (4h). 
 
It was then relevant to assess whether tollip m-RNA transcripts would be 
affected at a later point during infection. Therefo an experiment was designed 
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constitutive levels of tollip m-RNA at 24 hours. However, after exposure to live
S. aureus strain Newman, there were no bands either in the lan s that contained 
the gene of interest or in the lanes concerning the house keeping gene GAPDH. 
In contrast, the wells in which the cells were exposed to S. aureus killed by 







Figure 4.14 Expression of tollip mRNA in the human nasal epithelial cell 
line RPMI 2650 before and after 24 hours infection with S. aureus strain 
Newman.  
RPMI 2650 cells were plated at 1 x 106 per well. Once the cells achieved 90% 
confluence, they were infected as described previously. RNA extraction was 
performed followed by RT-PCR using the primers OM1 and OM2. 
Lane 1) positive control for tollip, cell line T84; 2,3)unstimulated RPMI 2650 
cells; 4,5) RPMI 2650 cells infected with S. aureus at a concentration of 1.1 x 
105cfu/ml; 6,7)Cells infected with S. aureus at 1.6 x 105cfu/ml; 8,9)Cells 
exposed to killed S. aureus at 1.1 x 105 cfu/ml 10,11)cells exposed to killed S.
aureus at 1.62 x 105 cfu/ml. 
GAPDH was used as the housekeeping gene. 
 
 
The absence of bands suggests cellular death caused by the infection with S. 
aureus at 24 hours, this observation was supported morphologically, and 
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4.3.2.3 Role of tollip during infection with a MRSA strain  
After it was noted that a methicillin-sensitive strain of S. aureus had no effect on 
the transcription of tollip at 4 hours, I wanted to assess whether there was a 
different response after infection with a methicilln-resistant strain of S. aureus. 
The MRSA strain 252 was a kind gift from Dr. Ross Fitzgerald from the Centre 
for Infectious Diseases (CID), University of Edinburgh. This strain was used for 








Figure 4.15 Expression of tollip mRNA in the nasal epithelial cell line 
RPMI 2650 before and after infection with MRSA strain 252 for four 
hours. 
RPMI 2650 cells were plated at 1 x 106 per well. Once 90% confluence was 
achieved, they were infected as described previously. RNA extraction was 
followed by RT-PCR using primers OM1 and OM2. 
Lanes: 1) positive control for tollip from cell line T84, 2,3) unstimulated cells, 
4,5) cells infected with MRSA 252 at a concentration of 1.1 x 105cfu/ml and 
6,7) cells infected with MRSA 252 at 1.6 x 105 cfu/ml. 
GAPDH was used as a housekeeping gene.  
 
 
The results of PCR showed a similar result to those u ing the MSSA strain. 
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4.3.2.4 Role of quantitative PCR for tollip during S. aureus infection 
Since the conventional nested PCR did not provide clear data about regulation of 
tollip during S. aureus infection, I decided to use a quantitative method to assess 
the changes at the transcription level. QPCR primers and probe were designed 
with the assistance of Dr. Thomas Wilkinson using the software Primer3®: 
forward primer: 5’-TGGAATAAGGTCATCCACTG-3’, reverse primer: 5’-
AGAAGGCTCTCTCATCGAA-3’, and probe: 5’-
CCCAGGCGTGGACTCTTTCTA-3’.  
 
Primers and probe were also designed for the housekeeping gene GAPDH using 
the same software. Forward primer: 5’-GAAGGTGAAGGTCGGAGTC-3’, 
reverse primer: 5’-GAAGATGGTGATGGGATTTC-3’ and probe: 5’-
CAAGCTTCCCGTTCTCAGCC-3’. Primers were tested and dissociation curves 
were performed to assess specificity and to rule out the presence of primer 
dimmers. 
 
QPCR was performed in the samples after a 4 hour infect on of the cell line 
RPMI 2650 with S. aureus. It was possible to observe up-regulation in the 
transcripts for tollip, although when assessing the response in the housekeeping 
genes the results were contradictory. Whereas GAPDH appeared to be up-
regulated upon infection, 18S appeared to be down-regulated as a result of S. 
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Figure 4.16 Expression of tollip, GAPDH and 18S mRNA in the human 
nasal epithelial cell line RPMI 2650 before and after 4 hours infection with 
S. aureus strain Newman.  
RPMI 2650 cells were plated at 1 x 106 per well. Once the cells achieved 90% 
confluence, they were infected as described previously in the Materials and 
Methods section. RNA extraction was performed followed by a)tollip  QPCR 
using the primers and probe as described above, b)GAPDH and c)18S were used 
as house keeping genes.  






The lack of correlation between the gene of interest and the housekeeping genes 
probably indicates that the cells are overwhelmed by the infection with multiple 
cellular processes occurring simultaneously. This makes the model a very 
difficult one for establishing a mechanism.  
4.3.2.5 Tollip protein levels in the cell line RPMI 2650 
Due to the difficulties trying to establish an i -vitro live model of infection, I 
decided to move onto a model in which epithelial cel s were in contact with 
bacterial ligands in order to try to establish the behaviour after stimulation with 
single proteins. RPMI 2650 cells were plated, allowed to reach confluence and 
then left untreated or stimulated with TLR ligands such as ultrapure 
Pseudomonas aeruginosa LPS, S. aureus PGN and LTA, and the cytokine TNF-
α. Tollip appeared to be an abundant protein in thiscell line with median 
baseline intracellular levels of 5922ng/mg protein (range: 1635 – 26067). These 
levels did not seem to increase after stimulation with P. aeruginosa LPS or S. 
aureus PGN or LTA. Stimulation with the pro-inflammatory cytokine TNF-α 
was not associated with significant changes in tollip protein levels. 
4.3.3 Identification of tollip in the cell line A549 
4.3.3.1 Immunocytochemistry 
 
Using confocal microscopy it was possible to detect ollip protein in the human 
type II alveolar cell line A549. The stain was cytoplasmic and varied in intensity. 
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Some cells stained strongly whereas others showed no stain. In some cells it was 





Figure 4.17 Detection of tollip in the alveolar epithelial cell line A549.  
Cells were seeded onto coverslips, fixed with methanol, blocked with 2% goat 
serum and incubated with a polyclonal rabbit antibody against a)tollip, b)Isotype 
control. Nuclei were stained with DAPI (blue). Seconary antibody was  anti-
rabbit IgG conjugated withAlexa 488 (green).  
Images were analysed using confocal microscopy.  
Strong cytoplasmic stain can be observed in the cells. 




4.3.3.2 m-RNA tollip levels during infection with S. aureus strain Newman 
After the successful identification of tollip protein by immunocytochemistry, m-
RNA transcripts for tollip were found in the cell line A549. Expression seemed 
to be constitutive and not influenced after infection with S. aureus strain 
Newman. GAPDH was used as the housekeeping gene (Figure 4.18). 
 











Figure 4.18 Expression of tollip mRNA in the human alveolar epithelial cell 
line A549 before and after 4 hours of infection with S. aureus strain 
Newman.  
A549 cells were plated at 1 x 106 per well. Once 90% confluence was achieved, 
they were infected as described previously. RNA extraction was followed by 
RT-PCR using primers OM1 and OM2. 
Lanes: 1) positive control for tollip from cell line T84, 2,3) unstimulated cells, 
4,5) cells infected with S.aureus at a concentration of 1.1 x 105cfu/ml and 6,7) 
cells infected with S. aureus strain Newman at 1.6 x 105 cfu/ml. 
GAPDH was used as a housekeeping gene.  
 
 
A549 cells were plated at 1 x 106 per well and then infected with two different 
doses of S. aureus strain Newman as described in the Materials and Methods 
section 2.7, page 68, and RT-PCR was performed. The findings were similar to 
those for RPMI 2650 cells, i.e. tollip m-RNA transcripts were found in the A549 
cell line but there was not a significant increase in the quantity of the transcripts 
during bacterial infection when compared to transcripts for GAPDH. 
 
500 bp 347 bp 
Tollip 






4.3.3.3 Tollip protein levels in the cell line A549 
Median constitutive tollip levels in the human epithelial cell line A549 were 
2886ng/mg of protein (range: 444 – 30435). There were modest increases in the 
intracellular levels after stimulation of the cells with LPS from P. aeruginosa and 
PGN from S. aureus, although these did not achieve statistical significance. 
TNF-α stimulation did not have any effects on intracellular levels of tollip. 
 
4.4 Identification of Tollip in primary cells of the respiratory tract 
 
After the demonstration of tollip in cell lines, I decided to assess if it would be 
possible to transfer the same techniques used onto primary human epithelial cells 
in order to confirm the presence of this protein in a more physiological model. For 
this cells from human volunteers were used. 
 
4.4.1 Immunocytochemistry in nasal cells 
 
Primary human nasal epithelial cells were obtained from healthy volunteers and 
patients undergoing partial or total lobectomy due to lung neoplasias as described 
in Chapter 3. 
Using confocal microscopy it was possible to find tollip in the primary nasal 
epithelial cells, these cells stained in a different pattern when compared with 
their cancer cell line counterpart. There is evidence of punctate staining 
distributed diffusely around the cytoplasm, probably in the endosomal 
compartment, although markedly less strong than for the cell lines RPMI2650 or 
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A549 (see pages 184 and 192 respectively). The pattrn of the stain appears to be 
similar to the observations made by Brissoni, B., et al, 2006 when they studied 
mouse embryonic fibroblasts (MEFs) and observed staining for tollip in the 
cytosol and suggested that this localisation is likely to be in late endosomes.  
More recently, Ciarrocchi, A., and coworkers, (2009) demonstrated in HeLa cells 
that tollip is found in small aggregates in the cytoplasm in a perinuclear position 
that could correspond to the Golgi apparatus and/or endosomes. In comparison to 
the cell line the primary nasal epithelial cells displayed a weaker nucleolar 
staining.  
 
After demonstrating the evidence of tollip in primary nasal epithelial cells, I 
wanted to assess whether the location of this protein was altered in response to 
stimulation with TLR ligands. In relation to the effects of different stimuli on the 
staining pattern, it was interesting that the cells that received S. aureus PGN 
showed multiple aggregates of tollip protein around the cytoplasm. It would be 
interesting in the future to follow this observation further to ascertain if these 
aggregates are formed in early or late endosomes. There were no changes in the 
distribution of tollip in the cells stimulated with TNF-α, as expected, TNF-α acts 



















c) PGN d) LTA 
e) TNF 
f) Isotype control 
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Figure 4.19 Detection of tollip in primary human nasal epithelial cells.  
Cells were seeded onto coverslips for 24 hours and then stimulated with TLR 
ligands or TNF-α: a) untreated, b) LPS, c) PGN, d)LTA, e) TNF, f) isotype 
control for 24 hours. They were then fixed with methanol, blocked with 2% goat 
serum and incubated with a rabbit polyclonal antibody against tollip. Nuclei 
were stained with DAPI (blue). Secondary antibody was anti-rabbit IgG 
conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy.  
Diffuse cytoplasmic stain can be observed in the cells. In the cells exposed to 
petptidoglycan there is evidence of deposits of tollip around the cytoplasm and 
in the nucleus. There is no evidence of change in the appearance of the deposits 
in the cells treated with TNF-α. 
Scale bar equals 50µm. 
Results presented are of one representative experiment of four. 
   
4.4.1.1 Role of tollip m-RNA transcripts in nasal epithelial cells 
As seen previously I identified tollip protein in human primary nasal epithelial 
cells (Figure 4.19 above). QPCR was performed on 5 sets of primary nasal 
epithelial samples from the patients illustrated in Table 4.3.  RNA was extracted 
after lysis of the cells and real-time PCR was performed. Tollip CT values were 
normalised to 18S which was used as the housekeeping gene; results are given as 
a relative value of the expression of these two genes using the standard curve 
method. 
Subject Age Sex Smoker 
Patient 3 66 M Y 
Patient 6 57 M Y 
Patient 9 64 F Y 
Patient 20 57 M Y 
Patient 23 69 F Y 
Table 4.3 Characteristics of the five patients from whom primary nasal 
epithelial cells were isolated and PCR was performed 
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The results show great variability in the tollip m-RNA transcripts from the five 
different patients. Stimulation with LPS, PGN or LTA was not associated with an 
increase in tollip transcription. Stimulation with TNF-α was not associated with an 
up-regulation of this gene either, as expected.  
 
4.4.2 Immunocytochemistry in bronchial epithelial cells 
 
Using confocal microscopy it was possible to find tollip in the primary bronchial 
epithelial cells from a patient. These cells stained in a similar way in comparison 
with their primary nasal epithelial cell counterparts. There is evidence of a 
diffuse punctate staining in the cytoplasm, nucleolar staining is weak. This 
pattern appears to be consistent with my previous observations made in primary 
nasal epithelial cells. 
 
In relation to the effects of different stimuli on the staining pattern,  the cells that 
received PGN from S. aureus showed multiple aggregates of tollip protein 
around the cytoplasm, and more particularly in this ca e toward the cellular 
membrane as well as some aggregates in the nucleus. Unfortunately due to 
technical difficulties it was not possible to isolate and culture a larger number of 
cells from different subjects and therefore, there are limitations to these findings. 
It would be interesting in the future to follow this observation further. There 
were no changes in the distribution of tollip in the cells stimulated with TNF-α as 
expected (Figure 4.20).  
 199 





 Figure 4.20 Detection of tollip in primary human bronchial epithelial cells.  
Cells were seeded onto coverslips for 24 hours and then stimulated with TLR ligands as 
follows: a) untreated, b) LPS, c) PGN, d ) LTA, e) TNF, f) isotype control for further 24 
hours. They were then fixed with methanol, blocked with 2% goat serum and incubated 
with a rabbit polyclonal antibody against tollip. Nuclei were stained with DAPI (blue). 
Secondary antibody was anti-rabbit IgG conjugated with Alexa 488 (green).  
Images were analysed using confocal microscopy.  
Scale bar equals 50µm. Results presented are for one experiment. 
 
a) Untreated b) LPS 
c) PGN d) LTA 
e) TNF 
f) Isotype control 
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4.4.3 Immunocytochemistry in primary type II alveolar epithelial cells 
 
Following the demonstration of tollip in cells from the upper respiratory tract and 
the airway, I wanted to establish whether tollip was expressed in primary type II 
alveolar epithelial cells and to determine any differences. I prepared the 
conditions necessary to perform immunocytochemistry. Using confocal 
microscopy, I was able to find tollip in primary type II alveolar epithelial cells 
from a patient. These cells displayed a stronger cytoplasmic stain which, in 
comparison to the nasal and bronchial cells, appears more concentrated in the 
perinuclear region. It was also possible to observe a marked positive nucleolar 
staining (Figure 4.21). 
 
  
Figure 4.21 Detection of tollip in primary type II alveolar human epithelial 
cells.  
Cells were seeded onto coverslips pre-coated with bovine type I collagen. They 
were then fixed with 4% paraformaldehyde, blocked with 2% goat serum and 
incubated with a polyclonal rabbit antibody against tollip. Nuclei were stained 
with DAPI (blue). Secondary antibody was anti-rabbit IgG Alexa 488 (green).  
Images were analysed using confocal microscopy.  
Strong diffuse cytoplasmic stain can be observed in the cells and a very strong 
nuclear stain can also be observed. 
Scale bar equals 10µm. 
 
a) Tollip b) Isotype control 
 201 
4.4.3.1 Role of Tollip m-RNA in type II alveolar epithelial cells 
As seen previously I identified tollip protein in human primary type II alveolar 
epithelial cells (Figure 4.21 above), although due to the technical difficulties 
involved in the isolation of these cells and the variable numbers obtained from 
different sized lung resection specimens, it was not possible to perform protein 
extraction for all of the samples from the different patients. It was however 
possible to extract RNA after lysis and to perform real-time PCR. QPCR was 
performed on 6 lung tissue samples from the patients illustrated in Table 4.4.  
Tollip CT values were normalised to 18S which was used as the housekeeping 
gene. Results are given as a relative value of the expression of these two genes 





Final diagnosis Smoker 
5 59 F LU Squamous cell Ca Y 
6 57 M LL Non small cell lung Ca Y 
7 70 F RU Bronchogenic Ca Y 
8  63 F L* Single lung metastasis 
from malignant melanoma 
N 
9 64 F L* Squamous cell Ca Y 
12 60 F M Non small cell lung Ca Y 
 
Table 4.4 Patients from whom QPCR for tollip was performed. 
RL, right lower lobe; LL, left lower lobe; RU, right upper lobe; M, right middle lobe; 
*pneumonectomy; N/A, non applicable. 
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The results suggest that tollip in the lower respiratory tract is up-regulated after 
stimulation with P. aeruginosa LPS.  PGN and LTA from S. aureus also 
demonstrated a trend toward up-regulation of this gene although there is higher 
variability among subjects in response to these stimulants and the differences are 
not statistically significant, possibly due to the small number of samples analysed. 
Taken together these results illustrate the similar behaviour of this protein in a 
completely different compartment in comparison to the gastrointestinal tract. 
There was not a significant change in tollip m-RNA levels after stimulation of 
primary type II alveolar epithelial cells with the pro-inflammatory cytokine TNF-α 
as expected. 
 
4.4.4 Comparison of tollip response between the upper and the lower 
respiratory tract. 
Following the identification of tollip m-RNA transcripts in cells of the upper and 
lower respiratory tract, the difference between reaction of these cells to challenge 
by bacterial ligands was analysed. It is well established that nasal colonisation of 
pathogens happens asymptomatically, whereas the presenc  of the very same 
organism in the lower respiratory tract is associated with a severe inflammatory 
response. The results show that constitutive m-RNA levels of tollip are 
significantly higher in nasal epithelial cells in comparison to their type II alveolar 
epithelial counterparts. However, both compartments tend to behave in a different 
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manner after challenge with bacterial ligands such as LPS, PGN or LTA. While it 
seems that LPS is associated with a more profound effect in the lung epithelial 
cells, there were no significant changes in the respon e of these cells after 


















Figure 4.22 Comparison of tollip m-RNA transcripts in primary human 
nasal epithelial cells and primary human type II alveolar epithelial cells. 
Human primary nasal epithelial cells were seeded onto 6 well plates and human 
primary type II alveolar epithelial cells were seedd onto collagen type I-pre-
coated 6 well plates.  
After achieving confluence, cells were washed and lysed, RNA was extracted 
and QPCR performed as described in the Materials and Methods section.  
Data was analysed using the standard curve method and is presented as 
individual data points and median (line).  
Statistical analysis was performed using the Mann-Whitney test for non 
parametric data.  






Primary human nasal epithelial cells express TLRs (Vandermeer, J., et al, 2004; 
Wang, J., et al, 2007 and Lane, A., et al. 2006). Although this fact is well 
established in the literature, I wanted to confirm the expression of these proteins in 
my system, using primary human monocytes as the positive control. Establishing 
differences in expression of these receptors among different subjects was out of 
the scope of the proposed research and therefore, there could be limitations to the 
data presented since TLR expression patterns/levels are subject to biological 
variation among individuals. The studies are consistent in finding high expression 
of TLR3 mRNA and low expression of TLR4 mRNA transcripts, and TLR2 
mRNA expression was variable, although the limitation of these studies is that 
they were performed using specimens of nasal mucosa fr m patients with chronic 
rhinosinusitis. Furthermore, the study by Lane established differences in TLR2 
expression associated with this disease when they noted that the expression of this 
gene was increased in patients compared to healthy controls, although they did not 
establish a relationship with TLR2 protein levels in these patients.  
In my study, using an immunocytochemistry approach I was able to find TLR1, 
TLR2, TLR4 and TLR9 in primary human nasal epithelial cells. I could not 
identify TLR6 in primary monocytes or primary nasal epithelial cells.  
TLR1, displayed a diffuse cytoplasmic stain in primary nasal epithelial cells, 
whereas in monocytes it was expressed in the cytoplasmic membrane. Primary 
nasal epithelial cells also expressed TLR2 at a lower degree than primary human 
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monocytes. This finding coincides with the one from Wang and coworkers in 
2007, in which although they could not detect signif cant expression of TLR2 
protein, when looking into transcription, they detected low levels of TLR2 mRNA 
transcripts. These findings are supported further by the observation from Mayer, 
A., et al (2006) when they studied bronchial epithel al cells and found low 
expression of TLR2 mRNA which correlated in their studies to unresponsiveness 
to certain TLR2 ligands. They suggest that in airway epithelium low TLR2 
expression might play a role in limiting uncontrolled activation by inhaled 
bacteria. 
In my experiments in primary human nasal epithelial ce ls, TLR4 appears 
predominantly as intracellular ring-like structures. This result is in accordance 
with the report by Guillot, L., et al, 2004, in whic  they found that in pulmonary 
epithelial cells and human primary bronchial epithel al cells, TLR4 localises 
intracellularly. 
I was unable to identify TLR6 in primary human monocytes or in primary human 
nasal epithelial cells. This finding is consistent wi h the data reported by Nakao, 
Y., and colleagues, (2005) when they looked at the expression profiles of TLR1 
and TLR6 and found that the expression varied within different subsets of cells 
from peripheral human blood. Further observations by Greene, C., et al, 2005 
noted that when the expression of cell surface protein for TLRs was examined in 
the airway cell lines CFTE29o- and 16HBE14o-, cell surface expression was 
detected for TLRs 1-5 and TLR9 but not TLR6 using laser scanning microscopy, 
although they were able to identify mRNA transcripts for this gene. 
 206 
TLR9 has been shown to be essential for the recogniti n of bacterial DNA 
(Hemmi, H., et al, 2000). One of the main characteristics of bacterial genomes is 
that they contain a higher frequency of unmethylated deoxycytidyl-
deoxyguanosine (CpG) dinucleotides (Krieg, A., et al, 1995 and Bauer, S., et al, 
2001). Small oligodeoxynucleotides (ODN) with unmethylated CpG dinucleotides 
(CpG ODN) are able to mimic the immunostimulatory activity of bacterial DNA. 
It has been reported that the CpG backbone itself has immunostimulatory effects 
independent of TLR9 agonist activity (Jurk, M., et al, 2004). There are three 
different types of oligonucleotides. CpG class A (also called type D) ODN, are 
especially potent in activating human plasmacytoid dendritic cells (pDC) to 
produce high amounts of IFN-α. It has also been noted that this type of CpG is 
also a poor B cell stimulator. CpG class B, also called K-type, is a very potent Th1 
inducer, has anti-tumour activity and stimulates strong B and NK cell activation 
and cytokine secretion. More recently, a third class of CpG (class C) has been 
characterised by Vollmer, J., and colleagues, (2004). They demonstrated that this 
class strongly stimulates B cells as well as type I IFN secretion in vitro on human 
peripheral blood mononuclear cells, and in vivo it also acts as a strong Th1 
inducer. It is also efficient in enhancing expression of co-stimulatory molecules 
causing B cell production of IL-6 and IL-10 as well as stimulating strong B cell 
proliferation. It has also been demonstrated that tis class of CpG induces IL-6 
secretion in mouse splenocytes and also appears to induce more efficient IFN-γ 
secretion than the B-class CpG ODN in the same cells. CpG-C ODN also 
efficiently induces IFN-α-mediated NK cell lytic activity. CpG-C is also 
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associated with the down-regulation of CD14 and up-regulation of CD80 on 
monocytes, which characterises the transition from monocytes into myeloid DC 
and indicates that the C-class CpG ODN promotes the maturation of monocytes 
into functional DC that will be able to efficiently support antigen-specific cellular 
responses.  
Jurk, M., et al (2004) demonstrated that CpG-C ODN strongly stimulated 
transcription of the chemokine IP-10 in human PBMC, as well as being associated 
with the induction of IL-18 mRNA up-regulation. IL-18 has been described as a 
cytokine that is able to directly induce IFN-γ production (Okamura, H., et al, 
1995) and was also demonstrated to augment NK cell a tivity and to exhibit anti-
tumour effects. They also reported that all three classes of CpG ODN were 
associated with down-regulation of TLR9 mRNA levels within 4 hours of 
incubation with human PBMC, with reconstitution to n rmal levels after 16 hours. 
C-class ODN appear to stimulate strong Th1-like respon es in vitro on human 
PBMC, including type I and II interferon, IL-18 and IP-10 production and NK cell 
stimulation. They suggest that this type of ODN might prove to be useful to induce 
potent anti-tumour effects or long-lasting anti-viral activity in the therapy of 
chronic viral diseases. The study by Robbiani’s group (2006) used the CpG-C 
ODN C274 in vivo and documented that it is a good activ tor of leukocytes (DCs 
and B cells) in the lymph nodes of macaques (both naïve and chronically infected 
with simian HIV (SHIV)). They also observed increas endogenous cytokine and 
chemokine activity in the lymph nodes injected, which could be important to help 
control virus replication within these tissues. After specific re-stimulation they 
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detected cellular activation and cytokine and chemokine responses and this finding 
places this group of CpG ODNs in the list of potential adjuvants to be used for 
improving the immunogenicity and protective efficacy of vaccines.  
 
I chose to use the CpG-class C in my experiments because it is a potent 
immunostimulator, acts as an intermediate between classes A and B CpG ODNs, 
and it might have even broader local immune effects which are more likely to 
mimic the in-vivo situation in which dying bacteria within the airways will release 
a vast amount of bacterial DNA. In addition, there is vidence that it could be used 
as a potent adjuvant for the development of vaccines that could be nebulised to 
access the lower respiratory tract. So it could have  potential therapeutic effect. 
Moreover, although CpG class C ODN has been used to test responses from 
PBMC, dendritic cells and intranodally as described above, since there is to my 
knowledge no evidence of its responses in airway epith lial cells I thought that 
this would be a great opportunity to test its effects in primary human cells of the 
respiratory tract. 
 
I found that TLR9 is strongly expressed in primary human nasal epithelial cells 
and the staining pattern was not affected by stimulation with TLR ligands. After 
stimulation with CpG-C ODN, the nasal epithelial cells displayed variable 
behaviour. IL-8 and IL-6 showed an increase in two subjects producing high 
levels, whereas in three subjects the levels tended to decrease. There was not a 
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clear association between TLR9 stimulation and the production of IL-1β, IL-10 
and IL-12p70. TNF-α production appeared to be decreased in 4 subjects. 
 
Primary lung epithelial cells expressed TLR9 strongly in their cytoplasm. 
However, it was not possible to assess the response after stimulation due to 
technical difficulties obtaining and culturing these cells. This would be an 
interesting area to assess in future research. The cytokine response in primary type 
II alveolar epithelial cells showed a significant icrease in the production of IL-8 
after CpG-C ODN stimulation and a modest increase in the production of IL-1β, 
although non statistically significant. Secretion of the other cytokines (IL-6, IL-10, 
TNF-α and IL-12p70) was unchanged.  
 
The fact that TLR9 stimulation did not achieve a response in cells from the upper 
respiratory tract, whilst being more active in cells from the lower respiratory tract 
has also been documented previously in vivo by Albiger, B., et al (2006) when 
they challenged TLR9 deficient and wild type C57BL/6 mice intranasally with the 
Steptococcus pneumoniae strain TIGR4 and found no differences in bacterial 
counts in nasopharyngeal tracheal lavages from both types of mice. On the 
contrary, when examining BAL samples they observed that the TLR9-/- mice were 
less able to clear pneumonia given by the fact that 40% and 20% of wild type mice 
showed the persistence of bacteria in BAL samples at 8 nd 12 hours post-
infection respectively, in contrast to 70% and 60% of the mutant mice at the same 
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two time-points, indicating that TLR9-/- mice were significantly more susceptible 
to pneumococcal infection. They also found associated reduced survival and the 
development of bacteraemia. They did not observe a d fect in the recruitment of 
immune cells to the lungs of the mutant mice, although they observed a decrease 
in the ability to phagocytose and kill pneumococci from the macrophages of the 
mutant mice. Furthermore, the effects of TLR9 defici n y on the susceptibility to 
develop pneumonia with Legionella pneumophila were shown by Bhan, U., et al, 
(2008) when they also showed increased mortality and reduced bacterial clearance 
in TLR9-/- mice in comparison to wild type BALB/c mice. They also noted a 
decrease in the internalisation of bacteria by alveolar macrophages from the 
mutant mice which was associated with a significantly decreased expression of 
iNOS mRNA by lung macrophages isolated from TLR9-/- mice, as in the absence 
of NO production the macrophage remains permissive for L. pneumophila 
replication. NO inhibits the growth of L. pneumophila in the lungs during the 
initial stages (within 3-5 days) of infection by limiting intrapulmonary replication 
prior to the development of L. pneumophila specific cellular immunity. Their 
results show that TLR9 is required for classical lung macrophage activation in 
intracellular bacterial infection and that TLR9 plays a critical role in the 
programming of the macrophage phenotype. They also demonstrated that host 
immunity could be restored in mutant mice by the adoptive transfer of syngeneic 
wild type DCs but this was not achieved using bone marrow derived DCs from 
TLR9-/- mice, which suggests that impaired DC function in TRL9-/- mice is 
responsible for the immune defects observed. In addition, they found that intra-
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tracheal but not systemic treatment with CpG class A ODN was associated with a 
7.5 fold reduction in L. pneumophila cfu counts at 72 hours after bacterial 
administration in A/J mice, and also describe similar results using the C-class CpG 
ODN 10101, suggesting that compartmental pre-treatmn  with a synthetic TLR9 
agonist can stimulate protective innate immunity in murine Legionella pneumonia. 
 
After establishing the presence of TLRs in primary cells of the respiratory system 
I went to look for the potential regulator called toll-interacting protein (tollip). 
Tollip m-RNA transcripts and protein were identified in the human colon 
carcinoma cell line T84 in accordance to the data published by Otte, J., and 
coworkers (2004) and Melmed, G., and colleagues, (2003).  Following this, it was 
possible to identify tollip protein using confocal microscopy analysis in the human 
nasal epithelial cell line RPMI 2650. The cells stained strongly with tollip 
antibody not only in the cytoplasm, but also in thenucleolus. The morphological 
appearance of the stain in these cells is similar in distribution and localisation to 
that described by Li, T., et al, 2004, who showed that tollip localises to the 
cytoplasm of HeLa cells stably transfected with TLR4 and MD2 (HeLa-MAT). 
Further work after transfection with pEGFP-tollip in the same cells noted that 
tollip colocalises with pECFP-golgi, which suggests that tollip preferentially 
localies to the Golgi apparatus. Observations made by Brissoni, B., et al, (2006) in 
mouse embryonic fibroblasts (MEF) showed staining for tollip in the cytosol and 
suggested that this localisation is likely to be on late endosomes,. Moreover, 
Ciarrocchi, A., (2009) also demonstrated small aggre ates of tollip in HeLa cells 
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in a perinuclear position probably corresponding to the Golgi apparatus or 
endosomes. They also demonstrated colocalisation between tollip and the protein 
SUMO-1 in human SAOS-2/IL-1R osteoblastoma cells (in which IL-1RI is 
constitutively expressed). Concluding that SUMO-1 and tollip are translocated 
into the nucleus and internalised into nuclear bodies. Furthermore, they found in 
the same type of cells that Daxx (a transcriptional co-repressor interacting with 
many sumoylated factors) interacts with tollip, given by their colocalization in 
defined nuclear structures suggesting a nuclear role as well as involvement in 
nuclear cytoplasmic trafficking. 
 
During infection with S. aureus strain Newman, it was observed that RPMI 2650 
cells constitutively express tollip. Although convetional PCR at 4 hours was not 
helpful in predicting changes in m-RNA transcription during infection, when a 
later time point such as 24 hours was assessed, it was observed that the bacteria 
had successfully overgrown and killed the cells. Exposure to ultraviolet light-
killed bacteria was not associated with significant changes in tollip m-RNA 
transcription at both time points. In view of these results, quantitative PCR was 
performed in order to try to understand the effects of live infection by S. aureus on 
the nasal epithelial cells. The results confirmed that by 4 hours the infection not 
only affected tollip transcription but the whole cell integrity displayed by changes 
in 18S and GAPDH during the active infective process. Infection of the nasal 
epithelial cell line RPMI 2650 with an MRSA strain also failed to show significant 
changes in tollip m-RNA transcription using RT-PCR. 
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 In view of the multiple difficulties during the live prokaryotic-eukaryotic 
experiments, a sterile model was designed to assess th  interaction with purified 
TLR ligands implicated in the infection process such as LPS, PGN and LTA. In 
these experiments it was noted that tollip protein l vels in lysates from the RPMI 
2650 cell line were very high and also remained uncha ged after a 24 hour 
stimulation with bacterial products. 
 
Tollip was also identified in the human type II alveolar epithelial cell line A549 
using immunocytochemistry. The staining pattern was similar to that in RPMI 
2650 cells: diffuse cytoplasmic with an associated nuclear staining. During live 
infection, conventional RT-PCR revealed a similar pttern in tollip transcripts: 
tollip was constitutively expressed and there were no significant changes after 
infection with two different doses of live bacteria. Intracellular tollip levels in the 
human type II alveolar epithelial cell line A549 were also very high but remained 
constant after 24 hour stimulation with bacterial lgands. Although this cell line 
appeared to be more responsive after stimulation, these changes were not 
statistically significant. Comparison of the tollip response after stimulation with 
bacterial products between the two cell lines did not show significant differences. 
A possible explanation for this finding is the fact that tollip’s response to TLR 
ligands may happen in a relatively short period of time. The original description 
by Burns, K., in 2000 shows that tollip is rapidly associated and dissociated from 
its receptor complex. Tollip was detected two minutes after IL-1β stimulation but 
not at earlier or later time points in lysates from EL-4.6.10 cells. Furthermore, 
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Brissoni’s work (2006), using MEF cells with wild type tollip and tollip-/- cells 
showed that 1 hour after IL-1β stimulation, the distribution of internalised IL-1RI 
was similar in both wild-type and tollip-deficient cells. However stimulation for 
longer periods (3-6 hours) showed that whilst in wild type cells IL-1RI was 
progressively more difficult to detect, in tollip-deficient cells significant levels of 
IL-1RI continued to accumulate in late endosomes. This accumulation could be 
reversed by stable reconstitution of tollip-deficient cells with tollip but not with 
empty vector, suggesting that tollip is required for efficient sorting of IL-1RI at 
late endosomes. Tollip’s behaviour also appears to be related to the specific 
compartment in which it is found. The study by Otte, J., et al, 2004 used the 
intestinal epithelial cell lines T84, SW480 and Colo 205 and showed that after 
stimulation with LPS or LTA expression of tollip mRNA was up-regulated in both 
cell lines as early as 2 hours, reaching peak levels after 8 to 12 hours. This was 
also demonstrated at protein level. It is therefore lik ly that in my experiments, 
which involved a 24 hour incubation with the ligand, the cells achieved a balance 
in response to the ligands that stimulated them in the first instance faster, which is 
consistent with tollip’s role as an endocytic adaptor. Sorting of the cargo to the 
early and late endosomal compartments happens in a relatively fast and highly 
coordinated manner in order to allow the cell to get back to its original 
homeostasis state and in doing so, achieving toleranc  to the antigens expressed. 
One exception for this in my experiments was when the cells were incubated with 
peptidoglycan. Multiple deposits intracellularly appeared to stain positive with the 
tollip antibody possibly suggesting that peptidoglycan itself induces a change in 
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the conformation of tollip or affects the sorting of the cargo in the endosomal 
compartment. Future experiments could focus on addressing this issue in more 
detail.  
 
Tollip protein was successfully identified in primary human nasal epithelial cells 
by immunocytochemistry. The pattern of the staining was punctate and distributed 
around the cytoplasm, probably in endosomes as previously described by Brissoni, 
B., et al, 2006 although markedly less strongly when compared to the cancerous 
cell line RPMI 2650. Nucleolar staining was less evid nt too. After stimulation 
with bacterial ligands, there was a change in the saining pattern, particularly with 
peptidoglycan from S. aureus, when the presence of multiple aggregates around 
the cytoplasm and in the nucleolus was observed; suggesting that stimulation with 
this ligand could affect the conformation of tollip or its ability to sort cargo in the 
endosomal compartment. Stimulation with TNF-α was not associated with any 
changes in the cellular staining pattern of tollip as expected.  
 
Using real-time PCR it was possible to identify tollip m-RNA transcripts in 
primary nasal epithelial cells; although their response was different to that 
expected. LPS was not associated with an increase in mRNA transcription, and 
neither were PGN or LTA. These findings correlated with the 
immunocytochemistry findings in which there was notan increase in the protein 
expression of the protein. 
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Confocal microscopy analysis of primary bronchial epithelial cells showed similar 
findings to those from primary nasal cells, i.e. there was a diffuse punctate staining 
throughout the cytoplasm and nuclear staining was more subtle than in cancerous 
cell lines. These cells responded to peptidoglycan stimulation in a similar manner 
to the nasal epithelial cells, by forming tollip aggregates in the cytoplasm. 
 
Immunocytochemistry in primary human type II alveolar epithelial cells also 
showed a diffuse cytoplasmic stain, but in contrast with the upper respiratory tract 
cells, the stain was stronger and distributed more in the perinuclear area of the cell. 
Nucleolar staining for tollip was more clearly defined. Due to technical difficulties 
obtaining and culturing these cells, it was not possible to fully assess the pattern of 
the tollip response to bacterial ligands, although this would be an area for further 
work in the future. 
 
Taken together, the morphological appearances of tollip differs significantly when 
comparing cancer cell lines to primary cells in that the pattern of the staining is 
much stronger in cancer cells. This observation coincides with the observations 
made by Chen, Y., et al, 2007, in which, using a phos oproteomics approach 
they validated tollip as a novel tyrosine kinase substrate implicated in breast 
cancer development. The relationship of this associati n is unknown, yet on the 
other hand, chronic inflammation and cancer usually go hand in hand and 
therefore it is likely that tollip might also have a role in cancer cell development. 
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Due to the technical difficulties in obtaining enough numbers of primary human 
epithelial cells, it was not possible to perform protein measurements on cell lysates 
in order to ascertain if there was a difference in the content of this protein 
intracellularly which could explain the difference in the staining pattern, although 
this is another aspect that could be pursued in the future.   
 
Tollip’s role in the lower respiratory tract seems to be similar to that described in 
the gastrointestinal system by Melmed, G., et al, 2003 and Otte, J., et al, 2004, as 
stimulation of primary human type II alveolar epithelial cells is associated with the 
up-regulation of tollip in response to LPS, whereas there appeared to be high 
variability among subjects after stimulation with PGN and LTA. Although these 
differences are not statistically significant, these could reflect biological variation 
among subjects. 
 
Because of the nature of this study and of the primary cells used, it was not 
possible to ascertain the role that tollip plays in the interface with adaptive 
immunity, which certainly will be an area of further interest in the future. 
 
When comparing the compartmental role that tollip could play in the upper and 
lower respiratory tract, it appeared that basal m-RNA transcripts were higher in 
primary nasal epithelial cells when compared to type II alveolar epithelial cells. In 
addition to this, stimulation with bacterial ligands was associated with a different 
response in the nasal to the alveolar compartment. In relation to LPS, nasal cells 
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appeared refractive to stimulation with TLR ligands. It could be that higher 
intracellular levels of tollip require an even higher dose of LPS to elicit a response. 
I noted that in the study by Otte, J., et al (2004), they used a dose of 2µg/ml 
whereas the LTA dose was the same (10µg/ml). These findings support the 
hypothesis that the nasal epithelium behaves as a compartment more tolerant of 
bacteria and it is highly likely that tollip plays an important role in allowing 






















5.1. Role of the respiratory epithelium during Staphylococcus aureus 
colonisation 
5.1.1. Introduction 
Staphylococcus aureus is a bacterium that commonly colonises humans. The 
dynamics of colonisation have acquired increasing relevance recently since it has 
been observed that colonisation constitutes the detrmining step prior to infection 
by this organism (Dall’antonia, M., et al, 2005 and Watanabe, H., et al, 2000). 
The bacterium finds its niche in the anterior nares in the vestibulum nasi which 
consists of fully keratinised epithelium, apocrine sweat glands, sebaceous glands 
and hair follicles (Gluck, U., et al, 2000 and Werth im, H., et al, 2005). It is 
accepted that approximately 20% of the population are persistent carriers, 30% 
are intermittent carriers and 50% are non carriers (Wertheim, H., et al, 2005). 
Published literature about this subject varies, although the bacterial, 
epidemiological, genetic, and host factors in general have been studied 
extensively. However, the role of the epithelium in inducing an immunological 
response to the presence of this organism has been less well studied. 
 
Not only is the physical presence of the whole bacterium required to elicit an 
immunological response. Assuming that under normal circumstances the innate 
immune system is able to contain the infection, some f the bacterial cells would 
be lysed and as a consequence will release bacterial DNA onto the epithelium. 
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Under these conditions, which I believe are physiological, the epithelium will not 
only recognize but mount a response to the presence of bacterial DNA. 
 
The hypothesis that I would like to test are: 
1. “the nasal epithelium plays an active role in the surveillance of 
microorganisms” 
2. “Priming of the epithelium by bacterial DNA is associated with an 
inflammatory response”. 
 
My aims are to look at the innate immune responses established by the nasal 
epithelium in association with carrier status and to try to establish if there are 
differences in how upper and lower respiratory tract epithelium reacts to the 
presence of bacterial DNA. 
 
5.1.2. Definition and characterisation of nasal carriage of S. aureus 
Nasal swabs were performed in all the subjects who consented to nasal brushings 
as described in the Materials and Methods section. P sitive carrier status was 
defined by identification of colonies with a morphotype suggestive of S. aureus 
which were isolated in pure culture and identified using catalase, latex 
agglutination and tube coagulase tests as described in the Materials and Methods 
section (see Table 5.1 at the end of this chapter page 260).  
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A total of 47 nasal swabs were performed, and 3 subjects were sampled 
exclusively for flow cytometry. For detailed results on the identification of the 
bacterial strains associated with these experiments please refer to Tables 5.1 and 
5.2 at the end of this chapter, pages 260 and 262 respectively. 
 
5.1.3. Primary human nasal epithelial cells 
After performing the nasal swabs in the subjects, I obtained primary human nasal 
epithelial cells using a nasal brushing technique as reported by McDougall, C., et 
al, 2008. Cells from healthy volunteers and patients who underwent partial 
lobectomy or pneumonectomy were obtained as described in the Materials and 
Methods section. Two major type of experiments were designed: the first one 
with the objective to establish the cellular type recovered from the subjects after 
performing nasal brushings and the second one, to establish a tissue culture 
model of primary human nasal epithelial cells in order to test their response to 
TLR ligands and to the presence of S. aureus in the nasal mucosa. 
 
5.1.4. Flow cytometry of nasal brushings 
Flow cytometric analysis was performed on cells recov red from nasal brushings 
performed on 20 healthy adult volunteers. A restricted panel of fluorescently 
labelled antibodies was used to ascertain cell phenotype. Nasal swabs were also 
performed and cultured to establish the colonisation status of each one of the 
subjects. This work is the result of collaboration with Dr. Paul Fitch from the 
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Schwarze/Immunity and Chronic Inflammation Group based at the QMRI, 
University of Edinburgh.  
 
The antibody panel included antibodies raised against CD16 (FITC-labelled) for 
the identification of neutrophils, EpCAM (epithelial cell adhesion molecule; PE-
labelled) to identify epithelial cells, CD14 (PERCP-labelled) for the 
identification of monocytes and macrophages and CD3 (APC-labelled) for the 
identification of lymphocytes (Figure 5.1). These markers are not exclusive to 
these cell types. CD16 can for example be found on a small subset of circulating 
monocytes and some natural killer cell subsets. Low level EpCAM expression 
can be present on some mucosal immune cell subsets and ome highly activated 
cells can express both CD16 and CD14. However, given th  limitation of small 
cell numbers in some samples and a 4 colour flow cytometer for analysis, this 
antibody panel was used. Where cell numbers permitted, staining was also 
performed for dendritic cells using antibodies raised against CD11c, CD123, 
MHC HLADR, LINEAGE (CD3, CD14, CD16, CD19, CD20, CD56), NK/B 
using anti CD16, CD20 and CD3 and for T lymphocyte subsets using antibodies 
raised against CD3, CD4, and CD8. However, the DC, NK/B and T lymphocyte 
stain results were not conclusive as insufficient cells were identified in either the 





Figure 5.1 Flow cytometry analysis of a sample of primary nasal epithelial cells 
after brushing.  
Cells were obtained after brushing of the inferior turbinate of the nose and resuspended 
in DMEM prior to antibody staining. Cells were washed in PBS-1%BSA containing 
0.05% sodium azide and a single cell suspension obtained via ~15 passages through a 
19g needle. Non-specific antibody binding was blocked with mouse serum. Antibodies 
were added (3µl per test with cells in 50-100µl volumes) for 30 minutes. Cells were then 
washed and fixed with 4% paraformaldehyde prior to analysis on a 4 colour FACS 
Calibur flow cytometer. The forward scatter (relative size) verses side scatter (relative 
granularity) gate above was defined using a heat- and UV-killed propidium iodide 
stained cell control to exclude dead cells. Cells at the bottom left are therefore debris and 
dead cells. Material in the top right hand corner represents clumped material.  
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After repated analysis, it was observed that the number of cells recovered from 
the first cohort of subjects had insufficient numbers of cells to make detailed 
conclusions. The latter group of volunteers (n=10) demonstrated that the 
dominant viable cell population recovered during the brushing was EpCAM 
positive cells, negative for CD14, CD16 and CD3 and therefore assumed to 
represent epithelium, median: 58.3% (range:24.7 – 74.6), followed by variable 
proportions of CD16 positive cells, assumed here to be neutrophils, median 5.6% 
(range: 0.8 – 32.7) and the number of CD14 positive cells assumed here to be 
macrophage/monocytes was small, as well as, a  very small proportion of CD3 
positive cells (lymphocytes) was identified in some volunteers. Results of the 
bacterial identification of the colonies can be seen in Table 5.2 at the end of this 
chapter. 
In order to establish if there was a relationship in the amount of neutrophils 
recovered during brushing and the S. aureus colonisation status, the presence of 
CD16+ cells was analyzed. CD16+ cells are expressed a  a percentage of total 
live cells recovered from the inferior turbinate of healthy volunteers. The data 
suggest that individuals colonized with S. aureus have a slightly higher 
proportion of neutrophils in their nasal mucosa in comparison to non-colonized 





NEUTROPHILS (CD16+) PRESENT IN BRUSH SAMPLES


























Figure 5.2 Association of S. aureus nasal carriage with presence of 
neutrophils during nasal brushing.  
Cells were obtained after brushing of the inferior tu binate of the nose and 
resuspended in DMEM prior to antibody staining as de cribed above and in the 
Materials and Methods section. S aureus carrier status was performed as 





5.1.5. Description of healthy volunteers and patients for culture of 
primary nasal epithelial cells 
A total of 44 subjects were consented for the isolation of primary nasal epithelial 
cells for culture. Of these 22 were healthy volunteers (HV) and 22 were patients 
undergoing partial lobectomy or pneumonectomy in the Cardiothoracic Surgical 
Department of the Royal Infirmary of Edinburgh. For further demographic 
information of the subjects involved please refer back to Chapter 3, section 
3.2.2., page 103 and table 3.1 in page 105. 
 
Overall, the sex and colonisation status were non statistically significant by Chi 
square (p>0.05) (Table 5.1). In the healthy volunteer group 10 subjects (45%) 
were colonised with S. aureus. For four subjects, this was the predominant 
morphotype found in culture. Twelve were non-colonised. In the patient group, 
only five patients were found colonised with S. aureus (22.7%) and 17 were non-
colonised. The median number of morphologically different colonies in the 
colonised group with S. aureus was 3 (range 1-5), whereas in the group without 
S. aureus the equivalent median was also 3 (range 2-5). There w re two subjects 
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in which an alpha- and a beta-haemolytic Streptococcus were found and three 
other subjects in which a Gram negative bacillus waisolated in culture. Since 
the main objective of this study was to assess the presence of Staphylococcus 
aureus in nasal swabs, no further attempts were made to make detailed 
identification of the other bacterial strains isolated. A predominant feature during 
the bacteriological identification process was the pr dominance of Micrococci 
species in the nasal swabs of individuals who did not have colonisation with S. 
aureus. Micrococci were found in 21 of the swabs from indivi uals without S. 
aureus colonisation, as compared with only 5 of the S. aureus-colonised 
individuals (p=0.0225) by Fisher’s exact test. (Table 5.1) 
 
5.2. Cytokine response to TLR ligands during nasal carriage with S. 
aureus 
For the successful cultures, once the cells achieved confluence they were 
incubated with TLR ligands (LPS, Staphylococcus aureus PGN and LTA) and 
the pro-inflammatory cytokine TNF-α for 24 hours. Cell-free supernatants were 
taken and stored at -80oC prior to assay, cells were lysed for RNA extraction as 
described in the Materials and Methods section.  
 
For this part of the study, cells from 12 subjects were included: six subjects were 
found non colonised with S. aureus or any other pathogenic bacteria and six 
subjects were asymptomatic carriers for S. aureus. However, only one patient: P3 
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also had β-haemolytic streptococci spp isolated from a nasal swab) as seen in 
Table 5.4. The median age in the colonised group was 34 (range: 26 - 66), 
whereas in the non colonised group was 49.5 (range: 26 – 69). There were no 
statistical differences between the two groups for age (Mann Whitney test) or by 
sex or smoking status using Fisher’s exact test. It would have been ideal to obtain 
higher numbers of subjects for this part of the study, although the numbers are 
small, the observations made are relevant for future studies. 
Subject Age Sex Smoker S. aureus colonisation 
HV1 42 M N N 
HV2 31 M N Y 
HV4 35 F N N 
HV5 34 M N Y 
HV8 26 F N Y 
P3 66 M Y Y 
HV10 33 M N Y 
HV11 26 F N N 
P6 57 M Y Y 
P9 64 F Y N 
P20 57 M Y N 
P23 69 F Y N 
Table 5.4 Demographic data for healthy volunteers and patients included in 
the colonisation study. 






Median baseline IL-8 levels in non-colonised subjects were 274pg/ml (range: 
192 – 647); whereas colonised subjects showed a significantly increased basal 
production of this cytokine with a median production of 1384pg/ml (range: 726 – 
22456) (Figure 5.3).  

















Figure 5.3 Constitutive IL-8 production by primary human nasal epithelial 
cells in relation to S. aureus nasal colonisation (n=12).  
Cells were seeded in 6 well plates. After confluence cells were washed, and 
supernatants were removed after 24 hours. S. aureus colonisation was 
determined as discussed above.  
Data are presented as individual data points and median (line). 
Data were analysed using GraphPad Mann-whitney test. 





Median constitutive IL-6 production was significantly increased during S. aureus 
carriage.  IL-6 levels in non-colonised subjects were 16.2pg/ml (range: 5 – 28.6) 
whereas in colonised subjects it was 166pg/ml (range: 9.3 – 1982) (Figure 5.6). 
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Figure 5.6 Constitutive IL-6 production by primary human nasal 
epithelial cells in relation to S. aureus nasal colonisation (n=12).  
Cells were seeded in 6 well plates. After confluence, cells were washed 
and supernatants were removed after 24 hours. S. aureus colonisation 
was determined as discussed above.  
Data are presented as individual data points and median (line).  
Data were analysed using GraphPad Mann-whitney test. 




Median IL-1β production by non colonised subjects was 3pg/ml (range: 0 – 7.2), 
whilst subjects carrying S. aureus displayed significantly higher constitutive 
























Figure 5.9 Constitutive IL-1β production by primary human nasal 
epithelial cells in relation to S. aureus nasal colonisation (n=12).  
Cells were seeded in 6 well plates. After confluence, cells were washed 
and supernatants were removed after 24 hours. S. aureus colonisation 
was determined as discussed above.  
Data are presented as individual data points and median (line).  
Data were analysed using GraphPad Mann-Whitney test. 
Statistical significance (*) was established when p value <0.05  
 
  
The cells responded to stimulation with TLR ligands as well as with the pro-
inflammatory cytokine TNF-α, reflecting the overall increase in the baseline 
levels of production associated with S. aureus carriage.  
Median baseline levels of the cytokines IL-10, TNF-α and IL-12p70 were not 
affected by the colonisation status. 
 
For a summary of the cytokine production in primary nasal epithelial cells in 




Cytokine S. aureus carriage Non Carrier P value 
 (pg/ml) (pg/ml)  
IL-8 1384 (726 - 22456) 274 (192 - 647) 0.0022* 
IL-6 166 (9.3 – 1982) 16.2 (5 – 28.6) 0.0260* 
IL-1β 8.7 (6.4 – 68) 3.1 (0 – 7.2) 0.0152* 
TNF-α 4.1 (1.7 – 46) 6.8 (0 – 10.9) 0.8182 
IL-10 4.4 (3 – 16) 5.9 (2.6 – 18.7) 1 
IL-12p70 5.5 (3.6 – 15.6) 8 (2.2 – 19.8) 0.93 
 
Table 5.5 Cytokine production by primary nasal epithelial cells in 
association with S. aureus nasal carriage. 
Data are presented are median cytokine concentration (range) for each cytokine 
studied 
Statistical analysis was performed using Mann-Whitney test 




5.3. Role of tollip during S. aureus colonisation 
In order to address the question if tollip plays a role during S. aureus colonisation, 
primary nasal epithelial cells from healthy volunteers and patients were grown in 
culture. Bacterial identification in nasal swabs was performed, as previously 
described. Cells were left untreated or stimulated for 24 hours with TLR ligands 
such as LPS (positive control), PGN, LTA and the pro-inflammatory cytokine 
TNF-α (negative control). After completing incubation the cells were lysed and 
RNA extraction was performed. QPCR was performed for tollip, 18S was used as 
the housekeeping gene, as described in the Materials and Methods section. 
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The median relative value for tollip m-RNA transcripts in non colonised subjects 
was 6.4 (range: 5 – 8.2), whereas in colonised subjects was 4.2 (range: 2.5 – 16.3). 





5.4. Cytokine response after stimulation of TLR9 in primary human 
respiratory epithelial cells 
The effects of TLR9 stimulation in primary cells of the respiratory tract have not 
been extensively studied. We must start with the premise that an infection is a 
highly dynamic process during which complex interactions happen both at the 
host cellular level and at the pathogen level, while bacterial cells simultaneously 
multiply and die throughout. Once a bacterial cell dies its contents, including 
bacterial DNA, are presumably released into the surrounding lung parenchyma. 
Extracellular bacterial DNA may therefore play a role in the inflammatory 
response. Although there is evidence that bacterial DNA CpG motifs promote 
pro-inflammatory responses in the lower respiratory tract (Schwartz, D., et al, 
1997), the specific response has not been evaluated in primary epithelial cells 
from the respiratory tract. The following experiments were designed to attempt 




5.4.1. Cytokine response after stimulation of TLR9 in primary nasal 
epithelial cells 
 
Human primary nasal epithelial cells were obtained from consented patients. For 
patient demographic details please see Table 5.6. 
 
Subject Age Sex Smoker Diagnosis Culture 
Successful 
P10 71 M Y Squamous cell Ca Y 
P13 67 M Y Lung adenocarcinoma Y 
P15 61 M N Interstitial lung disease Y 
P16 60 F N Pleural fibroma Y 
P19 72 M N Interstitial lung disease Y 
Total      5 
 
Table 5.6 Demographic details of patients from whom primary nasal epithelial cells 
were obtained for TLR9 stimulation experiments  
 
Cells were extracted and cultured as described in the Materials and Methods 
section. After confluence was achieved, cells were washed and incubated for 24 
hours with vehicle only (medium), CpG-C or the inhibitory oligonucleotide - 
ODN TTAGGG human TLR9 signaling inhibitor (InvivoGen, San Diego, 
California). The inhibitory ODN TTAGGG chosen belongs to the telomeric class 
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of inhibitory oligonucleotides, is a 25 mer, and its full sequence is as follows:  
5’-TTT AGG GTT AGG GTT AGG GTT AGG G-3’. 
 
The experiments were designed using two models: a non colonisation model and 
a colonisation model trying to mimic the physiological situation.  In the non-
colonised model cells received vehicle (culture media only) for 24 hours and  
were then challenged with CpG-C, LPS and LTA for a further 24 hours. In the 
model of colonisation, the cells were primed with CpG class C for 24 hours and 
then challenged for a further 24 hours with CpG-C, LPS, LTA or the inhibitory 
oligonucleotide (ODN). I was also keen to assess the effects that the inhibitory 
ODN could have on the cells and also included wells in which the cells were 
primed with ODN. After a total of 48 hours, cell-free supernatants were removed 
and stored at -80oC until processed using the Becton Dickinson CBA Human 
Inflammation kit as per the manufacturer’s instructions. Cell lysates were 
processed for total protein measurement using the Pierce assay as described in 
the Materials and Methods section. Cytokine concentration in supernatant was 
normalised to lysate protein content for each individual sample. 
 
5.4.1.1. IL-8 and IL-6: 
Median constitutive levels of IL-8 secretion in primary human nasal epithelial 
cells were 2984 pg/mg of protein (range: 362  - 26458 pg/mg of protein) and 
1173 pg/mg of protein (range: 18.4 - 2761 pg/mg of protein) for IL-6.. These 
levels are approximately 10 and 40 fold higher respectively in comparison to the 
 237 
24 hour time point experiments described in Chapter 4 section 4.2.5.1.2 page 
173. This could be related to the longer time point as secreted cytokine 
accumulates in supernatant. 
Priming with CpG-C was not associated with an increase in the secretion of IL-8 
or IL-6 after further challenge of the cells with CpG-C, LPS or LTA. However, 
secretion of these cytokines appeared to have responded to down-regulation of 
TLR-9 as seen by a decrease in the secretion of these cytokines after stimulation 
with the inhibitor ODN. 
 
 
5.4.1.2. IL-1β, IL-10, TNF-α and IL-12p70: 
Median constitutive levels of IL-1β, IL-10, TNF-α and IL-12p70 appeared 
unchanged from the levels reported in the experiments at 24 hours described in 
Chapter 4, (section 4.2.5.1.2). 
Priming with CpG-C at 24 hours was not an associated increase in the secretion 
of the above mentioned cytokines upon further challenge with CpG-C, LPS and 
LTA, although a decrease in the secretion of these cytokines was observed after 
challenge with ODN in some of the patient’s cells. 
 
5.4.2. Cytokine response after stimulation of TLR9 in primary type II 
alveolar epithelial cells : 
 
Primary human type II alveolar epithelial cells were obtained from consented 
patients as described in the Materials and Methods section. Lung specimens were 
processed as described in the Materials and Methods section and single cells 
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were cultured onto type I collagen-coated plastic ware. All experiments were 
performed at passage 1. For a list of the subjects from whom primary cells were 






Final diagnosis Smoker Cultures 
Successful 
8  63 F L Single lung metastasis 
from malignant Melanoma 
N Y 
9 64 F L Squamous cell Ca Y Y 
12 60 F M Non small cell lung Ca Y Y 
14 77 F RL Lung Adenocarcinoma N Y 
Table 5.7 Demographic details of patients from which primary type II alveolar 
epithelial cells were obtained for assessment of TLR9 function 
 
 
After achieving confluence monolayers were washed and treated in the same way 
as previously described for primary nasal epithelial cells. Experiments were 
designed using the colonised and non-colonised models as explained in the 
previous section. Cells were stimulated with TLR ligands, and cell-free 
supernatants were removed and stored at -80oC until analysed. Supernatants were 
processed using the Becton Dickinson CBA Human Inflammation kit as per the 
manufacturer’s instructions. Monolayers were lysed and processed for total 
protein measurement using the Pierce method. 
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5.4.2.1. IL-8, IL-6 and IL-10: 
Median constitutive levels of IL-8 in primary human type II alveolar epithelial 
cells were 14379 pg/mg of protein (range: 286 - 84309 pg/mg of protein) after 48 
hours in culture. These levels are increased by approximately a 6 fold in 
comparison to the experiments performed at 24 hours in Chapter 4, section 
4.2.5.2.2, page 176 during which, stimulation with CpG-C was associated with a 
significant increase in IL-8 secretion. Priming with CpG-C was associated with a 
slight increase in the secretion of IL-8 after challenge with CpG-C and LTA, 
whereas this was not observed after LPS challenge. Challenge with CpG-
C+ODN induced a decrease in IL-8 secretion.  
 
Median constitutive levels of IL-6 in primary human type II alveolar epithelial 
cells were 944 pg/mg of protein (range: 9.5 - 2715 pg/ mg of protein) at 48 
hours. These levels are increased by approximately  3 fold in comparison to the 
24 hour experiments (Chapter 4, section 4.2.5.2.2). Priming with CpG-C was not 
associated with an increase the secretion of IL-6 after being challenged with 
CpG-C, LPS or LTA; inhibition of TLR9 by ODN was associated with a 
decrease in the secretion of IL-6. 
  
Median baseline levels of IL-10 in primary human type II alveolar epithelial cells 
were 1088 pg/mg of protein (range: 9 – 1504 pg/mg of pr tein) at 48 hours. 
These levels appear greatly increased by approximately  70 fold in comparison 
to the 24 hour experiments described previously (Chapter 4, section 4.2.5.2.2). 
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Stimulation with CpG-C was associated with an increase in the secretion of IL-
10 into supernatant. Priming with CpG-C produced variable results after 
challenge of the cells with TLR ligands. Challenge with the TLR9 inhibitor ODN 
was associated with a decrease in the secretion of IL-10.  
 
 
5.4.2.2. IL-1β, TNF-α and IL-12p70: 
Median constitutive levels of IL-1β, TNF-α and IL-12p70 in primary type II 
alveolar epithelial cells remained equivalent from the 24 hour time point as 
described in Chapter 4, section 4.2.5.2.2.  Priming with CpG-C was not 
associated with an increase in cytokine secretion. However, incubation with the 
TRL9 inhibitor ODN showed a slight decrease in the secretion of the above 
mentioned cytokines. 
 
5.4.3. Comparison in the cytokine response between human primary 
nasal and lung epithelial cells to TLR9 stimulation and 
inhibition: 
 
One of the main objectives of this research was to assess the differences in the 
response between cells from different compartments within the respiratory tract. 
In the following data, I will be comparing the cytokine production by cells from 
the upper respiratory tract (nasal) to cells from the lower respiratory tract 
(alveolar), when subjected to the same experimental conditions. The response 
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between unstimulated, TLR9-stimulated (CpG-C primed) cells and TLR9 
inhibited (ODN TTAGGG primed) cells will be examined. 
 
5.4.3.1. IL-8 and IL-6: 
Median constitutive IL-8 production of this cytokine was higher in primary type 
II alveolar epithelial cells; which appeared to increase the secretion after 
incubation with CpG-C, although not in a statistically significant manner. 
Inhibition of TLR9 after incubation with the oligonucletide inhibitor ODN was 
associated with a decrease in IL-8 secretion.  
Primary nasal epithelial cells appeared more refractive to stimulation with a 
TLR9 agonist. However, inhibition of TLR9 with ODN was associated with a 
decrease in IL-8 secretion. 
  




Surprisingly, the type II primary human alveolar epithelial cells produced median 
constitutive levels of IL-10 that were higher in comparison to primary nasal 
epithelial cells. In response to stimulation of TLR9 the levels of IL-10 secreted 
by lung epithelial cells increased in comparison to primary nasal epithelial cells 
in which median levels of IL-10 secreted into supernatant remained unchanged. 
Inhibition of TLR9 after incubation with the ODN was associated with decrease 
in the secretion of this cytokine which appeared more marked in type II alveolar 
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cells in comparison to primary nasal epithelial cells in which IL-10 levels 
remained unchanged. 
 
5.4.3.3. TNF-α, IL-1β and IL-12p70: 
The constitutive production of TNF-α, IL-1β and IL-12p70 by human primary 
cells of the upper and lower respiratory tract was similarly low. Upon stimulation 
of these cells with a TLR9 agonist, there were modest increases in the production 
of TNF-α and IL-1β in both cell types. In contrast, TLR9 stimulation had no 
effect in IL-12p70 secretion.  
Inhibition of TLR9 with the inhibitor ODN was not associated with changes in 
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1.6 (1.1 – 
6.6) 
 
1.8 (1.7 – 
3.5) 
 
1.6 (0.7 – 
7.8) 
 
3 (1.8 – 5.2) 
 
4.9 (4 – 7.6) 
 
2.4 (0 -10.4) 
 
 
Table 5.8 Summary of cytokine responses by primary nasal and type II alveolar epithelial 










I tried to make my project as translational as possible, therefore I spent the first 
two years designing the tools and optimising techniques and experiments with 
cell lines in order to try these in primary cells in an attempt to bring science as 
close to the bedside as possible. Nevertheless, despite a considerable effort, it 
became obvious that translation of science is a highly complex and inevitably 
slow process. As a result, some of the observations described in this chapter 
although novel, have the main limitation of not being a representative sample of 
the population since the numbers of subjects studied are rather small and 
definitive assumptions can not be made for some of the experiments. 
Nevertheless, these observations could constitute pilot data for follow up studies 
in the future. 
 
Current medical practice has advanced greatly. As aresult patients with diseases 
that used to be thought of like a “death sentence” now live longer. Parallel to 
these advances our internal bacterial reservoir has also adapted and evolved to 
the new challenges during this symbiotic relationship. As a result, new 
treatments introduced by medicine into man have also been followed by the 
adaptation of microorganisms to these new “environme tal” conditions and we 
are now facing the threat of increasing antimicrobial resistance. One of the most 
relevant organisms involved in this transition is Staphylococcus aureus, which 
as discussed earlier has successfully developed antimicrobial resistance and 
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strains with the methicillin resistance gene (mecA) are now implicated in 
infections in the hospital as well as in the community setting (Woodford, N., and 
Livermore, D., 2009).  The main reason why this bacterium represents a real 
threat to current clinical practice is because of its ability to colonise humans. 
The molecular mechanisms involved in colonisation are just starting to emerge. 
Some of the studies emphasise bacterial factors, but the specific role of the 
epithelium - particularly the nasal epithelium which is its main niche - has 
somehow been ignored. 
 
In this study, I found 16 subjects (34%) colonised with Staphylococcus aureus in 
the anterior portion of the nose, in accordance with the current literature 
(Gordon, R., and Lowy, F., 2008; Van,Belkum, A., 2006 and Wertheim, H., et al, 
2005). I did not establish the pattern of colonisation (permanent, transient or non-
colonised), since that is out of the scope of this re earch. The bacterial 
identification process was performed identifying colony morphotypes plated in 
duplicate to avoid error. Predominant morphotype colonies were subcultured 
further and tested for Staphylococcal markers. Staphylococcus aureus 
identification was performed using two different methods in all the predominant 
morphotypes recovered from nasal swabs. While these methods were not 
exhaustive, they are in accordance with current stadard operating procedures for 
the identification of S. aureus (HPA SOP, 2007). In the colonised group, there 
was one patient in which a beta-haemolytic Streptococcus species was isolated 
from a nasal swab. 
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It is important to mention that in 4 colonised subjects, S. aureus was the 
predominant bacterial morphotype isolated during bacteriological culture, 
whereas non-colonised subjects had more than two morphotypes isolated with 
predominance of Micrococcus species. This finding suggests that Micrococcus 
could have a protective role in the nasal epithelium by competing against S. 
aureus strains. Bacterial competition for the niche has been highlighted in the 
study by Dall’Antonia, M., et al, 2005, in which they showed that there is 
competition between methicillin-sensitive (MSSA) and methicillin-resistant 
Staphylococcus aureus (MRSA) strains in the anterior portion of the nose among 
a group of 680 patients in London. Furthermore, the rol  of bacterial interference 
in relation to S. aureus colonisation has also been studied when Shinefield, H., et 
al, 1963 observed that inoculation with a non-pathogenic strain of S. aureus 
(strain 502A) protected neonates from colonisation with a pathogenic S. aureus 
strain (phage type 80/81). In addition, other bacteria such as Lactobacillus spp 
and Corynebacterium spp have proven to successfully interfere with S. aureus 
colonisation in an animal model as well as in human c rriers (Gan, B., et al, 2002 
and Uehara,Y., et al, 2000). 
 
 
Primary human nasal epithelial cells were obtained by gentle brushing of the 
medial aspect of the inferior turbinate. In order to ascertain the phenotype of the 
cells extracted, flow cytometry was performed demonstrating that the dominant 
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population (median: 75%) were EpCAM positive cells, negative for CD14, 
CD16 and CD3, and highly likely to represent epithel um, followed by CD16 
positive cells likely to be neutrophils, and CD14 positive cells likely to be 
monocytes/macrophages. A very small proportion of CD3 positive cells assumed 
to be lymphocytes were identified in some volunteers. It is important to note that 
these markers are not strictly exclusive of the cell types mentioned since CD16 
can be found is subsets of monocytes and natural killer cells, and mucosal 
immune cell subsets can express EpCAM at a low level. This data agrees with 
the data published by Ramanathan, M., and Lane, A., (2007) who compared 
nasal brushings with ethmoid mucosa specimens for the isolation of primary 
nasal epithelial cells and showed by flow cytometry that brush biopsy specimens 
contained 75% epithelial cells.  
 
When we tried to establish a relationship between the different cell populations 
recovered from nasal brushing specimens and nasal colonisation with S. aureus 
an attempt was made to determine whether colonised subjects had an increased 
neutrophil count in nasal brushings. The results indicate that colonised 
individuals have a slightly higher proportion of neutrophils in their nasal mucosa 
in comparison to non-colonised subjects, although the difference was not 
statistically significant, probably due to the small size of the sample studied. The 
study by Cole, A., et al, 1999 showed that concentrations of neutrophil-derived 
host defence peptides were significantly elevated in nasal fluid from carriers of S. 
aureus in their nasal mucosa, suggesting that neutrophil recruitment happens in 
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response to nasal colonisation. They also mention that light microscopy 
examination of the nasal fluid with Wright’s stain confirmed that neutrophils 
were present in carrier and acute rhinitis donor fluids but not in fluid from 
normal donors. 
 
I then went on to assess the cytokine response to TLR ligands during nasal 
carriage of S. aureus. It appears that the presence of this bacterium in vivo 
“primes” the cells in vitro (and for a considerable amount of time after isolati n) 
toward a pro-inflammatory phenotype. Constitutive levels of IL-8, IL-6 and IL-
1β were significantly higher in association with nasal carriage. This response was 
enhanced further after stimulation with ligands predominantly from S. aureus 
such as peptidoglycan. Stimulation with the pro-inflammatory cytokine TNF-α 
was also associated with a rise in secretion of IL-8, IL-6 and IL-1β. It was also 
noted that constitutive levels of these cytokines wre higher in healthy volunteers 
in comparison to patients’ cells probably due to volunteers being younger and 
non-smokers. Smoking itself has been associated with alterations in TLRs 
expression in respiratory epithelial cells, which could account for the differences 
in the cytokine responses observed between non smokers and smoker subjects 
(MacRedmond, R., et al, 2007). Their cells appeared to respond in a more 
efficient manner in comparison to patients’ cells upon stimulation with PGN and 
TNF-α. The high constitutive production of primarily pro-inflammatory 
cytokines such as IL-8, IL-6 and IL-1β in supernatants from subjects colonised 
with S. aureus reveals that although colonisation appears to behave in an 
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asymptomatic manner, at epithelial level there is increased inflammation even 
after a relatively long period of time ex-vivo in the cells. Data published by 
Ramanathan, M., and Lane, A., 2007, comparing the expression of immune 
markers in primary nasal epithelial cells studied acutely or after six weeks in 
culture showed that primary epithelial cells maintai  their innate immune 
receptor expression profile and that alterations in innate immune gene expression 
may be intrinsic to the individual set of epithelial cells. Although my study only 
shows the response of epithelial cells sampled once, all experiments were 
performed at passage 2 and median time to reach confluence prior to performing 
an experiment was 3 weeks. Therefore, although the cells were grown ex-vivo, 
they were used in experiments in conditions as close as possible to their original 
precursors in order to avoid confounding factors due to multiple passages.  The 
study by O’Brien, G., et al (2006) compared primary nasal epithelial cultures in 
asthmatic patients to healthy donors, and found that asthmatic patients produced 
significantly higher IL-8 secretion levels in cell culture supernatants. Priming of 
the cells with the pro-inflammatory cytokine IFN-γ was associated with a further 
increase in the secretion of IL-8. In addition, they also exposed the cells to S. 
aureus enterotoxins A an B at non-toxic concentrations and observed an 
associated increase in the production of IL-8, while they found no differences in 
TNF-α, RANTES and eotaxin production. Asthma is considere  an inflammatory 
disease of the airways caused by hypersensitivity mediated by IgE, associated 
with an increase in local cytokines and infiltration of the epithelium by 
eosinophils, basophils and TH2 cells. It is likely that the pro-inflammatory 
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environment associated with the disease itself had greatly influenced the 
responses observed ex-vivo. 
  
Viral infections have been associated with exaggerated IL-8 and IL-6 responses 
in airway epithelium-like NCI-H292 cells. Roger, T., et al, 2004, they observed 
that parainfluenza virus type 4a (PIV-4a) enhances production of IL-8 and IL-6 
in airway cells by increasing the DNA-binding activity for the transcription 
factors NF-κB and CCAAT-enhancer binding protein (C/EBP). This appears to 
be the cause of the first peak in the cytokine secretion, whereas the second peak 
appears to be related to a reduction in IL-8 and IL-6 degradation. These factors 
have been considered to play an important role in the virus-induced potentiation 
of inflammation in the airway epithelium. Furthermore, in the study by Lopez-
Souza, N., et al, 2004, using primary nasal epithelial cultures, an increase in the 
output of IL-8 and IL-6 following rhinovirus infection was observed. This was 
also associated with an increase in mRNA levels for these cytokines, which 
correlated with levels of viral mRNA. 
 
Further evidence for epithelium acting as a surveillance organ in establishing an 
adaptive immunological response was provided by Ritz, H., and colleagues 
(1984) when they found an association with high serum titres of antibodies to 
Staphylocococcal toxic shock antigen (TSA) in subjects colonised with a TSA-
producing strain of S. aureus. More recently, Verkaik, N., et al, 2010, have 
published a study in which they followed 57 children from birth to 2 years of 
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age. They found that IgG and IgA levels against S. aureus proteins were 
significantly higher among children colonised with S. aureus. 
 
Taken together, these findings suggest that nasal colonisation with S. aureus, far 
from being a silent process, is the result of successful innate as well as adaptive 
immune responses in order to contain the infection by this pathogen. 
Furthermore, some evidence suggests that the developm nt of antibodies against 
S. aureus strains has a protective role (Wertheim, H., et al, 2004). 
 
It was also noted that the cells did not respond to stimulation with LPS or LTA, 
this is probably due to the physiological down-regulation of the specific 
receptors involved in their recognition as described previously in Chapter 3. 
 
There were no major changes in the basal production of TNF-α, IL-10 or IL-
12p70, although patients’ cells displayed slightly higher constitutive levels of 
these cytokines in supernatant in comparison to healthy volunteers’ cells. The 
very low levels of IL-12p70 are probably associated with the purity of the 
cultures since this cytokine is predominantly produced by macrophages and 
dendritic cells. 
 
It is important also to highlight that the results were obtained using monolayers 
submerged in culture, which are associated with poor differentiation. Although 
my study is in accordance with the current published literature, ideally it would 
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be desirable to have grown the cells at an air-liquid culture interface and 
although it was not possible for this study, it could be achieved in the future. 
 
The negative regulator of the TLR signalling pathway tollip did not appear to 
have a significant role in relation to nasal colonisation with Staphylococcus 
aureus.. 
 
The presence of TLR9 was demonstrated earlier during this work in primary 
cells of the upper as well as the lower respiratory ract (sections 4.2.5.1 page 171 
and 4.2.5.2, page 174 respectively).  The first repo t in the literature of the effects 
of bacterial DNA in the lower respiratory tract was from Krieg’s group in 1997, 
three years prior to the discovery of TLR9 by Akira’s group (Hemmi, H., et al, 
2000). They found that bacterial DNA is pro-inflammatory when compared to 
eukaryotic DNA and these effects are independent of endotoxin contamination.  
Furthermore, the effects were significantly reduced by DNA methylation. They 
recovered DNA from the sputum of patients with cystic fibrosis and after 
intratracheal instillation of 50µg of this DNA in the lower respiratory tract of 
mice were able to reproduce acute pulmonary inflammtion given by the increase 
in the concentration of total cells and neutrophils in lavage fluid. A previous 
report also by Krieg’s group showed that mice pre-treated with bacterial DNA 
had much higher mortality when challenged with LPS probably due to an IFN-γ 
mediated mechanism (Cowdery, J., et al, 1996).   
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The study by Platz, J., et al, 2004, found that TLR9 is expressed in airway 
epithelium. TLR9 mRNA levels were relatively low incomparison to those in 
the human B cell lymphoma cell line Raji. They observed up-regulation of the 
pro-inflammatory cytokines IL-6 and IL-8 which appear d to be related to an 
increase in NF-κB dependent activity. 
 
The role of TLR9 during the development of bacterial pneumonia has been 
studied by Albiger, B., et al (2007) and Bhan, U., and colleagues in 2008. Both 
studies conclude that TLR9 is essential for the successful clearance of bacteria 
within the lungs. The latter study suggested that compartmental pre-treatment 
with a synthetic TLR agonist can stimulate protective nnate immunity during 
infection with the Gram negative Legionella pneumophila. 
 
Since CpG oligonucleotides are currently being considered as potential vaccine 
adjuvant candidates, and having shown previously that their main action appears 
to be increasing the secretion of IL-8 predominantly in primary type II alveolar 
epithelial cells (whilst secretion of IL-6 and IL-10 remained unchanged), I 
wanted to explore how upper and lower respiratory tract cells would respond 
when TLR9 activators or inhibitors were used either as priming agents 
(colonisation experiments) or administered simultaneously with CpG-ODN. 
 
High constitutive secretion of IL-8 and IL-6 by primary nasal epithelial cells was 
observed during the colonisation experiments. This could reflect accumulation of 
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these cytokines in cultured supernatant since the tim course of the experiments 
was doubled in comparison to the experiments shown in section 4.2.5.1.2 (page 
173).  
My experiments suggest that the nasal epithelial response to TLR9 activation is 
likely to be dependent on other local inflammatory factors and that in an attempt 
to control an undesirable inflammatory response local y, the nasal epithelium 
could behave in an anergic manner. Nevertheless, the incubation with the TLR9 
inhibitor ODN TTAGGG was associated with a decrease in the secretion of IL-8 
and IL-6 in cultured supernatant.  
 
During the quest for the answer to the immune effects of DNA dichotomy (i.e. 
bacterial DNA being stimulatory and mammalian being hibitory) Pisetsky’s 
group noted that synthetic oligonucleotides that contain poly-G sequences could 
block bacterial DNA-induced activation (Halpern, M., and Pisetsky, D., 1995).  
Furthermore, the inhibitory sequences were over-expessed in certain strains of 
adenovirus (Krieg, A., et al, 1998). Further work established that the CpG motif 
itself is not required for inhibition, but that three consecutive G nucleotides are 
necessary for inhibition and that the length of the oligonucletide itself is one of 
the main determining factors contributing to the activity. Currently, inhibitory 
ODNs are classified as class B-broadly active, R-restricted activity or G-
telomeric. For a detailed explanation of the characteristics of each class please 
refer to Lenert, P., 2010. 
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The inhibitory oligonucleotide that I chose to use in my study belongs to the 
telomeric class. It is known that the ends of linear ukaryotic chromosomes have 
specialised DNA protein structures called telomeres. These telomeres contain 
large numbers of single-stranded hexanucleotide repeats of the sequence 
TTAGGG, which physiologically protect mammalian chromosomes from 
degradation (Gursel, I., et al, 2003; Blasco, M., et al, 1999). Moreover, whilst 
telomeric-rich G repeats are present at high frequency in the genomes of 
eukaryotes, they are extremely rare in bacteria and it is likely that during 
evolution this mechanism was selected as a manner to differentiate host versus 
foreign DNA. Furthermore, the presence of these sequences could be available in 
high local concentrations in tissues following the d ath of host cells and this 
could be a mechanism for limiting immune activation after cellular death in 
tissues. The study led by Gursel, demonstrates that repetitive TTAGGG motifs 
down-regulate the response to CpG DNA by blocking the co-localisation of CpG 
DNA with TLR9 in endosomal vesicles. TTAGGG multimers inhibited all forms 
of CpG-induced immune activation including the stimulation of B lymphocytes, 
dendritic cells and macrophages. Mammalian telomeres are not the only 
sequence motifs with suppressive properties. Althoug  they claim that they are 
non toxic, they also say that they did not inhibit mitogen- or LPS-induced 
immune activation. They did not prevent the binding or uptake of CpG DNA by 
immune cells. They interfered with the maturation of endosomal vesicles and the 
colocalisation of CpG DNA with TLR9 in the vesicles. Other studies have shown 
that very early events in CpG-mediated signalling (NF-κB translocation) are 
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inhibited by suppressive ODN (Yamada, H., et al, 2002; Lenert, P., et al, 2001). 
In vivo, suppressive ODN blocked CpG-induced cytokine production by more 
than 75% (Gursel, I., et al, 2003). 
 
When studying type II alveolar epithelial cells in the colonisation experiments it 
was also possible to observe high constitutive levels of IL-8, IL-6 and IL-10. 
Constitutive secretion of these cytokines has been r ported previously and is 
probably related to the role that the alveolar epithel um plays in surveillance 
against foreign and potentially dangerous particles/microorganisms. The high 
levels in these experiments could also reflect an accumulation of these cytokines 
in cultured supernatant as a result of the longer time of incubation that the 
experiments took (48 hours) in comparison when the experiments performed at 
24 hours as seen in section 4.2.5.2.2 (page 176). The response of these cells to 
TLR9 stimulation was quite different; CpG-C stimulation of these cells was 
followed by an increase in the median secretion predominantly of IL-8, although 
IL-6 and IL-10 also displayed an increase in their median secretion. Furthermore, 
incubation with the inhibitor ODN was associated with a decrease of the 
secretion of these cytokines. 
 
The study by El Kebir, D., et al, 2009, looked at the activation of HUVEC cells 
by bacterial DNA and observed it to be a potent amplifier of the inflammatory 
response. In addition, they also observed that unmethylated CpG motifs evoked 
endothelial cell activation associated with increased nuclear translocation of NF-
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κB and subsequent up-regulation of adhesion molecules such as ICAM-1 and E-
selectin. Their study coincides with mine in that they also used a telomeric ODN 
with the same sequence used in my study (TTAGGG) which as described before 
has the ability to diffuse into cells and disrupt the co-localisation of CpG DNA 
with TLR9 in endosomal vesicles, therefore affecting cellular uptake. They 
observed a significant decrease in the production of IL-8 after priming with the 
inhibitory ODN followed by challenge with CpG DNA. They also found that the 
inhibitory ODN produced a higher degree of inhibition of TLR9-mediated NK-
κB activation in HUVECs than the endosomal acidification inhibitors used.  
 
The study published by Trieu, A., et al, 2009 demonstrated that inhibitory ODN 
2114 amplifies the intracellular Salmonella typhimurium load in mouse bone 
marrow-derived macrophages in a TLR9-independent manner. They also found 
that although its activity did not interfered with bacterial LPS (TLR4) or 
zymosan (TLR2/6/Dectin-1) responses, it partially suppressed the response to the 
bacterial lipoprotein analogue Pam3Cys (TLR1/2), as well as to the TLR7 agonist 
R837. Since TLR2 is required for the response to S. typhimurium, they conclude 
that it is likely that inhibitory ODN interferes with the host antimicrobial 
response by suppressing TLR2. A report by Stacey, K., et al, 2003, also 
demonstrated that ODN 2114 potently inhibited CpG-mediated activation of a 
NK-κB reporter in RAW264 murine macrophages.  
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These reports coincide with my findings in that, ODN TTAGGG incubation was 
associated with decreased secretion of IL-8 and IL-6 in primary nasal epithelial 
cells as well as a trend toward decrease predominantly in the secretion of IL-8, 
IL-6 and IL-10 in primary type II alveolar epithelia  cells. These findings were 
consistent whether cells were only primed with ODN or if they were also 
challenged with CpG-C simultaneously; further studies need to look further into 
this observation. Whilst most studies published to ate have produced evidence 
for the role of this inhibitory ODN in cells of the innate immune system 
(macrophages, dendritic cells and lymphocytes), this report highlights the 
potential deleterious effects that TLR9 inhibition could have on the host 
immune’s response if TLR9 is inhibited at epithelial level since it could 
predispose the host towards an increasing risk of invasive Gram positive 
bacterial infections if these molecules were to be administered locally in the 
respiratory epithelium. 
 
Although the differences in the responses of both types of epithelial cells appear 
genuine, they lack statistical significance probably due to the low numbers of 











Subject Colonies Catalase Staphytect plus Tube coagulase 
Colonisation 
status Micrococci 
       
1 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
2 3 pos/pos/pos neg/neg/pos neg/neg/pos Positive high  
3 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative  yes 
4 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
5 4 pos/pos/pos/pos neg/pos/pos/neg neg/pos/pos/pos Positive-high  
6 (P1) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
7 (P2) 2 pos/pos neg/neg neg/neg Negative  
8 3 pos/pos/pos pos/pos/neg pos/pos/neg Positive - high  
9 (P3) 5 neg/pos/pos/pos/pos n/a/neg/neg/pos/neg n/a/neg/neg/pos/neg Positive yes 
10 2 pos/pos pos/neg pos/neg Positive - high  
11 2 pos/pos neg/neg neg/neg Negative  
12 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
13 (P4) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
14 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
15 1 pos pos pos Positive - high  
16 4 gnb/pos/pos/pos n-a/pos/neg/pos n-a/pos/neg/pos Positive yes 
17 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
18 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
19 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative yes 
20 (P5) 3 pos/pos/pos pos/neg/neg pos/neg/neg Positive  
21 (P6) 3 pos/pos/pos pos/neg/neg pos/neg/neg Positive  
22 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
23 4 pos/pos/pos/pos pos/pos/neg/neg pos/pos/neg/neg Positive yes 
24 (P7) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative  
25 (P8) 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative yes 
26(P9) 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative  
27 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative yes 
28 2 pos/pos pos/neg pos/neg Positive - high  
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29 (P10) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
30 2 pos/pos pos/pos pos/pos Positive  
31 5 gnb/pos/pos/pos/pos n-a/neg/neg/neg/neg n-a/neg/neg/neg/neg Negative yes 
32 4 pos/pos/pos/pos pos/neg/neg/neg pos/neg/neg/neg Positive yes 
33 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative  
34 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative  
35 1 pos pos pos Positive - high  
36 (P11) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative  
37(P12) 3 pos/pos/pos neg/neg/equivocal neg/neg/neg Negative  
38(P13)  3 pos/pos/pos neg/neg/neg neg/neg/neg Negative yes 
39(P14) N/A      
40(P15) 3 pos/pos/pos pos/neg/neg pos/neg/neg Positive yes 
41(P16) 3 pos/pos/pos neg/neg/equivocal neg/neg/neg Negative yes 
42(P17) 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative yes 
43(P18) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative  
44(P19) 5 neg/pos/pos/pos/pos n-a/neg/neg/neg/neg n-a/neg/neg/neg/neg Negative yes 
45(P 20) 4 pos/pos/pos/pos neg/neg/neg/neg neg/neg/neg/neg Negative yes 
46(P 21) 4 gnb/pos/pos/pos n-a/neg/neg/neg n-a/neg/neg/neg Negative yes 
47(P 22) 3 pos/pos/pos pos/pos/pos/neg pos/pos/pos/neg Positive  
48(P 23) 3 pos/pos/pos neg/neg/neg neg/neg/neg Negative  
 
 
Table 5.1 Results of bacterial identification in nasal swabs from healthy volunteers and patients.  

















      4 h  24 h   
HV 2 1 Large white colonies Positive Negative Negative Negative   
   Large grey colonies Positive Positive Positive Positive Positive 
  2 Large white colonies Positive Positive Positive Positive   
   Smaller grey colonies Positive Negative Negative Negative   
HV 3 1 Small white colonies Positive Positive?? Equiv Negative Negative Negative 
   Small grey colonies Positive Positive Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Large white colonies Positive Negative Negative Negative   
   Small grey colonies Positive Positive?? Equiv Negative Negative   
   Small white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 4 1 Large grey colonies Positive Negative Negative Negative Negative 
   Large white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Small white colonies Positive Negative Negative Negative   
   Large grey colonies Positive Negative Negative Negative   
   One yellow colony Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 5 1 Large yellow colonies  Positive Positive Positive Positive Positive 
   Small white colonies Positive Negative Negative Negative   
   Large grey colonies Positive Negative Negative Negative   
  2 Large yellow colonies  Positive Positive Positive Positive   
   Small white colonies Positive Negative Negative Negative   
   Large grey colonies Positive Negative Negative Negative   
HV 8 1 Large yellow colonies  Positive Positive Positive Positive Positive 
   Small white colonies Positive Negative Negative Negative   
   Small grey colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Contaminated       
HV 10 1 Large yellow colonies  Positive Positive Positive Positive Positive 
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  2 Large yellow colonies  Positive Positive Positive Positive   
   White colonies Positive Negative Negative Negative   
HV 12 1 Small grey colonies Positive Positive?? Equiv Negative Negative Negative 
   Yellow colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Grey colonies Positive Negative Negative Negative   
   Small white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 14 1 Large white colonies Positive Negative Negative Negative Negative 
   Large grey colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Large white colonies Positive Negative Negative Negative   
   Grey colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 15 1 Large yellow colonies  Positive Positive Positive Positive Positive 
  2 Large yellow colonies  Positive Positive Positive Positive   
HV 16 1 Large cream ? S. aureus Positive Positive Positive Positive Positive 
   Large green colony ?gnb  N/A N/A N/A   
   Middle size white colony  Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Large yellow colonies  Positive Positive Positive Positive   
   White colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 17 1 Large grey colonies Positive Negative Negative Negative Negative 
   Small white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Micrococci Positive Negative Negative Negative   
   Grey colonies Positive Negative Negative Negative   
   Large white colonies Positive Negative Negative Negative   
HV 18 1 White colonies Positive Negative Negative Negative Negative 
   Micrococci Positive Negative Negative Negative   
   Grey colonies Positive Negative Negative Negative   
  2 Micrococci Positive Negative Negative Negative   
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   White colonies Positive Negative Negative Negative   
   Grey colonies Positive Negative Negative Negative   
HV 22 1 Small grey colonies Positive Negative Negative Negative Negative 
   White colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Grey colonies Positive Negative Negative Negative   
   White colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 28 1 Yellow colony ?S.aureus Positive Positive Positive Positive Positive 
   White colonies Positive Negative Negative Negative   
  2 Large yellow colony Positive Positive Positive Positive   
   Large white colonies Positive Negative Negative Negative   
HV 30 1 Large yellow colonies ?S.aureus Positive Positive Positive Positive Positive 
   Small grey colonies Positive Equivocal Negative Negative   
  2 Large yellow colonies ?S.aureus Positive Positive Positive Positive   
   White colonies Positive Negative Negative Negative   
HV 31 1 Large mucoid colonies gnb  N/A N/A N/A   
   Grey colonies Positive Negative Negative Negative Negative 
   Yellow colonies Positive Negative Negative Negative   
  2 Mucoid colony ?gnb Positive Negative Negative Negative   
   Yellow colonies Positive Negative Negative Negative   
   White colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 32 1 Large yellow colony ?S.aureus Positive Positive Positive Positive Positive 
   White colonies Positive Negative Negative Negative   
   Alpha-haemolytic Strep Negative N/A N/A N/A   
  2 Large yellow colony ?S.aureus Positive Positive Positive Positive   
   White colonies Positive Positive Positive Positive   
   Micrococci Positive Negative Negative Negative   
HV 33 1 Yellow colony ?S.aureus Positive Negative Negative Negative Negative 
   Large white colonies Positive Negative Negative Negative   
   Large grey colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
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  2 Large grey colonies Positive Negative Negative Negative   
   Large white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 34 1 Large yellow colonies ?S.aureus Positive Negative Negative Negative Negative 
   Small grey colonies Positive Negative Negative Negative   
   Small white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
  2 Large yellow colonies ?S.aureus Positive Negative Negative Negative   
   Grey colonies Positive Negative Negative Negative   
   Small white colonies Positive Negative Negative Negative   
   Micrococci Positive Negative Negative Negative   
HV 35 1 
Single dominant yellow col 
?S.aureus Positive Positive Positive Positive Positive 
  2 
Single dominant yellow col 
?S.aureus Positive Positive Positive Positive   
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